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 La fibromialgia es una enfermedad crónica, de causa actualmente desconocida, que se 
caracteriza por la presencia de dolor músculo-esquelético generalizado, asociado a una serie de 
puntos dolorosos específicos que nos ayudan a su diagnóstico (Wolfe et al., 1990). Con 
frecuencia se asocia con fatiga crónica, alteraciones del sueño, rigidez matutina, alteraciones del 
estado de ánimo (ansiedad y depresión), cefaleas, problemas en la menstruación, dolor 
temporomandibular y síndrome del intestino irritable. Esta enfermedad afecta a la esfera 
biológica, social y psicológica del paciente, llegando incluso a provocar invalidez en 
determinados casos (Wolfe et al., 1990). 
La frecuencia de esta enfermedad se sitúa en torno al 2-3% de la población (Wolfe et al., 
1995), por lo que en España se estima que el número de afectados se sitúa entre 800.000 y 
1.200.000 individuos. De hecho, la prevalencia de la fibromialgia en las consultas de 
reumatología es del 12% (2,2% en hombres y 15,5% en mujeres) (Valverde et al., 2000). Debido 
a la alta prevalencia, el enorme impacto clínico que la enfermedad produce sobre el paciente a nivel 
de discapacidad y pérdida de calidad de vida y el elevado gasto sanitario que genera, la fibromialgia 
es uno de los principales problemas sanitarios de los países occidentales en la actualidad.  
El dolor es el síntoma más frecuente e incapacitante en fibromialgia. El origen de la 
hiperalgesia en la fibromialgia es poco conocido. Se sospecha que existe una alteración en el 
funcionamiento de las estructuras neurobiológicas centrales. La neurofisiología del proceso 
doloroso ha presentando los últimos años un incremento de interés y diferentes métodos de 
neuroimagen, como el PET (Mountz et al., 1995), SPECT (Kwiatek et al., 2000), resonancia 
magnética funcional (García-Campayo et al., 2001) y más recientemente espectroscopia, difusión y 
tensor-difusión por resonancia magnética, identificando estructuras cerebrales que son activadas 
durante condiciones de dolor en pacientes y controles (Cook et al., 2004). Estas estructuras 
incluyen la corteza primaria y secundaria sensitivo-motora, la ínsula, el cíngulo anterior, tálamo, 
corteza prefrontal dorso-lateral y los ganglios basales. Estas regiones han sido denominadas “la 
matriz del dolor”, siendo activadas en respuesta a un estímulo doloroso.  
El dolor se considera una experiencia compleja y subjetiva, en la que los aspectos 
afectivos y cognitivos son cruciales en el pronóstico del paciente. Aún en el presente, existe una 
gran investigación que continúa tratando de entender los factores claves psicológicos y 
conductuales que influyen de una manera relevante en el desarrollo y la perpetuación del dolor y 
en la incapacidad asociada éste. Los primeros trabajos se centraron en los factores de 
personalidad, ya que se pensó que estaban asociados con la intensidad y persistencia del dolor 
(Bulmer y Heilbronn, 1982; Gentry et al., 1974). Algunos factores propuestos fueron la evitación 
emocional, la excesiva preocupación por los síntomas somáticos o mostrar características 
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asociadas con una “personalidad depresiva”, tales como el pesimismo. Las relaciones entre dolor y 
afecto continuó siendo un área primaria de investigación en laboratorio y estudios clínicos tratando 
de especificar objetivos para el tratamiento psicológico. La perspectiva cognitivo conductual, tuvo 
una gran importancia para alentar a la investigación e identificar los factores cognitivos concretos 
que correlacionaban de una manera positiva con la gravedad de dolor y la incapacidad (Turk et al., 
1983). Entre los factores que han mostrado una gran evidencia empírica están los constructos de 
auto-eficacia (Litt, 1988), estilos de coping (Jensen, 1994), miedo-evitación (Vlaeyen y Linton, 
2000; 2006), rendición (Tang et al., 2007), injusticia (Sullivan et al., 2008) o catastrofismo (Sullivan 
et al., 2001; Turner y Aaron, 2001). En la actualidad, otros constructos psicológicos 
complementarios han sido propuestos desde una perspectiva contextual cognitivo conductual; 
aceptación (McCracken et al., 2004), mindfulness (McCracken y Gauntlett-Gilbert, 2007), defusion 
(Masuda et al., 2009), acciones valiosas (McCracken y Yang, 2006) o flexibilidad psicológica 
(McCracken y Velleman, 2010). 
 Todos ellos han demostrado ser relevantes en el pronóstico de pacientes con dolor crónico 
pero son dos los que parecen más determinantes para prevenir la discapacidad y preservar la 
calidad de vida de los sujetos; el catastrofismo y la aceptación.  
El catastrofismo es entendido en la actualidad como un conjunto de procesos cognitivos y 
emocionales que predisponen a que el dolor se convierta en crónico (leeuw et al., 2007; Buenaver 
et al., 2008) que están implicados en una mayor percepción en la experiencia del dolor (Sullivan et 
al., 2001) y que además son una importante variable mediadora para el resultado del tratamiento 
(Smmets et al., 2006). Los individuos que catastrofizan esperan lo peor sobre su problema de dolor, 
analizan pormenorizadamente los síntomas de su dolor y refieren una gran indefensión cuando se 
trata de controlar el dolor. Además, muestran unos pobres resultados en su afrontamiento del dolor 
en comparación con aquellos otros que no presentan esas ideas inadecuadas. Principalmente, el 
catastrofismo está relacionado de manera significativa con una mayor intensidad del dolor, una 
mayor sensibilidad, ánimo depresivo, procesos inflamatorios y discapacidad.  
La escala utilizada para la medición del catastrofismo, es la Pain Catastrophizing Scale 
(PCS) (Sullivan et al., 1995), la cual presenta unas adecuadas propiedades psicométricas. Consta 
de tres subescalas; la magnificación, la rumiación y la indefensión. La rumiación se refiere a que el 
paciente no puede apartar de su mente el dolor, no puede dejar de pensar en él. La magnificación 
alude a la exageración de las propiedades amenazantes del estímulo doloroso, y la indefensión, a 
la estimación de la persona por no poder hacer nada para influir sobre el dolor. 
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Aunque los individuos alguna vez son dicotomizados como catastrofistas y no catastrofistas, 
la mayoría de la investigación entiende el catastrofismo como una variable continua que se 
distribuye normalmente (Sullivan et al., 2001). El catastrofismo también aparece como una variable 
continua en sujetos sanos y sin dolor; de hecho los sujetos sin dolor que muestran unas altas 
puntuaciones de catastrofismo, predicen el futuro desarrollo de dolor crónico y la demanda de 
servicios de la salud relacionados con el dolor (Picavet et al., 2002; Severeijns et al., 2004).  
Un área rica de debate se ha fundamentado sobre si el catastrofismo está mejor 
conceptualizado como un rasgo estable y duradero, tal y como una dimensión de personalidad, o 
como una característica modificable con evidencias que sustentan ambos supuestos. Por un lado, 
varios estudios demostraron que el catastrofismo tiende a ser estable con el paso del tiempo tanto 
en población sana como en sujetos con dolor, mostrando una gran fiabilidad test-retest medido a lo 
largo de semanas o meses (Sullivan et al., 1995; Keefe et al., 1989). Por otro, están los que 
sugieren que el catastrofismo aunque parece desarrollarse pronto en la vida y poseer muchas 
características estables tipo rasgo (Bedard et al., 1997), es también sensible de ser reducidas por 
tratamientos cognitivo-conductuales (Smmets et al., 2006), indicando que podría ser 
sustancialmente modificable.  
Entre las diversas líneas de investigación sugeridas para tratar de conocer los posibles 
mecanismos de acción la que tiene más peso hace referencia a que la expresividad del 
catastrofismo podría reflejar un enfoque común de afrontamiento del dolor (Sullivan et al., 2001). 
Dentro de este enfoque, se asume que los individuos,  en su esfuerzo para afrontar el estrés, se 
marcan diferentes objetivos interpersonales (Sullivan et al., 2000). Se sugirió que los individuos 
más catastrofistas podrían exagerar sus respuestas ante el dolor para que alguien esté cerca de 
ellos, pedir ayuda u obtener respuestas empáticas de otros en su medio social. El modelo 
formulado, “The Communal Coping Model” (Sullivan et al., 2001; Thorn et al., 2004) representa un 
marcado punto de partida desde los tradicionales marcos cognitivos, posicionando que los 
esfuerzos de afrontamiento de los individuos que experimentan dolor no están necesariamente 
dirigidos al manejo del dolor. En su lugar, se sugiere que para los catastrofistas, la experiencia del 
dolor podría proporcionar el marco para la búsqueda de los objetivos interpersonales. 
La Aceptación es uno de los constructos cognitivos más prometedores y mejor asentados 
en las terapias contextuales. Por lo general, los resultados hallados indican que las personas con 
una mayor aceptación del dolor refieren menor dolor, ansiedad, depresión, discapacidad y mayor 
nivel de actividad y mejor funcionamiento general (Vowles et al., 2007; McCracken y Eccleston, 
2003; McCracken et al., 2005). Y lo que es más importante, el nivel de aceptación no estaba en 
función del dolor, es decir, las personas no presentaban más aceptación porque tuvieran menos 
Resumen 
 
“AFFECTIVE AND COGNITIVE ASPECTS IN FIBROMYALGIA: THE ROLES  OF CATASTROPHIZING AND ACCEPTANCE” VII 
 
dolor (Vowles et al., 2008a). Otros estudios muestran que los sujetos que presentan una mayor 
aceptación son los que menos uso hacen de los centros de salud, toman menos medicación y 
presentan una mejor calidad de vida (McCracken et al., 2004). Por último, parece también que la 
aceptación es una variable que se relaciona con una mejor adaptación a la respuesta del dolor, sin 
importar las influencias que pudieran tener variables tales como la depresión, la intensidad del 
dolor o la ansiedad, y con una predicción superior que las estrategias de afrontamiento ante 
variables como el dolor, la depresión, la incapacidad, la ansiedad o el funcionamiento físico y 
psíquico (McCracken y Eccleston, 2003). 
Hasta la fecha, el Chronic Pain Acceptance Questionnaire (CPAQ) (McCracken et al., 
2004) es el cuestionario utilizado para medir el nivel de aceptación en el dolor. Consta de 20 items, 
dos subescalas (a) implicación en las actividades (cumplir con mis actividades a pesar del dolor); 
(b) aceptación del dolor (reconocimiento de que la evitación y el control son métodos 
impracticables en mi adaptación al dolor crónico); y presenta unas  condiciones de validez y 
fiabilidad apropiadas (Vowles et al., 2008b).  
Una última matización haría referencia a cómo entender el concepto de aceptación. Pese a 
que los sujetos con dolor crónico a menudo se muestran inicialmente reticentes ante dicho término 
porque lo entienden como una “rendición” o algo que conduce a un sentimiento de desesperación 
(Viane et al., 2004), la aceptación no se concibe como resignación y tampoco se trata de sustituir el 
control por la ausencia de control. Más bien el control se aplicaría selectivamente a aquello que es 
controlable. Se trataría de la aceptación de lo que no se puede cambiar en base a actuar hacia 
aquello que les importa en su vida.  
Pese a la relevancia que el catastrofismo y la aceptación parecen tener sobre el pronóstico 
del dolor crónico, sus respectivos cuestionarios no han sido validados en nuestro idioma y apenas 
han sido estudiados en la fibromialgia, uno de los trastornos de dolor crónico más frecuentes. Por 
tanto, validar en primera instancia sus cuestionarios y posteriormente conocer las influencias 
específicas del catastrofismo y la aceptación en la fibromialgia, nos permitirá dirigir los tratamientos 
psicológicos hacia los aspectos claves para mejorar la calidad de vida y el funcionamiento de 
pacientes con fibromialgia. 
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OBJETIVOS DEL ESTUDIO 
 
Los objetivos principales serán los siguientes: 
1. La validación en nuestro idioma, y para una muestra de pacientes diagnosticados de 
fibromialgia, de los principales cuestionarios para la medición del catastrofismo, Pain 
Catastrophizing Scale (PCS), y de la aceptación del dolor crónico, Chronic Pain 
Acceptance Questionnaire (CPAQ). 
2. Analizar si el Tratamiento Cognitivo-Conductual es eficaz para la reducción del 
catastrofismo y observar si la aplicación de una técnica en exposición en imaginación 
influye en la mejoría de la rumiación.  
3. Averiguar la relación entre el catastrofismo y la incapacidad de los pacientes en el 
desarrollo de la fibromialgia (desde su diagnóstico) y comprobar si alguno de los tres 
componentes del catastrofismo (rumiación, indefensión y magnificación) predice la 
incapacidad mejor que otros. 
4. Comprobar si los componentes de la aceptación (aceptación del dolor y disposición a las 
actividades) muestran una predicción superior que otras estrategias de afrontamiento 
conductuales ante variables como la intensidad del dolor, el número de síntomas, impacto 
de la fibromialgia, el funcionamiento físico y social, vitalidad, salud general, depresión o 
ansiedad. 
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APORTACIONES DEL DOCTORANDO 
1. La validación de dos de los cuestionarios más utilizados en todo el mundo, además, en una 
enfermedad tan prevalente como la fibromialgia, será de gran valor para supervisar la 
efectividad de los tratamientos. 
2. Llevar a cabo el primer estudio de reducción del catastrofismo en población con 
fibromialgia. Asimismo, valorar la aportación de una técnica (exposición en imaginación) 
que parece prometedora para la reducción del pensamiento rumiativo. 
3. Existen muchos estudios sobre factores de vulnerabilidad cognitivos asociados a la 
incapacidad de los pacientes. Esta investigación nos permitirá además conocer la 
vulnerabilidad debida a los factores contextuales. 
4. Los resultados nos permitirán observar las diferencias entre los componentes de la 
aceptación (aceptación del dolor y disposición a las actividades) y otras estrategias de 
afrontamiento, y aclarar por tanto, los objetivos de intervención. 
5. La identificación del peso específico y la validez predictiva de los componentes del 
catastrofismo y de la aceptación permitirá:  
a. Orientar el tratamiento psicológico hacia el desarrollo de los constructos más 
eficaces para mejorar la calidad de vida y la función de los pacientes con 
fibromialgia. Actualmente, los abordajes psicológicos en esta enfermedad se 
consideran los más eficaces y coste-efectivos  
b. Mejorar la investigación sobre la enfermedad al poder identificar los constructos 
psicológicos relevantes en la enfermedad y buscar mediante técnicas de 
neuroimagen las aéreas cerebrales que se relacionan con estos constructos. 
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METODOLOGÍA 
 Diseño: se trata de un estudio multicéntrico, observacional y prospectivo. 
 Sujetos del estudio: se seleccionará una muestra de N=250 pacientes diagnosticados de 
fibromialgia primaria según los criterios de la American College of Rheumatology (Wolfe et al., 
1990) y deberán cumplir los siguientes criterios de inclusión y exclusión. Criterios de inclusión: 
1.- Edad: 18-65 años. 2.- Discontinuación del tratamiento 7 días antes. 3.- Otorguen 
consentimiento informado. Criterios de exclusión: 1.- Edad <18 años o >65 años. 2.- 
Enfermedad médica o psiquiátrica u otras características que impidan exploración psicológica. 
 Variables estudiadas: 
o Variables sociodemográficas y clínicas: Cuestionario diseñado para este estudio y que 
incluye las variables sociodemográficas habituales (sexo, edad, estado civil, nivel 
educativo, trabajo, incapacidad laboral), así como variables clínicas (antecedentes 
médicos y psiquiátricos familiares y personales, duración de la enfermedad, síntomas 
principales, comorbilidad médica, etc). 
o Constructos relacionados con el dolor: 
 Catastrofismo: Se mide con la la Pain Castrophizing Scale (PCS), una escala 
autoadministrada de 13 items con unas adecuadas propiedades psicométricas 
(Sullivan et al., 1995). Consta de tres subescalas; la magnificación, la 
rumiación y la indefensión. 
 Aceptación: La aceptación se relaciona con una mejor adaptación a la 
respuesta del dolor, sin importar la influencia de variables como la depresión, 
la intensidad del dolor o la ansiedad. Emplearemos el cuestionario existente 
para evaluar este constructo, el Chronic Pain Acceptance Questionnaire 
(CPAQ) (McCracken et al., 2004). 
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o Variables mediadoras: 
 Escala Analógica Visual del Dolor: El dolor es auto-reportado por el paciente 
en una escala analógica visual de 0 a 100 en la que 0 significa "ausencia de 
dolor" y 100 "el máximo dolor imaginable". La fiabilidad de estas analógicas ha 
sido ampliamente descrita (Sriwatanakul et al., 1983). 
 Fibromialgia Impact Questionnaire: El FIQ es un cuestionario auto-reportado 
de 10 ítems que mide el estado de salud de los pacientes con fibromialgia. El 
primer ítem se focaliza en la capacidad de los pacientes para realizar 
actividades físicas. Los dos siguientes requieren que el paciente indique el 
número de días de la semana anterior que se sintió bien y cuántos días de 
trabajo había perdido. Los otros siete restantes se refieren a la capacidad de 
trabajar, dolor, fatiga, cansancio matutino, rigidez, ansiedad y depresión, todos 
ellos medidos mediante escalas analógicas visuales. En este estudio hemos 
utilizado la versión española del FIQ (River y González, 2004). 
 El SF-36: escala de 36-items que mide 9 dominios de la salud incluida la 
función física, rol físico limitaciones, dolor corporal, salud general, vitalidad, 
funcionamiento social, limitaciones de rol emocional, la salud mental y el 
cambio en la salud. Puntajes más altos indican una mejor salud. El SF-36 se 
ha utilizado en numerosos estudios incluidos  pacientes con fibromialgia. En 
este estudio hemos utilizado la versión española del SF-36 (Alonso et al., 
1995). 
 Hospital Anxiety and Depression Scale (HADS): Es una escala autorreportada 
que detecta ansiedad y depresión en personas con enfermedades médicas. 
Comprende 14 ítems que se puntúan en una escala Likert de 4 puntos. Incluye 
dos subescalas: ansiedad y depresión, que se puntúan independientemente. 
La HADS ha sido validada en español (Tejero et al., 1986). 
 Inventario de Estrategias de Afrontamiento del Dolor Crónico CPCI-42. Evalúa 
diferentes tipos de estrategias de afrontamiento y está compuesto pos las 
siguientes escalas: evitación, descanso, ayuda, relajación, persistencia, 
ejercicio, apoyo y autoayuda. El CPCI-42 ha sido validado en español (García-
Campayo et al., 2007). 
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 Análisis estadístico: 
o Objetivo 1: Validación de la escala de catastrofismo (PCS) y aceptación (CPAQ).  En 
ambos casos, la validez de constructo se evaluará mediante un análisis factorial 
confirmatorio. La consistencia interna se evaluará mediante el coeficiente alfa de 
Cronbach y la fiabilidad test-retest mediante el coeficiente de correlación intraclase. 
Por último, la validez convergente se analizará mediante el coeficiente de correlación 
de Pearson.  
o Objetivo 2: Análisis pormenorizados de los efectos del catastrofismo y aceptación en 
pacientes con fibromialgia. Se calcularán medias y desviación estándar de cada una 
de las variables. Las posibles relaciones entre las variables sociodemográficas, las 
mediadoras y los constructos se evaluará mediante un análisis de correlación. 
Posteriormente, para valorar el peso específico de cada uno de los constructos se 
llevará a cabo un análisis de regresión.  
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CONCLUSIONES 
 
1. Proceso de validación: 
 
Las propiedades psicométricas de los dos cuestionarios validados, la escala de 
catastrofización ante el dolor (Pain Catastrophzing Scales; PCS) y el cuestionario de 
aceptación del dolor crónico (Chronic Pain Acceptance Questionnaire; CPAQ) resultaron 
adecuadas.  
 
2. Catastrofismo: 
 
2.1 El Tratamiento Cognitivo-Conductual parece adecuado para reducir la frecuencia de 
los pensamientos catastrofistas y la mejora en la calidad de vida de los pacientes. 
Además, la técnica de exposición en imaginación podría ser recomendable para 
aquellos pacientes caracterizados por una notable rumiación. 
 
2.2 La influencia del catastrofismo en el funcionamiento general de los pacientes con 
fibromialgia es variable y depende del contexto en el que se dan los pensamientos 
catastrofistas (ej. tiempo desde el diagnóstico). Por tanto, esta cuestión debería ser 
tenida en cuenta para dirigir adecuadamente las intervenciones psicológicas  
 
2.3 En concreto, el análisis de regresión mostró que era la subescala de rumiación la que 
mejor explicaba la discapacidad de los pacientes que habían sido diagnosticados de 
fibromialgia en un periodo menor a 2 años. En el grupo de pacientes que habían sido 
diagnosticados de fibromialgia en un periodo de entre 2 y 4 años, fueron las 
subescalas de magnificación e indefensión. Por último, la escala de indefensión fue el 
predictor más robusto en el grupo de pacientes que habían sido diagnosticados en un 
periodo mayor a 4 años. 
 
2.4 En los tres estadios, el catastrofismo predijo mejor el funcionamiento global del 
paciente que la intensidad de dolor. Además,  a pesar de que la discapacidad de los 
sujetos tendía a incrementarse con el tiempo, el indicador del catastrofismo se 
mantenía constante. 
 
Resumen 
 
“AFFECTIVE AND COGNITIVE ASPECTS IN FIBROMYALGIA: THE ROLES  OF CATASTROPHIZING AND ACCEPTANCE” XIV 
 
2.5 Estos resultados resaltan la importancia de una intervención temprana en pacientes 
con fibromialgia que pudiera prevenir patrones de afrontamiento desadaptados. Esto 
se traducirían una reducción de costes futuros tanto médicos como sociales.  
 
2.6 La eficacia de los programas de tratamiento psicológico podrían mejorar 
sustancialmente si clasificáramos a los pacientes de fibromialgia según sus 
características conductuales y cognitivas y las intervenciones se dirigiesen 
específicamente a esas variables de riesgo. 
 
 
3. Aceptación: 
 
3.1 La aceptación del dolor crónico predijo mejor que las estrategias de afrontamiento 
conductuales la adaptación al dolor crónico. 
 
3.2 Una mayor aceptación del dolor crónico en los pacientes con fibromialgia estuvo 
asociada con menor dolor, número de síntomas, ansiedad, depresión, discapacidad y 
mejor estado de salud general, vitalidad y funcionamiento tanto físico como social.  
 
3.3 Nuestros resultados mostraron que la gran mayoría de estrategias de afrontamiento 
conductuales (ej; relajación, descanso, pedir ayuda) parecen conducir a mayor 
sufrimiento y un pobre funcionamiento. En cambio, los dos componentes de la 
aceptación mostraron tipos de de conducta que conducen a un menor sufrimiento y un 
mejor funcionamiento. 
 
3.4 Las estrategias de afrontamiento conductuales que a menudo son objetivos de 
tratamientos psicológicos parecen no relacionarse con los resultados de la manera que 
se esperaban. Los componentes de aceptación parecen ofrecer mayor utilidad para 
guiar el tratamiento.  
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Fibromyalgia syndrome (FMS) is defined by the American College of Rheumatology as 
chronic (>3 months), widespread pain (axial plus upper and lower segment plus left and right sided 
pain) and tenderness in at least 11 of 18 tender points (Wolfe et al., 1990). Patients frequently 
describe sensations of fatigue, sleep disturbances, morning stiffness, symptoms associated with 
irritable bowel syndrome and affective distress, and the prognosis for symptomatic recovery is 
generally poor. When compared to patients with other chronic pain conditions, patients with FMS 
report higher levels of pain and functional disability and judge their quality of life as poorer 
(Burkhardt et al., 1993). Moreover, they make extensive use of health services, thus leading to high 
costs for medical and societal care (Penrod et al., 2004). The syndrome’s pathology is not well 
understood, and to date, no treatment has proven effective in fully alleviating its symptoms.  
 
There is an agreement about the prevalence of FMS being approximately 2 to 3% (Wolfe et 
al., 1995), which represents approximately between 800.000 and 1.200.000 individuals in Spain. 
Indeed the prevalence of FM at the Rheumatologist surgery is around 12% (2.2% in men and 
15.5% in women) (Valverde et al., 2000). Therefore, it is not surprising that in recent years, FMS 
has acquired greater significance and has become a first-order public health problem. There are 
several reasons for justifying this situation: (a) its high level of prevalence in the general adult 
population, (b) insufficient knowledge of its cause and the mechanisms that produce it (decrease of 
the nociceptive perception threshold), (c) absence of a curative treatment, and (d) dissatisfaction of 
patients and professionals with current therapeutic approaches (Ruiz et al., 2007; Soriano et al., 
2000; Tornero & Vidal, 1999).  
 
Widespread pain, is the most frequent and incapacitating FMS symptom. The 
pathophysiology that produces pain and disability in fibromyalgia appears to involve a combination 
of central sensitization and nociceptive input. However there is no doubt nowadays that pain is a 
complex experience which involves several procedures. Indeed, pain has been defined by the 
International Association for the Study of Pain as “an unpleasant sensory and emotional experience 
associated with actual or potential tissue damage, or described in terms of such damage”. Taking 
into account this global definition, the biopsychosocial model of pain has been considered as an 
appropriate approach. 
 
Biopsychosocial models describe the transition of acute to chronic pain, independent of a 
biomedical cause, as in FMS. In acute pain, three response systems are involved: behavioural 
reactions (eg, avoidance behaviour), cognitive reactions (eg, increased attention to bodily 
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sensations and catastrophising) and physiological reactions (eg, an elevated autonomous arousal 
and muscle tension). All are appropriate adaptive short-term reactions to acute pain, but they 
become less functional and even detrimental when applied long term and in response to chronic 
pain (Flor et al., 1990).  
 
Avoidance behaviour has been described as an important aspect contributing to the 
aggravation of pain. This behaviour is affected by classic and operant learning processes, and is a 
prominent factor of the fear–avoidance model (Vlaeyen et al., 1995). The key concept of the model 
is fear of pain following the sensation of acute pain—for example, pain experienced during or after a 
road accident. People may react to this pain-related fear with avoidance or withdrawal of activities in 
order to prevent or escape pain. Cognitions such as the expectation that an activity will lead to pain 
or an increase in pain may also trigger avoidance behavior (Sharp, 2001). Avoidance behaviour is 
easily reinforced by the belief that one has successfully prevented increments in pain. As long as 
activities are avoided, it is impossible to refute the belief that activity will lead to pain. Long-lasting 
avoidance of activities can lead to changes in the musculoskeletal system caused by physical 
deconditioning and impairments in muscle coordination, also called the disuse syndrome (Bortz, 
1984) The resultant deficient physical condition may in turn exacerbate the pain problem. 
Physiological reactions to pain such as heightened muscular tension and increased autonomic 
arousal may also lead to higher levels of pain and functional disability in the long term (Flor et al., 
1990). Furthermore, this autonomic arousal could be interpreted as evidence of physical harm and 
subsequently lead to more avoidance behavior (Norton, 2003).  
 
This habitual pattern of physiological, behavioural and cognitive reactions to pain might be 
generalized to various other situations and areas independent of objective pathology and intensity 
of pain. Patients with high levels of avoidance behaviour have been shown to have a tendency to 
restrict their daily and social activities and withdraw from work, which will negatively affect long-term 
pain outcomes (Vlaeyen & Linton, 2000). Social factors, such as external reinforcements from the 
patient’s social network, can further reinforce and maintain avoidance behaviour. In addition, 
avoidance may also include withdrawal from positive reinforcers such as leisure activities which in 
turn can exacerbate psychological distress and reduce their quality of life (Sharp, 2001). A vicious 
cycle has thus been established.  
 
Therefore, the main object for the psychological approaches consists in identifying which 
are the crucial psychological processes or constructs which are responsible for the avoidance 
behavior. Preventing individuals from getting stuck in their fears, will drive us to better prognosis. 
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Two of the constructs that have shown to be relevant mediators in this area are catastrophizing and 
acceptance.  
 
Catastrophizing refers to a combination of negative thoughts and expectations regarding 
pain, and research shows that it is a critically important variable in understanding the experience 
of pain in rheumatologic disorders as well as other chronic pain conditions. It is also an 
important target for both psychosocial and pharmacological treatment of pain due to its 
relevant influence in a negative prognosis (Sullivan et al., 2001). The construct of catastrophizing 
incorporates magnification of pain-related symptoms, rumination about pain, feelings of 
helplessness, and pessimism about pain-related outcomes and it is typically measured using a self-
report inventory, the Pain Catastrophizing Scale (PCS) (Sullivan et el., 1995). 
 
Although individuals are sometimes dichotomized as catastrophizers and 
noncatastrophizers, most research treats catastrophizing as a continuous, normally distributed 
variable (Sullivan et al., 2001). A rich area of debate has centered on whether catastrophizing is 
best conceptualized as a stable and enduring trait, such as a dimension of personality, or as a 
modifiable characteristic (Jensen et al., 2001; Smeets et al., 2006), with some evidence supporting 
both positions. 
Catastrophizing has been correlated with adverse outcomes such as pain severity, pain 
sensitivity, depression and disability. Concerning hypothesized mechanisms of action, several 
alternatives has been proposed such as catastrophizing interferes with pain-coping and beneficial 
behaviors, increases attention to pain, amplifies pain processing in the CNS or catastrophizing has 
a maladaptive impact on the social environment. 
However, the effects of catastrophic thoughts on patient functioning presumably rely not 
only on their content or frequency, but also on the experiences and current circumstances of the 
person having them. For example, behavior disruptions and suffering from catastrophic thoughts 
are more likely to occur when they overwhelm other potential influences on behavior and limit 
response choices, such as when they lead to exaggerated emotional responses and unnecessary 
avoidance. On the other hand, everyone, including those who suffer with chronic pain, has likely 
had the experience of having a catastrophic thought but dismissing it as unimportant or of no 
particular concern. Therefore, there is a need for analyses of the processes by which catastrophic 
thinking exerts its behavioral and emotional impact. 
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Emerging psychological theories discuss acceptance in relation to effects of the experience 
of aversive thoughts, moods, or sensations (Hayes, Strosahl, & Wilson, 1999). Acceptance entails 
having contact with painful or discouraging experiences without some of their added influences on 
behaviors, particularly influences that lead to unnecessary avoidance, limit participation in life, or 
impede the pursuit of important goals (Hayes et al., 1999; McCracken, 1998, 2005). With regard to 
chronic pain, this line of reasoning suggests that sensations of pain, even when intense, need not 
inhibit success at living a meaningful life, nor do they need to be fought against, ignored, 
suppressed, or conquered before success can occur.  
 
The construct of acceptance of pain is based on two components (activities engagement 
and pain willingness) and it is typically measured using the Chronic Pain Acceptance Questionnaire 
(CPAQ) (McCracken et al., 2004b). Although the notion that it is possible to live with these difficult 
and distressing aspects of chronic pain is somewhat counterintuitive, there is increasing supportive 
evidence for acceptance of chronic pain. In clinical samples acceptance of pain is associated with 
less pain, distress, disability (McCracken, 1998; McCracken et al., 2004a), and greater psycho-
logical wellbeing (Viane et al., 2003). In treatment outcome studies acceptance-based methods 
are associated with improved emotional, psychosocial and physical functioning, and reduced 
healthcare use (Dahl et al., 2004;McCracken et al., 2005; Wicksell et al., 2007; Vowles et al., 2008).  
 
The final goal of the Acceptance-based interventions is to prevent the experiential avoidance 
promoting the psychological flexibility through the use of diverse components such as acceptance, 
contact with the present moment, values-based action, committed action, self-as-context, and 
cognitive defusion (Hayes et al., 1999; Hayes et al., 2006). All of them, encourage clients to make 
willing contact with aversive psychological content altering the relationship between pain-related 
cognitions and overt behavior. As a result, the person is taught how to go ahead having thoughts and 
not being entangled in thoughts.  
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AIMS OF THE RESEARCH 
 
1) To validate the Pain Catastrophizing Scale (PCS) and the Chronic Acceptance 
Questionnaire (CPAQ) into Spanish in an fibromyalgia sample. 
 
2) Regarding Catastrophizing: 
 
a. To check the efficacious of a Cognitive-Behavioural intervention. 
b. To study the relationship between catastrophizing and dysfunction in relation to the 
development of fibromyalgia. 
c. To study how contextual factors associated with fibromyalgia might interact with 
catastrophizing in contributing to disability. 
 
3) Regarding Acceptance of pain: 
 
a. To check if acceptance is better in predicting important aspects of patient wellbeing 
and functioning compared to behavioral coping strategies.  
b. To elucidate targets of intervention in fibromyalgia patients. 
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METODOLOGY 
Design:  
A multi-center, cross-sectional study. 
Participants: 
To be included in the study, patients were required to fulfill several inclusion criteria: (1) be 
between 18 and 65 years old; (2) be able to understand and read Spanish; (3) meet the American 
College of Rheumatology criteria for primary FMS; and (4) have been diagnosed by a Spanish 
National Health Service rheumatologist. Exclusion criteria included the following: (1) diagnosis of a 
severe Axis I psychiatric disorder (dementia, schizophrenia, paranoid disorder, or abuse of alcohol 
and/or drugs) or a severe Axis II disorder; and (2) refusal to participate. 
 
Primary outcomes: 
 Pain Catastrophizing Scale (PCS) 
The PCS is a 13-item scale designed to assess the catastrophizing cognitions of individuals by 
asking them to reflect on thoughts or feelings associated with current painful experiences 
(Sullivan et al., 1995). The PCS can be subdivided into three subscales: rumination, 
magnification and helplessness. Its validity and reliability have been previously reported. Our 
group was responsible for validating the Spanish version of this questionnaire (García-
Campayo et al., 2008). There is no established "cut-off" point because pain catastrophizing is 
considered a personality trait distributed in a continuous way in the general population. 
 Chronic pain acceptance questionnaire (CPAQ)  
The CPAQ was originally a 34-item measure of acceptance of pain. All items of the CPAQ are 
rated on a 0 (never true) to 6 (always true) scale. Based on recent analyses the CPAQ has 
been shortened to 20 items and now yields scores for two subscales, derived from factor 
analysis: Activity Engagement and Pain Willingness (McCracken et al., 2004b). Following the 
scoring procedure, a single total score was calculated based on the nine reverse-keyed items 
measuring pain willingness and the other eleven items measuring activities engagement. The 
maximum possible total score is 120, with a higher score indicating better acceptance. The 
Spanish version of the CPAQ, has been validated by our team and achieves adequate reliability 
(Rodero et al., 2010). 
Abstract 
 
“AFFECTIVE AND COGNITIVE ASPECTS IN FIBROMYALGIA: THE ROLES  OF CATASTROPHIZING AND ACCEPTANCE” XXVI 
 
Secondary outcomes 
 Demographic and Pain-Related Variables 
 
Each participant was interviewed and provided information about a number of demographic 
and pain-related variables including age, work status, time diagnosed with FMS, 
medications and other medical treatments. 
 
 
 Pain Visual Analogue Scale (PVAS) 
 
The PVAS was designed to allow a subjective assessment of pain. It consists of a 10 cm 
long straight line whose tips represent the limits of pain intensity ("No pain" to "maximum 
pain ever experienced"). The patients estimated the pain intensity experienced on the same 
day between 0 and 100. Previous studies have demonstrated PVAS to have adequate 
psychometric properties (Huskisson et al., 1993). 
 
 Fibromyalgia Impact Questionnaire (FIQ) 
The (FIQ) is a 10-item self-report questionnaire developed to measure the health status of 
fibromyalgia patients (Burckhardt et al., 1991). The first item focuses on patients' ability to 
perform physical activities. The next two items ask patients to circle the number of days in 
the past week that they felt good and how often they missed work. The remaining seven 
items concern the ability to work, pain, fatigue, morning tiredness, stiffness, anxiety, and 
depression and are measured with the visual analogue scale (VAS). This instrument has a 
translated and validated Spanish version (Rivera et al., 2004). 
 
 Physical symptoms 
 
The number of comorbid physical symptoms was obtained from a standardised symptom 
checklist (Casanueva, 2009). This self-report checklist instructs participants to indicate 
whether they experienced each of the 75 symptoms for at least 3 months over the past year. 
A score was obtained by totalling the affirmative responses to all 75 symptoms. Sample 
symptoms include dry eyes, shortness of breath, dizziness, irregular heartbeat, tingling in 
the extremities, urinary urgency, and coughing spells. 
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 Medical Outcome Study Short Form 36 (SF-36) 
 
The Medical Outcome Study Short Form 36 (SF-36) is a 36-item instrument designed to 
measure general health status and health-related quality of life (Ware et al., 1992). One 
item assesses perceived change in health status, while 35 items examine eight generic 
domains in both physical and mental health. The eight domains include Physical Function, 
Physical Role, Bodily Pain, General Health,Vitality, Social Function, Emotional Role and 
Mental Health. Scores in each subscale range from 0 to 100 with higher scores indicating 
better health status. The Spanish version of SF-36 has been shown to be reliable with good 
construct validity (a = 0.78-0.96) (Alonso et al., 1995). 
 
 The Chronic Pain Coping Inventory - 42 (CPCI-42) 
 
The Chronic Pain Coping Inventory (CPCI) (Jensen et al., 1995) was originally a 65-item 
self-report questionnaire; based on recent analyses, it has been shortened to 42 items 
(Romano et al., 2003). It asks patients to rate the frequency of use of behavioural and 
cognitive strategies over the previous week. It has the same CPCI-65 strategies, which are 
grouped into the following eight subscales: Guarding, Resting, Asking for Assistance, 
Relaxation, Task Persistence, Exercise/Stretch, Seeking Social Support and Coping Self-
Statements. This instrument was translated and validated into Spanish by our team. 
Reliability coefficients were adequate based on the current data (a = 0.65-0.82) and test-
retest reliability (intraclass correlation coefficient 0.76) (García-Campayo et al., 2007). 
 
 Hospital Anxiety and Depression Scale (HADS) 
 
The HADS (Zigmound et al., 1983) is a self-report scale designed to screen for the 
presence of depression and anxiety disorders in medically ill patients. It comprises 14 items 
that are rated on a 4-point Likert-type scale, and it is appropriate for use in community and 
hospital settings. Two subscales assessed depression and anxiety independently (HADS-
Dep and HADS-Anx, respectively).This has been validated in a Spanish sample (Tejero et 
al., 1986). HADS was selected for use in the present study as it is considered to be one of 
the best questionnaires for assessing depression and anxiety in patients with pain disorders. 
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Statistical analyses: 
 Spanish validation of the Pain Catastrophizing Scale (PCS) and the Chronic Pain 
Questionnaire (CPAQ) 
Both followed the same steps. In order to determine the suitability of the data for principal 
components analysis, the Kaiser-Meyer-Olkin Measure of Sampling Adequacy and 
Bartlett's Test of Sphericity were calculated. The dimensionality of the scale and the 
questionnaire were inspected with a Principal Components Analysis (PCA) followed with 
oblique (direct oblimin) rotation to permit correlations among factors. The criterion validity 
was examined by calculating the correlations between the Spanish PCS and CPAQ scores 
and the other questionnaires, using Pearson's r correlation coefficient. We also examined 
the association among the questionnaires scores and the socio-demographic and clinical 
characteristics of the sample, applying correlational analyses for the association with 
continuous variables (age and pain duration) and non-parametric tests (Mann-Whitney or 
Kruskal–Wallis) for categorical data (gender, marital status, educational level, and work 
status). Internal consistency was determined using Cronbach's alpha and item-total 
correlation coefficients. Test-retest reliability, evaluated with the intraclass correlation 
coefficient, was assessed for the 1- to 2-week follow-up interval, during which time the 
patients did not change baseline treatment  
 Assessing the influences of the Catastrophizing and Acceptance in fibromyalgia patients 
In the descriptive analysis of the samples, means and standard deviations were calculated 
for continuous variables (i.e., age and pain), and percentages were calculated for 
categorical variables (i.e., gender and treatment setting). Analysis of variance (ANOVA) 
was used to compare the different groups. Pearson correlations were used to assess the 
relationship between the two main psychological constructs (catastrophizing and 
acceptance) and other psychometric variables such as pain intensity, global functioning, 
anxiety and depression. Finally, a hierarchical regression analysis was performed to 
determine the effects of the catastrophizing and acceptance on fibromyalgia patients. All 
analyses were conducted with SPSS 15.  
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CONTRIBUTIONS OF PhD CANDIDATE 
 The validation of two questionnaires used throughout the world, and furthermore in a 
disorder as prevalent as FMS, will be invaluable for monitoring the effectiveness of 
treatments. 
 There are many studies on vulnerability factors associated with the disability of patients. 
This research will also allow us to know the vulnerability due to contextual factors. 
 The results will further allow us to observe the differences between the components of 
acceptance (activities engagement and pain willingness) and other coping strategies, and 
thus clarify the intervention objectives. 
 The identification of their unique contributions of processes and how these processes may 
interact to affect patient functioning will: 
o Improve research on FMS to be able to identify psychological constructs 
relevant to the disease 
o Guide psychological treatment to the development of more effective 
constructs to improve the quality of life and function of patients with 
fibromyalgia. Currently, psychological approaches in FMS are considered 
the most effective and cost-effective. 
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CONCLUSIONS 
 
Validation process: 
 
 Both psychometric properties of the Spanish validated versions of the Pain 
Catastrophzing Scales and the Chronic Pain Acceptance Questionnaire, are 
adequate.  
 
 
Regarding Catastrophizing: 
 
 
 The Cognitive-Bahavioral treatment is useful to decrease the catastrophizing scores. 
 The influence of catastrophizing on global functioning in fibromyalgia patients is 
variable and dependent on the context (i.e., duration of diagnosis) in which the 
catastrophizing thoughts occur.  
 Catastrophizing was a stronger predictor of global functioning than pain itself . 
 
 
Regarding Acceptance: 
 
 
 Acceptance of chronic pain predicted adjustment to chronic pain better than    
behavioural coping strategies in fibromyalgia patients. 
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1. Fibromyalgia 
In clinical practice the diagnosis of “fibromyalgia” is often given to individuals with chronic 
widespread pain for which no alternative cause can be identified. The 1990 classification criteria of 
the American College of Rheumatology (ACR) for fibromyalgia syndrome (FMS) combine chronic 
widespread pain (CWP), which indicates pain on both sides of the body, above and below the waist, 
and axial pain for at least 3 months, and tenderness on manual palpation in at least 11 out of 18 
defined tender points (Wolfe et al., 1990). Most clinicians would recognize that FMS, in its typical 
manifestation, is accompanied by a combination of additional symptoms such as sleep disturbance, 
fatigue, and anxiety, and by other clinical manifestations such as depression, gastrointestinal 
symptoms, and headache. In addition, FMS is often associated with chronic fatigue syndrome, 
irritable bowel syndrome (IBS), irritable bladder syndrome or interstitial cystitis, and 
temporomandibular disorder (Claw, 2009). The common theme is that patients have chronic pain 
and other somatic symptoms, but without apparent tissue damage or inflammation. 
The debate whether fibromyalgia is a rheumatological, psychiatric, somatoform, or 
neuroendocrine disorder, or no distinct clinical entity at all, is ongoing. However, the focus of 
fibromyalgia research has shifted to research on epidemiology, risk factors, and biomarkers, and to 
controlled trials testing drugs or other interventions in FMS. Furthermore, there is consensus that 
FMS is a heterogeneous condition and that subgroups may exist that have different 
pathophysiologies with different response characteristics to treatment (Turk et al., 1998) 
Heterogeneity has been confirmed, for example, based on sensory symptoms and comorbidities 
(Rehm et al., 2010) and on patterns of tender point responses (Wilson et al., 2009) 
A review of 10 studies from different Western countries reported a prevalence of FMS 
according to the ACR criteria in the general adult population of between 0.7% and 3.3%, (Gran, 
2003) with a prevalence in women between 1.0% and 4.9%, and in men between zero and 1.6%. It 
has been suggested that the male-female ratio reported in the literature may be biased, because 
most of the data come from tertiary care centers. In Spain, between 800.000 and 1.200.000 
individuals are thought to be affected (Valverde et al., 2000). 
Widespread musculoskeletal pain is the most frequent and incapacitating FMS symptom. 
The pain is typically diffuse or multifocal, and its intensity varies over time. Patients also may 
complain of morning stiffness and swelling of joints or limbs, resembling symptoms of rheumatoid 
arthritis (Table 1). Other frequently encountered symptoms are fatigue, reduced energy and drive, 
and disturbed sleep (Kranzler et al., 2002). Many patients complain of problems with concentration, 
attention, or memory. In fact, cognitive impairment was found in FMS patients in neuropsychological 
studies. Often, gastrointestinal symptoms and bladder disturbances are reported. FMS may present 
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concomitantly with other disorders, which does not exclude the diagnosis. Commonly associated 
diseases are chronic autoimmune disorders such as rheumatoid arthritis or lupus erythematosus, 
and a variety of functional disorders such as IBS or palpitations. Patients with FMS seen in tertiary 
pain centers often give the physician elaborate descriptions of their complaints. It has been 
suggested that patients aim at controlling the dialogue by means of lengthy but vague descriptions 
of their somatic complaints, and the resulting difficult physician-patient interaction has been 
regarded as a diagnostic criterion (Kirsch and Bernardy, 2007). This difficult interaction pattern may 
lead to the finding that patients feel isolated from health care professionals and find it difficult to 
convince them that they have a real disease (Rodham et al., 2010). 
Widespread pain 
Fatigue 
Disturbed sleep 
Joint pain 
Headaches 
Restless legs syndrome 
Numbness 
Problems with memory 
Stiffness 
Problems with concentration 
Restlessness 
100% 
96% 
86% 
72% 
60% 
56% 
52% 
46% 
42% 
41% 
32% 
Table 1. Frequency of Pain Complaints and Symptoms for Fibromyalgia Patients during the diagnosis. 
The prevalence of FMS is increased in family members of patients suffering from FMS. For 
example, the frequency of FMS among the firstdegree relatives of patients was 6.4% (Arnold et al., 
2004). There are findings indicating a role for polymorphisms of genes in the serotoninergic, 
dopaminergic, and catecholaminergic systems in the etiology of FMS. These polymorphisms all 
affect the metabolism or transport of monoamines, so they might lead to disturbed sensory 
processing and an altered stress response (Buskila, 2009). However, there are negative and 
positive findings regarding the associations between these polymorphisms and FMS. Thus, it is 
likely that the development of FMS is influenced by multiple genes, as in other complex genetic 
diseases (Bradley, 2009). Furthermore, the gene polymorphisms found are not specific for FMS, but 
have also been studied in other chronic pain syndromes, as well as in major depressive disorder. 
Rare missense variants of the familial Mediterranean fever gene increase the risk of FMS and are 
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present in about 15% of FMS patients. These patients have high plasma levels of the 
proinflammatory cytokine IL-1ß (Feng et al., 2009), indicating that this subtype of FMS might be 
more closely related to rheumatoid disorders than other subtypes. Recently, there has been 
increased interest in resilience, or factors that protect against chronic disease. For example, non-
affected relatives of FMS patients had a reduced frequency of the met/met genotype of the 
catechol-O-methyl transferase (COMT) gene, which may protect them from developing the disorder 
(Cohen et al., 2009). 
Along with a certain genetic susceptibility, environmental factors may have a large impact in 
modulating the variance encountered, and external events may trigger the development of FMS. 
Such triggers consist of physical trauma, a regional myofascial pain syndrome, psychological 
distress or emotional trauma, or an acute illness (Bennett et al., 2007; Cakit et al., 2010). Some 
factors that have previously been thought to trigger FMS could be shown to be unrelated to the 
disorder, such as silicone breast implants or whiplash injury (Tishler et al., 2010). In women, the 
frequency of abuse correlates with the prevalence of FMS (Ruiz-Perez et al., 2009). Among 
psychosocial stressors, there is the highest evidence for those related to the workplace (Harkness 
et al., 2004). Certain lifestyle factors also seem to promote the occurrence of FMS. For example, 
overweight and obesity are associated with an increased risk of FMS, especially among women 
with low levels of physical exercise (Mork et al., 2010). In contrast, regular physical activity appears 
to promote a favorable long-term outcome of FMS (Dobkin et al., 2010).  
A number of biological abnormalities have been described in FMS, with possible relevance 
to its pathophysiology. The major caveat is that in most of these studies no disease controls were 
investigated, such that the specificity of a certain finding for FMS cannot be determined. 
Furthermore, there are few longitudinal studies. The hypothalamus-pituitaryadrenal (HPA) axis has 
frequently been studied, with the hypothesis that patients with FMS have a reduced stress response 
and hypocortisolism. While there is no evidence for reduced baseline cortisol secretion in patients 
with FMS, different authors have variously found enhanced or reduced glucocorticoid sensitivity, 
and this issue remains open (Tanriverdi et al., 2007). There is some evidence for reduced 
sympathetic activity in patients with FMS under stress, and capillary microvascularization is altered. 
There is some support in the literature for an altered cytokine system in FMS, similar to the findings 
in major depression, but in most studies there were no correlations with the severity of symptoms 
(Menzies et al., 2010). In particular, anti-inflammatory cytokines were found to be decreased in 
patients with FMS, indicating that a reduction in these protective, anti-inflammatory mediators may 
be an additional risk factor for FMS (Üçeyler et al., 2006). Interestingly, cytokine profiles could be 
modified by multidisciplinary pain therapy (Wang et al., 2008).  
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Elevation of the neuropeptide substance P in the cerebrospinal fluid was one of the first 
biochemical findings in FMS (Reynolds et al., 1988) and was confirmed in later studies. However, 
substance P was also elevated in patients with osteoarthritis and in full-term pregnant women, and 
therefore high levels cannot be regarded a specific biomarker for FMS. Similarly, the neurotrophic 
factors brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) were increased in 
cerebrospinal fluid from FMS patients, but also in persons with chronic migraine (Sarchielli et al., 
2007). 
Structural and functional imaging studies of the central nervous system have led to the 
concept that FMS is a disorder of central sensitization or a defective pain inhibitory system 
(Schweinhardt et al., 2008). The evidence of central augmentation in FMS has recently been 
reviewed (Williams and Claw, 2009). Functional brain-imaging studies reveal enhanced activation in 
pain related areas and thus corroborate the patients’ reports of increased pain (Gracely et al., 2002). 
A recent study using mu-opioid-receptor positron emission tomography (PET) demonstrated 
reduced mu-opioid receptors in several pain-related brain regions (Harris et al., 2007). These 
results may indicate altered endogenous opioid analgesic activity in FMS and may explain why 
therapeutic opiates have so little efficacy in FMS patients. 
As in other chronic pain conditions, studies have shown both increasesand decreases in 
regional gray matter density in FMS patients (for review see Schweinhardt et al., 2008). FMS 
patients had less total gray matter volume, less gray matter density, and an age-associated 
decrease in gray matter that was three times greater than in healthy controls, (Kuchinad et al., 
2007), which led to the hypothesis of premature ageing in FMS. Regional gray matter density 
analyses revealed gray matter loss in regions associated with pain modulation or stress, such as 
the cingulate, insular, and medial frontal cortices, the parahippocampal gyri, the thalamus, and the 
amygdala. Increased gray matter in the left orbitofrontal cortex, left cerebellum, and bilateral 
striatum was also described (Burgmer et al., 2009; Schmidt-Wilcke et al., 2007). Again, this finding 
is more likely to be related to chronic pain as such than specifically to FMS, and the underlying 
cellular and molecular processes are unknown. 
The aim of treating FMS is to decrease pain and the associated symptoms and to increase 
function and quality of life. Currently, FMS cannot be cured by any therapy, and overall treatment 
effects of single interventions are modest at best. A major goal in FMS research will be to better 
identify subgroups and to more clearly explain the pathophysiology of the syndrome so that 
individualized treatment can be developed and administered. Better outcome measures are needed 
to do justice to the complex array of symptoms in FMS (for review see Sommer, 2010). 
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2. Chronic Pain and Fibromyalgia 
The International Association for the Study of Pain defines pain as follows: “Pain is an 
unpleasant sensory and emotional experience associated with actual or potential tissue damage, 
or described in terms of such damage" (pp. 210-211, Merskey & Bogduk, 1994). This definition 
explicitly affirms that the pain experience has both a sensory and an emotional-evaluative 
component and acknowledges that pain may occur in the absence of physical pathology. 
 
Pain is one of the most frequent reasons why patients visit a physician and at the same 
time it is one of the least understood symptoms. Chronic pain is, to a large degree, regarded as 
acute pain that has persisted. The most common treatments for pain in primary care centres are 
pain killers, physical therapy, and transcutaneous electrical nerve stimulation (TENS). 
Unfortunately, the scientific evidence supporting the effectiveness of these methods on pain 
relief or functioning of the patient is limited (Bigos, Bowyer, Braen et al., 1994). There is a need 
for new thinking. 
 
a.  Early Theories of Pain 
 
Although any contemporary model of pain will include both physiological and psychological 
factors, early theories of pain were very different. Early civilizations offered a variety of explanations 
for pain and attributed it to such factors as religious influences of gods, the intrusion of magical 
fluids, the frustration of desires and deficiency or excess in the circulation of Qi (for review see 
Main, Sullivan and Watson, 2008) 
The early Greeks gave more specific consideration to the nature of pain. Plato believed that 
the heart and liver were the centers for appreciation of all sensation, and that pain arose not only 
from peripheral sensation but as an emotional response in the soul, which resided in the heart. 
Aristotle believed that the brain had no direct function in sensory processes. There was even less 
understanding of pain from internal or visceral causes. It was frequently attributed to the influence 
of evil spirits or the gods. 
Hippocrates considered that pain was a consequence of deficiencies or excesses in the 
flow of one of the four fluids, or humours (blood, phlegm, yellow bile or black bile). Galen, in 
contrast, clearly established the anatomy of the cranial and spinal nerves. He distinguished three 
types of nerve: 'soft' nerves, 'hard' nerves and pain nerves. He also considered that the centre of 
sensibility was the brain. 
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Nonetheless, Aristotle's theories had considerable influence. For a long time pain was still 
considered to be an emotion or sensation experienced in the heart or an effect possibly of the entry 
of evil spirits. The brain was thought to play no part in the experience of pain. Indeed, the 
controversy over whether pain should be regarded as a sensation or as an emotion has continued 
to the present day and has led to an overstated dichotomy between sensory and emotional factors. 
Descartes' new theory was, therefore, a massive leap in the understanding of the mechanism of 
pain, and drew significant criticism from his contemporaries at the time. 
Descartes' explanation of pain (Descartes 1664) needs to be understood against the 
background of his philosophy. Descartes attempted to show that humans consisted of an earthly 
machine (machine de terre) inhabited by and governed by a rational soul (ame raissonnable). He 
tried to explain how blood, itself derived from food, gave rise to animal spirits by means of which the 
special earthly machine, the brain with its nerves, carried out the behests of the rational soul. The 
spirits dilated the brain, thus enabling it to receive the impressions of external objects, and flowed 
from the brain along the nerves into the muscles, thus enabling the nerves to serve as 'the organs 
of the external senses'. Animal spirits constituted a very subtle fluid amenable to the physical laws 
governing fluids, and the nerves were hollow tubes along which the spirits flowed in a wholly 
mechanical manner (Foster 1901). The nerves were not merely hollow tubes, but contained also 
delicate threads which spread all over the body from their origins at the internal surface of the brain 
and served as organs of sense. These threads were easily set in motion by the objects of the 
senses and at the same instant pulled upon the parts of the brain from which they originated. 
“…If for example the fire comes near the foot, the minute particles of this fire, 
which as you know have a great velocity, have the power to set in motion the spot of 
skin of the foot which they touch, and by this means pulling upon the delicate thread 
which is attached to the spot of the skin, they open up at the same instant the pore 
against which the delicate thread ends, just as pulling at one end of a rope one makes 
to strike at the same instant a bell which hangs on the other end…” (Descartes 1664, 
translated by Foster 1901, p. 265.).  
As Foster points out, Descartes' theory required these nerves to have physical properties 
for which he had no evidence.  
Descartes offered a dualistic view of mind and body. The body essentially was a machine 
whose workings could be explained by the laws of nature. The 'rational soul' was the 'conductor of 
the orchestra'. Descartes never really satisfactorily resolved the relationship between the two. There 
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certainly does not seem to be any central 'processing' of the information, although it is consistent 
with the notion of summation. 
b.  The Medical/Pathological Model of Pain 
In understanding pain mechanisms, there have been two major assumptions that have 
been inherited from Descartes: firstly that of a one-to-one relationship between the amount of 
damage (or nociception) and the pain experienced, and, secondly, the separation of mind and body. 
The model of a one-to-one relationship between the amount of tissue damage and the 
amount of pain experienced has attractiveness, in that it seems to be consistent with the everyday 
experience of acute pain. It has to be remembered of course, that pain is first and foremost a 
biological warning signal. Pain is necessary to protect us from damage. The function of pain in 
alerting us to actual or potential tissue damage is extremely important. We are programmed to react 
rapidly to pain. Sudden pain produces an instinctive withdrawal response. We attend immediately to 
it. We attempt to escape from the source of pain and we try to protect the injured tissue from further 
damage. The pain is giving us important information about its source, nature and intensity. On 
occasions, such information may be of life-threatening importance. Avoidance of further painful 
experiences will necessarily avoid damage, aid healing and enable a return to the 'normal' state. 
The assumption that a higher level of pain is indicative of more serious physical damage is 
therefore useful, but an accurate appraisal of the pain is not necessary.  
This model of pain demonstrates a direct relationship between stimulus and the amount of 
pain. It implies information travelling in one direction only, and does not allow for any modulation of 
the stimulus. This model implies that a small stimulus may not cause pain, a large stimulus will 
always cause pain and when pain is sensed there is always damage causing it. Stopping the 
stimulus is the way of stopping the pain. Cutting the wire is the only other alternative. 
Four hundred years later, clinicians and patients alike continue to think of pain according to 
a Cartesian model. Pain is viewed as part of the 'mechanical' processes of the body, arising directly 
from injury or illness. First, pain is viewed as a signal of damage or the threat of damage, and pain 
is expected to be relieved once injury or illness has healed. Second, most patients have little 
understanding of the complexity of the neurophysiology and anatomy of nociceptive pathways and 
pain experience and indeed do not require such knowledge. Finally, the medical profession and 
allied disciplines will, to a large extent, have reinforced this model of pain and damage. Rest is 
usually prescribed for any painful injury, along with pain killers and other treatments. Certainly, 
patients are advised not to move something if it hurts. The message 'let the pain be your guide' is 
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commonly given to patients recovering from an acute injury, reinforcing the notion of pain being a 
direct measure of tissue damage. 
A legacy of the 'mind-body-split' has been the conceptualization of pain as being either 
physical or psychological. Patients' general defensiveness about considering anything from a 
psychological viewpoint has made contemporary pain management, which accepts an interaction 
between physical and psychological factors, difficult for patients to accept. (Some patients view 
discussions about 'non-physical' influences on pain with disbelief, suspicion and sometimes 
downright hostility.) This problem is highly susceptible in fibromyalgia where attribution to a 
psychological influence on the perception of pain by a professional may be taken by the patient as 
synonymous with an implication of some sort of mental illness, a suggestion that the pain is imag-
inary or even that the patient is malingering. 
Thus, it is natural and logical, given our usual experiences of injury and disease, to look for 
a physical cause of pain and seek relief on that basis. This makes sense in cases of acute pain 
from fractures, tumors, bacterial infections, or dental disease. Unfortunately, in chronic pain the 
picture is more complex. 
 The search for a medical solution for chronic pain is not always fruitful. Perhaps 64% of 
"pain-free" people walking along a given street have some abnormality such as a "bulging disk," as 
determined by magnetic resonance imaging (MRI) of their lumbar spine (Jensen et al. 1994). This 
finding suggests that disk abnormalities do not necessarily cause pain, and so positive MRI findings 
may be merely incidental. Studies of neck pain demonstrate no differences in pain or disability 
between patients with or without evidence of cervical spine degeneration (Peterson et al. 2003). We 
also know that patients with disk herniation and radiculopathy can improve without surgical 
intervention. In one small study, 83% of cases achieved clinical improvement without surgery, and 
78% of those cases showed resolution or improvement in the disk herniation on repeat computed 
tomography (CT) an average of 30.4 months later (Ellenberg et al. 1993). 
When researchers investigate the wide range of potential predictors of patient functioning in 
the context of chronic pain, the results are fairly consistent. Psychological or behavioral factors 
predict functioning well, while physical or medical variables appear unhelpful (Grossi et al. 1999; 
Hunt et al. 2002; Schultz et al. 2002). When we look at the effects of treatment on patients' daily 
functioning, the same results are obtained. For surgical (e.g., Herno et al. 1999; Schade et al. 1999) 
and behavioral or interdisciplinary treatment (Fishbain et al. 1995; McCracken and Turk 2002), 
psychological variables such as depression and perceptions of work are the strongest predictors of 
treatment outcome. For example, Herno et al. (1999) showed that disability following surgery for 
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lumbar spinal stenosis was unrelated to CT scan results with regard to degree of decompression, or 
to radiological results regarding spinal stability, but was best predicted by patient satisfaction with 
the results of surgery. 
Our objection to this model is more functional than ontological. Clearly there are many 
cases where identifiable medical circumstances underly the sufferer's pain, and it would be absurd 
to state that there is never an identifiable organic cause of pain. Each case, of course, should be 
analyzed individually. Nonetheless, the search for a physical cause, for many patients, simply does 
not yield an understanding of their pain or provide a clear basis for effective treatment for either the 
patient or provider 
c.  Behavior Medicine: Traditional Cognitive Behavior Therapy 
Behavior medicine was first presented in the 1970's as an application of behavior analysis 
for the treatment of unhealthy long-term symptoms in the genitourinary, gastrointestinal, 
cardiovascular, musculoskeletal, and nervous and respiratory systems. Treatment for traditional 
medical illnesses such as high blood pressure, torticollis, obesity, headache, pain, epilepsy and 
asthma were developed. At that time, behavioral medicine was applied as a complement to 
traditional medical / pathological model. Despite their superficial differences, this integration was 
not difficult. Behavior therapy interventions are executed at the level of the person/environment 
interaction, but their traditional aim and focus is quite similar to that of the medical model: control 
and management of the presenting symptoms. 
 
The first wave of traditional behavior therapy, and the second wave (cognitive-behavior 
therapy or CBT) that followed both adopted the position that psychological suffering is anomalous, 
and that psychological health is inversely related to the number and intensity of psychological 
complaints (Hayes et al., 2006). Instead of the intrusion of some biological malfunction, infectious 
agent, or toxic insult, behavior therapists posit anomalous, pathogenic learning histories that 
generate negative thoughts, emotions, memories, bodily states and behavioral predispositions. 
These are the behavioral equivalents of tumors, viruses, and bacteria that must be excised in order 
for good psychological health to return. The CBT model of pain includes behavior, physiological 
and cognitive components that interact with each other. For example, the tissue damage that 
results from a fall off a horse may influence our thinking about horses and influence how we 
behave or avoid behaving around horses. 
 
This is clearly a step forward, and the treatment options that this approach opens up are 
worthwhile. While there are physiological factors that predispose human beings to develop 
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symptoms, such as pain, our best behavioral treatments focused on providing the individual with a 
new learning history that will reduce pain or pain related behavior in what have been pain-
producing contexts. Central to this new learning history is systematic exposure to feared events 
such as fear of movement or an activity associated with pain. These applications of behavioral 
medicine are based both on behavioral principles (classical and operant conditioning) and in more 
recent times on cognitive concepts. 
 
In more traditional behavioral approaches, the goal has been to reinforce productive 
behavior and to stop the negative reinforcement of avoidance behavior, while at the same time 
reducing the spread and function of stimuli that elicit pain experience through classical conditioning. 
Exposure based treatments provide an example. Reinforced exposure to previously avoided 
situations and movements that patients incorrectly believed to be causing pain is mounted with the 
goal of improving functioning in such areas as reducing limping, walking longer distances, and 
lifting heavier weights along with general rehabilitation goals such as better physical fitness and 
returning to work (Fordyce, 1976). 
 
In CBT approaches the principles and targets of intervention have expanded to include 
changing negative feelings and thoughts as well more traditional behavioral goals such as reducing 
passive coping behavior (e.g., taking pills, resting) and increasing active coping behavior (e.g., 
exercising). There are usually elements of cognitive restructuring such as reframing dysfunctional 
thoughts, mental training for positive thinking, or the use of mental distraction. Stress management, 
time management, relaxation training, EMG biofeedback, social skills training, problem solving, 
activities of daily life training, and reduction of medication may all be included in these pain 
management programs, along with many other elements. 
 
There are many RCT studies which have evaluated CBT as a treatment of chronic pain 
(Alaranta et al., 1994; Altmaier et al., 1992; Edinger, Wohlgemuth, Krystal & Rice, 2005; Flor & 
Birbaumer, 1993; Fordyce, Brockway, Bergman, & Spengler, 1986; Haldorsen, Kronholm, Skouen, 
& Ursin, 1998;Jensen & Bodin, 1998 Jensen, Nygren, & Lundin, 1994; Keller, Ehrhardt-Schmelzer, 
Herda, Schmid, & Basler, 1997; Kerns, Turk, Holzman, & Rudy, 1986; Lindstrom, Ohlund, Eek, 
Wallin, Peterson, Fordyce, et al., 1992; Lindstrom, Ohlund, Eek, Wallin, Peterson, & Nachemsom, 
1992; Linton & Gotestam, 1984; Linton, Melin, & Sternlof, 1985; Moore & Chaney, 1985; Moore, 
Von Korff, Cherkin, Saunders & Lorig, 2000; Morley, Eccleston, & Williams, 1999; Newton-John, 
Spence, & Schotte, 1995; Nicholas, Wilson, & Goyen, 1991; Nicholas, Wilson, & Goyen, 1992; 
Peters & Large, 1990; Puder, 1988; Spence, 1989; Redondo et al., 2004; Spence, Sharp, Newton-
John, & Champion, 1995; Thieme, Flor, Turk, 2006; Turner, 1996; Turner, Clancy, McQuade, & 
Introduction 
 
“AFFECTIVE AND COGNITIVE ASPECTS IN FIBROMYALGIA: THE ROLES  OF CATASTROPHIZING AND ACCEPTANCE” 16 
 
Cardenas, 1990; Turner & Jensen, 1993; van Tulder, Koes, & Bouter, 1997; Vlaeyen et al., 1996; 
Von Korff, Moore, Lorig, Cherkin, Saunders, & Gonzalez, 1998; Wigers, Stiles, Vogel, 1996; 
Williams, Richardson & Nicholas, 1996). A recent meta-analysis about psychological treatments for 
fibromyalgia (Glombiewski et al., 2010) concluded that those groups of patients receiving CBT 
improved more compared to the waiting list control groups or groups that had participated in other 
forms of treatment. 
 
 Catastrophizing  
From the CBT perspective, researchers have consistently identified “catastrophizing” as a 
major clinical feature both in the chronic patient's symptom complex and also as a predictor of 
chronicity. Initially catastrophizing was conceptualised fairly specifically as a type of cognitive 
distortion (similar to the sorts of cognitive distortion found in depressed patients). According to 
Beck (1976), negative bias in information processing is maintained by general and systematic 
errors in logical appraisal. Catastrophizing, as originally defined, was, characterised by profoundly 
negative ruminations about one's present and future ability to cope, though often included in 
measures of coping strategies, it is probably best understood as a set of dysfunctional beliefs or 
appraisals (Jensen et al 1991). The tendency towards negative appraisal (or undue pessimism) 
has consistently been shown to be a better predictor of low pain tolerance, disability and 
depression than measures of disease activity or impairment, both at the time of testing and at long-
term follow-up (e.g. Keefe et al 1989). It may be based upon mistaken beliefs about pain and 
outcome of treatment, but is most clearly associated with depression. The cognitive distortion is not, 
however, simply a facet of depression, for it has been shown to be a significant predictor of self- 
reported disability and work loss even when the influence of pain severity and depression has been 
taken into account (Burton et al 1995, Main & Waddell 1991). 
The two most widely used self-report measures of catastrophizing are the catastrophizing 
subscale of the Coping Strategies Questionnaire (CSQ; Rosenstiel & Keefe 1983) and the Pain 
Catastrophizing Scale (PCS; Sullivan et al 1995). Both scales have been shown to have good 
psychometric properties and to be related to negative outcomes in response to acute and chronic 
pain experience (Rosenstiel & Keefe 1983, Sullivan et al 1995). An advantage of using the CSQ is 
that it includes six coping subscales in addition to the catastrophizing subscale. The 
catastrophizing subscale of the CSQ contains six items that are rated in relation to their frequency 
of occurrence on six-point scales with the endpoints (0) never and (5) almost always (Rosenstiel & 
Keefe 1983). The CSQ allows the clinician to examine a comprehensive profile of a patient's 
repertoire of adaptive and maladaptive cognitions associated with pain experience. 
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The PCS was developed specifically in order to assess catastrophic thinking associated 
with pain. The PCS yields subscale scores on three different dimensions of catastrophizing: 
rumination ('I can't stop thinking about how much it hurts') magnification ('I worry that something 
serious may happen') and helplessness ('There is nothing I can do to reduce the intensity of my 
pain'). The three-factor structure of the PCS has been replicated in clinical and non-clinical 
samples (Sullivan et al 1995, 2000, Osman et al 1997). 
The PCS total score and subscale scores are computed as the algebraic sum of the 
ratings for each item. PCS items are rated in relation to their frequency of occurrence on five-point 
scales with the endpoints (0) never and (4) almost always. The PCS is a 13-item self-report 
measure that can be completed and scored in less than 5 minutes, and thus is easily amenable to 
inclusion in standard clinical practice. 
Although individuals are sometimes dichotomized as catastrophizers and 
noncatastrophizers, most research treats catastrophizing as a continuous, normally distributed 
variable (Sullivan et al., 2001). Catastrophizing also exists on a continuum in healthy, pain-free 
individuals (Edwards et al., 2004); indeed, higher catastrophizing, assessed in pain-free adults, 
predicts the future development of chronic pain and pain-related health care utilization (Picavet et 
al., 2002; Severeijns et al., 2004). A rich area of debate has centered on whether catastrophizing is 
best conceptualized as a stable and enduring trait, such as a dimension of personality, or as a 
modifiable characteristic (Sullivan et al., 2001;Turner and Aaron, 2001), with some evidence 
supporting both positions. Several studies report a high test–retest stability of catastrophizing 
measured over time frames of up to a year in patients with rheumatoid arthritis and in other 
samples (Sullivan et al., 1995; Keefe et al., 1989). In contrast, catastrophizing often decreases 
when patients undergo cognitive-behavioral therapy (CBT; a set of psychologist-delivered 
interventions designed to facilitate the development of self-management skills, including regulating 
one's thoughts, emotions, and behaviors) (Jensen et al., 2001; Burns et al., 2003; Rodero et al., 
2008; Alda et al., 2011), indicating that catastrophizing can be altered by treatment. 
 
Catastrophizing is highly related to adverse outcomes Figure 1. Cross-sectionally, 
catastrophizing relates to higher pain severity, widespread pain and more emotional disturbance 
among individuals with fibromyalgia (Gracely et al., 2004; Viane et al., 2003; Hassett et al., 2000; 
Schochat et al., 2003; Rodero et al., 2010). In general, these associations persist even after 
statistically controlling for depression, anxiety, or neuroticism (Keefe et al., 2000; Affleck et al., 
1992).  
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Catastrophizing also shows positive associations with sensivity to pain. Specifically, 
measures of pain-related catastrophizing are well-known to correlate moderately to highly with 
counts of tender points in both clinic samples of fibromyalgia patients and in population studies 
(Gracely et al., 2003). 
 
 
Figure 1. Influence of Catastrophizing on Pain Related-Outcomes. Model proposed by Edwards et al., 
2011.  
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Hyperalgesia (that is, increased sensitivity to pain) is a central characteristic of fibromyalgia. 
Catastrophizing and depression are linked with patients' hyperalgesic responses (Lee et al., 2009), 
as they are associated with lower threshold and tolerance for thermal, electrical, and pressure pain 
among patients with fibromyalgia (Geisser et al., 2003; Campbell et al., 2010a). Interestingly also, a 
measure of catastrophizing that was collected during the actual assessment of pain responses was 
generally more predictive of hyperalgesia than a general questionnaire that measured patient recall 
of catastrophizing in day-to-day life (Campbell et al., 2010b). This finding highlights the value of 
assessing situation-specific indices of catastrophizing and emotional distress. 
 
In general, catastrophizing is strongly associated with measures of negative affect (Sullivan 
et al., 2001). Multiple investigators have documented positive associations between catastrophizing 
and depressive symptoms in fibromyalgia (Gracely et al., 2004; Hassett et al., 2000; Geisser et al., 
2003). Prospective studies have documented the association of high catastrophizing at baseline 
with increases in depressive symptoms over periods of up to 1 year in patients with fibromyalgia 
(Covic et al., 2003). It is likely that this relationship might in the future clarify why catastrophizing is 
also correlated with memory decrements (Jorge et al., 2009). Finally, it has been reported that 
catastrophizing and depression, especially when they co-occurred, were strongly related to the 
likelihood of recent suicidal ideation among patients with chronic musculoskeletal pain (Edwards et 
al., 2006). Of note, pain intensity was not predictive of suicidal ideation in this study, suggesting that 
cognitive and emotional factors, rather than symptom severity, could be the principal contributors to 
the increased risk of suicide among patients with persistent pain. Taken together, these findings 
suggest that in the context of chronic pain, catastrophizing may contribute to depressed mood on a 
short- and long-term basis.  
 
Disability is another adverse outcome related to catastrophizing. Occupational, recreational, 
and functional disability are common among patients with rheumatic disease, and pain is often cited 
as the primary reason for disability (Woolf and Pfleger, 2003). Psychosocial processes are 
important contributors to disability in the context of persistent pain, and catastrophizing is strongly 
associated with self-reported physical limitations, a reduced likelihood of returning to work, and 
impaired performance on tests of physical function (Gauthier et al., 2006; Evers et al., 2003; 
Goubert et al., 2004). 
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Finally, catastrophizing seems to also be related to enhanced inflammatory disease activity. 
Perceptions of helplessness have been linked to increased systemic inflammation (Evers et al., 
2003) - for example, as measured by levels of high-sensitivity C-reactive protein [CRP] (Dessein et 
al., 2004) - and early mortality (Keysor et al., 2004). Recent work also evaluated associations 
between catastrophizing and systemic levels of proinflammatory cytokines. In a sample of healthy 
adults, those who exhibited the most catastrophizing during a session of quantitative sensory 
testing also showed the highest elevations in interleukin (IL)-6 in the 60 min following the evaluation 
(Edwards et al., 2008).  
There have been several hypothesized Pathways of Action but further studies are needed 
to clarify these associations. The pathways suggested have been classified as behavioral, cognitive 
and physiological pathways: 
 
Behavioral pathways 
Limiting health-improving behaviors: Catastrophizing and depression reduce the likelihood 
of exercise and other health-promoting behaviors among patients with chronic pain. Helplessness 
specifically correlates with less-effective use of medication (Neame and Hammond, 2005) and 
decreased performance of positive health behavior such as exercise (Castaneda et al., 1998); 
these are plausible pathways by which psychosocial distress could enhance disease, amplify pain, 
and promote mortality. Finally, sleep is another class of health behavior that contributes to the 
hyperalgesia in patients with rheumatoid arthritis (Lee et el., 2009), osteoarthritis (Smith et al., 
2009), and widespread (fibromyalgia-like) pain (Gupta et al., 2007), this is likely to constitute one of 
the pathways by which depression and catastrophizing contribute to deleterious pain-related 
outcomes in patients with rheumatic disease. 
 
Interfering with adaptive pain-coping mechanisms: Negative cognitive and affective 
processes such as perceived helplessness and pessimism (for example, "There is nothing I can do 
to reduce the pain") can prevent high-catastrophizers from employing potentially effective pain-
coping strategies (such as distraction), which prevents them from realizing the potential benefits of 
those coping techniques (Quartana et al., 2009). Even when individuals who demonstrate high 
levels of catastrophizing do use coping strategies such as distraction, they are less efficient in 
reducing pain (Campbell et al., 2010a).  
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Impairing social interactions: Social forces can shape a range of health-related outcomes, 
and pain is no exception. A considerable amount of research also suggests that catastrophizing can 
exert profound effects on patients' social environments: some researchers have postulated that 
catastrophizing might serve a communicative function with the goal of attracting social support 
(Lackner et al., 2004). In support of this hypothesis, patients who report high levels of 
catastrophizing tend to report the most solicitous responses from their social environment, and to 
demonstrate an insecure adult attachment style (McWilliams and Asmundson, 2007).  
 
Cognitive pathways 
High levels of catastrophizing may produce biases related to information-processing and 
attention to pain that can lead individuals to selectively and intensely attend to pain-related stimuli 
(Quartana et al., 2009). Those who catastrophize about pain experience more difficulty in 
controlling or suppressing pain-related thoughts than do non-catastrophizers; the former individuals 
also ruminate more about their pain sensations, and anticipation of pain disrupts their performance 
of cognitive and physical tasks to a greater degree (Quartana et al., 2009). In a recent study, pain 
catastrophizing was associated with reduced cognitive- task performance during the administration 
of painful stimuli (Vancleef and Peters, 2006). Similarly, fibromyalgia patients with severe 
depression (mean Beck Depression Inventory score of 26) showed information-processing biases 
that included a tendency to selectively focus on negative illness-related words to the exclusion of 
pleasant words, and a tendency to ruminate about the meaning of pain-related words (Sitges et al., 
2007). Collectively, the results of these studies suggest that individuals who exhibit high levels of 
depressive symptoms or who frequently catastrophize about pain are most likely to anticipate pain, 
to interpret ambiguous signals as being related to pain, to attend to pain-related visual cues, and to 
experience interference of pain with other cognitive activities. 
 
Physiological pathways 
Alterations in CNS pain processing: Incoming signals in the CNS are subject to modulation 
(both facilitation and inhibition) at a variety of sites. One of the mechanisms by which 
catastrophizing is thought to influence the experience of pain is by promoting sensitization and/or by 
interfering with endogenous pain inhibition in the CNS (Campbell and Edwards, 2009), a hypothesis 
that can be readily investigated using noninvasive functional neuroimaging methods such as 
functional MRI (fMRI). Among patients with fibromyalgia, for example, those who catastrophized 
most showed the greatest extent of activation in pain-processing brain areas such as the anterior 
cingulated, the dorsolateral prefrontal cortex and the periaqueductal gray during the administration 
of calibrated noxious stimuli (Gracely et al., 2004; Burgmer et al., 2011). Taken together, these 
functional neuroimaging studies highlight the roles of negative cognitive and emotional processes in 
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amplifying transmission of pain-related signals in the cortex. Interestingly, structural neuroimaging 
studies are increasingly revealing that patients with chronic low back pain, fibromyalgia, and other 
chronically painful conditions exhibit loss of gray and white matter in certain brain regions associ-
ated with pain processing (Buckalew et al., 2008; Lutz et al., 2008).  
 
Hypothalamic-pituitary-adrenal axis dysfunction: Recent studies have evaluated the links 
between neuroendocrine dysfunction, pain, and psychosocial processes in patients with rheumatic 
diseases. Among patients with chronic back pain, those with the highest levels of catastrophizing 
and depression showed a flattened (or blunted) diurnal rhythm of endogenous glucocorticoids 
(cortisol) (Johansson et al., 2008), which, in previous studies, was identified as a prospective risk 
factor for adverse pain outcomes such as the development of widespread pain complaints (McBeth 
et al., 2007). Moreover, numerous reports have linked fibromyalgia symptoms with dysfunction in 
the hypothalamic-pituitary-adrenal (HPA) axis (Riva et al., 2010), and a large prospective study 
reported that altered circadian patterns of cortisol secretion (including a blunted cortisol response 
upon awakening) were risk factors for the development of chronic widespread pain (McBeth et al., 
2007). The HPA abnormalities observed in fibromyalgia are strongly related to psychosocial factors, 
especially symptoms of depression, which have consistently been correlated with hypocortisolism 
(Gur et al., 2004a; Gur et al., 2004b). Indeed, recent fibromyalgia studies suggest that emotional 
distress, rather than pain, is the primary driver of HPA axis dysfunction (Wingenfeld et al., 2010).  
 
Genetic influences: Several studies hint at a potential genetic underpinning for some of the 
overlap between pain, depression and catastrophizing. Recent work has focused on the gene 
coding for catechol-O-methyltransferase (COMT), an enzyme that degrades catecholamines (which 
in turn affect the functioning of endogenous opioid systems). To date, certain COMT genotypes 
have been associated with widespread pain (Cohen et al., 2009), depression (Fijal et al., 2010), and 
enhanced sensitivity to pain (Diatchenko et al., 2005). A daily diary study in patients with 
fibromyalgia reported a significant interaction between COMT genotype and pain fluctuations, such 
that individuals with the 'high pain sensitivity' genotype experienced a greater decline in positive 
emotion on days when pain was elevated than did individuals with other COMT genotypes.  
 
In conclusion, the literature on catastrophizing in the rheumatic diseases strongly implicates 
this factor as having a profound long-term influence on the shaping of pain responses and pain 
outcomes. To date, abundant evidence suggests that pain catastrophizing can serve as a 
prospective marker of risk for negative pain-related endpoints including severe physical disability, 
disease progression, and non-improvement following surgical or psychological interventions. 
Further research in this area should help tailor psychological interventions to individual 
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characteristics, and it seems likely that catastrophizing will be an important factor to consider in the 
selection of individualized treatments (see Edwards et al., 2011 for a review). 
 
 
d.  Acceptance and Commitment Therapy (ACT) Model. 
 
Studies from within a broad CBT framework have made a large contribution to our 
understanding and management of chronic pain over the past 20 years. This remains the popular 
approach today and has not been the target of much systematic criticism (Turk and Okifuji 2002). 
However, some limitations include the following: many chronic pain sufferers do not benefit from 
treatment to any discernible degree; we cannot reliably predict who will benefit and who will not; 
treatment programs are unique, making direct comparisons impossible; maintenance of treatment 
gains is a continuing challenge; and more important, specific mechanisms of treatment remain 
unknown. Of the several challenges that face cognitive-behavioral approaches today, the issue of 
treatment mechanism is, arguably, the most specific and important for the future. Within cognitive-
behavioral therapy a central role is given to method aimed at change in the form or frequency of 
particular thoughts and beliefs, which leads to other changes in patient behavior. Some data from 
outside pain management indicate that this model may be limited. For example, Longmore and 
Worrel (2007) concluded a recent review about CBT outcomes pointing out that ”…there is little 
empirical support for the role of cognitive change as causal in symptomatic improvements achieved 
in CBT..”. 
 
In this context, a number of therapies, under the name of the Third Wave of therapies, have 
been developed: Dialectical Behavior Therapy (DBT; Linehan, 1993), Functional Analytic 
Psychotherapy (FAP; Kohlenberg & Tsai, 1991), Integrative Behavioral Couples Therapy (IBCT; 
Jacobson & Christensen, 1996), and Mindfulness-Based Cognitive Therapy (MBCT; Segal, 
Williams, & Teasdale, 2002), among several others (e.g., Martell, 2001; McCullough, 2000). 
Acceptance and Commitment Therapy (ACT, Hayes, Strosahl, & Wilson, 1999) also pertains to this 
group. 
 
A major theme put forward in the ACT model (Hayes, Strosahl, & Wilson, 1999; Hayes & 
Wilson, 1993, 1994; Hayes, Wilson, Gilford, Follette, & Strosahl, 1996; Luciano & Hayes, 2001) is 
that attempts to control negatively evaluated aspects of experience may, in some contexts, actually 
increase suffering. In ACT, clients are asked to examine whether attempts at control have had 
beneficial effects over the long term. Instead of alleviating or controlling the "problem" (which is 
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usually conceptualized as the presence of aversive private experience), the client learns in ACT to 
accept private experiences and focus instead on long-term meaningful goals. 
 
From an ACT perspective the process of allowing symptoms to "get into the driver seat" is 
both logical and pathological. Popular culture embraces the notion that positive emotions, 
cognitions, and bodily states cause good behavior and negative emotions, cognitions, and bodily 
states cause bad behavior. We expend enormous effort in our schools and workplaces teaching 
people to feel more confident, to have higher self-esteem, to be cheerful and optimistic and to avoid 
pain. From the time we are little children we are taught that we can and should control negative 
aspects of experience. We are taught that we have the to go through life without pain and stress 
and that we, in fact should steer clear of these feelings. 
 
Others who have looked at pain from a medical-social-historical perspective have reached 
the same conclusion (Johannisson, 1997; Allen and Waddell, 1989; Waddell, 1991). Our negative 
reactions to pain are not purely instinctive - they are culturally imposed. They suggest that our 
attitude towards pain changed with the introduction of painkillers. The definition of anesthesia 
means literally to "not feel." But prior to the 17th century where painkillers did not exist yet, pain 
was accepted as an unavoidable part of life. It is not that pain itself has increased - rather our 
willingness to accept pain that has decreased. Ironically, they suggest that the seed of this shift is 
treatment itself: when pain was unavoidable, humans accepted, tolerated, and lived with integrated pain but 
when pain became avoidable it became, naked and unbearable (Johannisson, 1997; Waddell, 1991). 
This suggests that intolerance of pain is a modern phenomena created by the spread of 
commercially available painkillers. 
 
 
From an ACT point of view all of this is quite normal, and indeed is build into human 
cognition itself. Social institutions that used to resist these processes, particularly spiritual and 
religious traditions, have been greatly weakened in their ability to restrain what is quite logical. ACT 
is based on comprehensive theory of language and cognition called Relational Frame Theory (RFT: 
Hayes, Barnes-Holmes, & Roche, 2001). There about 70 studies supporting the tenants of RFT, 
which in its simplest form states human language is based on the learned ability to arbitrarily relate 
events. The simplest verbal problem solving situation requires that the person relate words to 
objects and events ("here is the problem and the objects I have to solve it"), to relate now to then 
("if I do this, then that will happen"), and to relate comparatively ("if that happens it would be better 
than my current situation"). 
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What happens when this repertoire is brought to bear on negative feelings or thoughts? 
Comparatively and evaluatively, they are undesirable. It is "better" to feel good than bad. 
Temporally, now can be related to better “thens” ("I used to feel better than I do now. I need to feel 
better again in the future"), and action can be taken on this basis (“if I rest more, I will feel better"). 
From an RFT perspective it is not possible to have verbal problem solving repertoire without having 
the ability to focus this repertoire on feelings and thoughts. When one does so, experiential 
avoidance is the result. Experiential avoidance is the attempt to alter the form, frequency, or 
situational sensitivity of private events (e.g., thoughts, emotions, memories, bodily sensations), 
even when attempts to do so cause behavioral harm. 
 
Verbal problem solving strategies work very well with external objects ("if a plant the seeds 
now I will have food later") which is why the weak, frail creatures called human beings have taken 
over the planet. These same strategies often work horribly when applied to historically produced 
private experiences. Verbal rules that specify private events to be avoided generally contain the 
verbal seeds of these very events. For example, trying deliberately to avoid thoughts of pain is likely 
to be unsuccessful because the rule being followed will a) remind the person of these very thoughts, 
and b) may contain memories, worries, or verbalized consequences that are themselves painful. 
Furthermore, avoiding pain makes pain and possible signs of pain more, not less, behaviorally 
relevant. In addition, the actions taken to avoid pain may produce patterns of action that are narrow, 
rigid, and less valued. 
 
Experiental avoidance predicts poorer long-term outcomes in a wide variety of 
psychological problems (Hayes et al., 1996). Examples include depression (Bruder-Mattson, & 
Hovanitz, 1990; DeGenova, Patton, Jurich, & MacDermid, 1994), survivors of child sexual abuse 
(Leitenberg, Greenwald, & Cado, 1992; Polusny & Follette, 1995), other traumatic events (Foa & 
Riggs, 1995), alcoholism (Cooper, Russell, Skinner, Frone, & Mudar, 1992; Moser & Annis, 1996), 
and many others. The experimental literature is fairly clear that avoidance and suppression of 
private events tends to increase their frequency and impact in normal populations as well (Purdon, 
1999). Wegner in his studies of thought suppression (e.g., Clark, Ball, & Pape, 1991; Gold & 
Wegner, 1995; Wegner, Schneider, Carter, & White, 1987; Wegner, Schneider, Knutson, & 
McMahon, 1991) have shown that attempts to suppress thoughts result in immediate suppression, 
but later rebound from the thoughts to even higher levels. Higher levels of the aversive thought may 
set the stage for yet another round of suppression and subsequent rebound. This sort of self-
amplifying loop bears striking similarity to the sort of catastrophic thinking that some cognitive 
interventions seek to stop. Gold and Wegner (1995) call this an "ironic process''- where attempts to 
reduce some cognition actually facilitate its propagation. 
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ACT claims that experiential avoidance is built into the normal functions of essential forms 
of human language (e.g., problem solving), and is then expanded by cultural forces. If this is true, it 
requires that less typical functions of human language must be developed, since it would be unwise 
to attack essential forms of behavior. From an ACT perspective, “Psychological Flexibility” is the 
main target.  Psychological Flexibility is a process based in the interaction of cognition and direct 
environmental contingencies that allows a person´s behaviour to persist or change in line with their 
long term goals and values (Hayes et al., 2006). This is done in five ways: acceptance, defusion, 
contact with the present moment, self-as-context, and values. These processes have all been 
extensively discussed in the ACT literature (Hayes et al., 2004; 2006; Cheung et al., 2008; Mason 
et al., 2008; McCracken, 1998; McCracken et al., 2007; McCracken and Thompson, 2009; 
McCracken and Velleman, 2010; McCracken and Vowles, 2008; McCracken and Yang, 2006; 
Nicholas and Asghari, 2006; Rodero et al., 2010; Rodero et al., in press; Strosahl, Hayes, Wilson, & 
Gifford, 2004; Viane et al., 2003; Wilson & Blackledge, 2000; Wilson, Hayes, Gregg, & Zettle, 2001; 
Wilson & Luciano, 2002). Let us briefly look at one of each component: 
 
Acceptance: From an ACT perspective, negative cognition, emotion, and bodily states may, 
but need not, produce bad behavioral outcomes. In ACT the natural experiential avoidance agenda 
built into human language is challenged on the basis of workability, with the goal of bringing literal 
language under better contextual control. Instead of avoidance and control, ACT teaches patients 
how to accept and embrace private experience in the service of chosen values. 
 
Defusion: Involves learning to see thinking as an ongoing process, and rather than treating 
its products as a window on reality, to view them as fallible tools to get things done. The same 
verbal relations that are useful in solving external problems may be unhelpful in "solving" the 
emotional and cognitive results of our history and current situation. In scores of ways, ACT provides 
contexts in which language and thought is looked at rather than looked from - in hopes that patients 
can both use literal language when it is helpful to do so and to simply be mindful of the process 
when it is not. 
 
Contact the present moment: Contacting the present moment as a conscious person 
provides some restraint on the usual process in which thoughts pull us into the past or future. Life 
always occurs here and now. Learning to contact the here and now gives patients a way to begin to 
let go off the struggle with one's own insides since, like all "problem solving" this struggle is based 
on the idea that one must be somewhere else other than here to begin to live.  
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Self as context: It is helpful to support the client, as they learn defusion and acceptance 
techniques, in finding a safe, humane place from which exposure can be done. Mindfulness and 
acceptance lead naturally to a transcendent sense of self (self as context) as the client starts to 
disidentify themselves with their own thoughts and feelings. The purpose is to establish a sense of 
the client as distinct from the psychological content that is being struggled with. Normal humans are 
conscious, verbal beings. By connecting with that sense of continuity of consciousness it is more 
possible to open to feared events, without a sense of imminent self- destruction. 
 
Values: The most important process of all is values, since values provide the motivation to 
make change. When a person gets stuck in a  chronic symptom such as pain by yielding to the 
problem and beginning to struggle with it, it is not just that symptoms occupy a larger and larger 
portion of that person's life - it is that valued and meaningful actions occupy less and less. As the 
avoidance agenda grows, the person loses flexibility and life quality and the individual's activities 
and thoughts become organized around prevention of pain or short-term symptom alleviation. 
Fighting the symptoms overshadows other valued directions and activities. Like a lighthouse in a 
storm, values provide a way forward toward a more meaningful and vital life, and help the person 
see how far off course experiential avoidance and cognitive fusion has taken them. 
 
The components of an ACT functional analysis of chronic pain are shown in Figure 2 and 
Figure 3. In the context of initial pain and stress, the client has fused with pain related thoughts and 
used experiential avoidance strategies as a dominant form of pain-related coping. These processes 
have been strengthened by such factors as initial negative reinforcement but a reduction in pain or 
stress (due to avoidance) and social / verbal support (e.g., support for being right; having a 
coherent explanation). As these verbal regulatory processes have dominated, the person has lost 
effective contact with the vitality the present moment affords, and they have become more 
entangled with their story about themselves and their life. Meanwhile, a valued life is put on hold, 
often so completely that the person is not really clear about what they want in their lives. This entire 
package is resulting in more rigidity and a loss of vitality, which further increases negative thoughts 
and feelings, leading to still more avoidance and fusion, and still less values based action. A self- 
amplifying loop emerges as the person slides into chronic pain syndrome. 
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Figure 2. A model of an ACT formulation of chronic pain Dahl et al., 2005. 
 
This analysis shares some features with a traditional CBT functional analysis. Situational 
antecedents and consequences are still relevant; thoughts and feelings are still relevant; and so on. 
What is different is that the form of difficult content is not a focus of the analysis. Thoughts are not 
parsed into rational or irrational varieties. Pain or stress is not presumed to be something that must 
be diminished. Instead, the key issue is one of function, and the analysis and the treatment 
components tied to it are centered on creating more flexible forms of responding linked to the larger 
life values of importance to the client. 
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Figure 3. An ACT model of intervention for chronic pain Dahl et al., 2005. 
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 Acceptance 
 
 Medical conditions such as chronic pain and stress fit readily info an experiential avoidance 
perspective. Because of some of the special properties of language, we avoid thoughts of an 
aversive event such as pain or stress, very much as we avoid the aversive event itself. For example, 
if we ask the reader to think about having their teeth drilled, they will likely resist that thought, even 
though there are no drills present in their environment. Any event related to that thought will also 
begin to be avoided. If pain and stress are associated with work, work activities or the working place, 
all of these will tend to be avoided - both in thought and in action. A serious pain problem and 
diagnosis is not something that is easy to hear or to think about. A permanent pain diagnosis is 
worse news still. However, an unwillingness to remain mindful of the pain/stress symptoms can 
have serious consequences. If an individual is unwilling to think about their pain and feelings of 
stress, consider all of the events that might be associated with these symptoms that would also 
need to be avoided such as doctors, medication, symptoms, work-events, work activities, and 
physical movement that precipitate the pain/stress reactions. In principle, all of the procedures that 
could be used to manage pain and stress will all serve to bring the concept of pain into the 
psychological present. 
 
If the ACT and RFT view of this process is accurate, what is needed in behavioral medicine 
is both the procedures that could help the patient to manage their medical condition and skills to 
cope with psychological reactions to having that condition through values, acceptance, defusion, 
and contact with the present as a conscious person. That combination is beginning to receive 
support in other areas of behavioral medicine such as diabetes management (Gregg, 2007), anxiety 
(Forsyth et al., 2008), depression (Strosahl and Robinson, 2008), anorexia (Heffner and Eifert, 
2004), epilepsy (Lundgren et al., 2004), obesity (Lillis, 2008), tinnitus (Westin et al., 2011), insomnia 
(Lundh, 2005), and cancer and terminal illness (Feros et al., 2011). 
 
We now know that experiential avoidance is one of the most powerful predictors of chronic 
pain (Wicksell et al., 2008; 2009). The original ACT measure of experiential avoidance, Acceptance 
and Action Questionnaire (Hayes, Nelson and Jarret, 1987) was modified to apply to chronic pain 
(Geiser, 1992), and developed in a series of studies by McCracken and his colleagues (McCracken, 
1998; McCracken, Vowles, & Eccleston, 2004). Work with the resulting Chronic Pain Acceptance 
Questionnaire (CPAQ) shows that there are two primary aspects of the pain acceptance concept: a) 
willingness to experience pain and b) engaging in important life activities regardless of pain 
(McCracken et al., 2004). Pain acceptance of pain is associated with reports of lower pain intensity, 
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less pain-related anxiety and avoidance, less depression, less physical and psychosocial disability, 
more daily uptime, and better work status. A relatively low correlation between acceptance and pain 
intensity showed that acceptance is not simply a function of having a low level of pain. Acceptance 
of pain predicts better adjustment on measures of patient function better than perceived pain 
intensity, and that continues to be true even when pain intensity is factored out. Interestingly, in a 
2011 study from our group, it reported that acceptance of pain was not only associated with less 
pain, symptoms, disability, anxiety, and depression but also with better general health, vitality and 
physical and social functioning (Rodero et al., 2011). 
 
From the pathology-oriented perspective described earlier, removal of pathology is 
supposed to free the individual to pursue whatever life direction they might take. From an ACT 
perspective, it is more powerful to move toward this behavioral end more directly. The struggle 
to avoid or reduce pain is not necessary in to that end, indeed this struggle often intensifies the 
centrality of pain and interferes with a life that is lived persistently in the pursuit of one's values. 
ACT is aimed squarely at helping clients to relinquish this struggle in order to live a life in pursuit 
of their most deeply held values. So far this approach is showing promising results (for review 
see Dahl, Wilson, Luciano and Hayes, 2005). Even surprisingly short ACT interventions (e.g., 
four hours) can make significant differences in terms of sick listing, health care and medication 
utilization and quality of life for individuals suffering from chronic stress and pain symptoms 
(Dahl, Wilson and Nilsson, 2004). 
 
In conclusion, research and clinical developments over the past 20 years are beginning to 
shed new light on thoughts, sensations, emotions, their role in influencing behavior, and the 
particular ways in which private experiences contribute to human suffering (e.g. Hayes et al., 2001). 
This has led to different approaches to treating a broad array of behavior problems, approaches 
that incorporate a partnership of acceptance and change. We have defined acceptance of chronic 
pain as an active willingness to engage in meaningful activities in life regardless of pain-related 
sensations, thoughts, and other related feelings that might otherwise hinder that engagement. It is 
about not engaging in unnecessary struggles with private experiences, struggles that often intensify 
the aversiveness of those experiences and enhance their life disrupting influences. 
What is novel about this approach is that it is not simply a new psychological variable but a 
description of a different set of processes of pain and suffering. This approach is fully situated within 
the broader empirical tradition of the behavioral and cognitive therapies. Indeed, the American 
Society of Clinical Psychology (APA’s Division 12) has recently listed ACT as having “strong 
research support” for the treatment of chronic pain. They reached the next conclusion: "There is 
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substantial basic research supporting ACT's fundamental processes, and preliminary evidence 
regarding their mediational role in ACT outcomes. As of late 2011, there are at least 11 clinical trials, 
including several that are randomized and controlled, demonstrating that ACT improves some 
outcomes in heterogeneous chronic pain samples, particularly functioning and mood, although pain 
severity may be less affected. ACT is superior to wait-list or no treatment, and thus far 
demonstrates outcomes for chronic pain that are comparable to CBT (Dahl and Lundgren, 2006; 
Dahl, Wilson and Nilsson, 2004; Dahl et al., 2005; Hayes, 2005; Luoma, Hayes and Walser, 2007; 
McCracken, Vowles and Eccleston, 2005; McCracken, 2005; Vowles and McCracken 2008; Vowles 
and Thompson 2011; Wetherell et al., 2011; Wicksell et al., 2008; Wicksell et al., 2009)”. The 
examination of its potential merits is already underway. 
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1) To validate the Pain Catastrophizing Scale (PCS) and the Chronic Acceptance 
Questionnaire (CPAQ) into Spanish in a fibromyalgia sample and assess their associations 
and correlations with several sociodemographic and outcomes measures. 
 
2) Regarding Catastrophizing: 
 
a. A rich area of debate has centered on whether catastrophizing is best 
conceptualized as a stable and enduring trait, such as a dimension of personality, 
or as a modifiable characteristic. Therefore, more research related to 
catastrophizing treatment is necessary to confirm whether it can be altered by 
treatment. Furthermore, it is unclear if rumination is the most important component 
and if imagined exposure might be a useful technique to reduce the rumination 
score. 
 
b. It has been proposed that the development of fibromyalgia involves an interaction 
between the experience of pain and catastrophizing, but it is unclear when and how 
this cognitive construct first becomes important. Consequently, there is a need to 
study the relationship between catastrophizing and dysfunction in relation to the 
development of fibromyalgia. We use cross-sectional comparisons where different 
stages of chronicity provide a proxy for the development process. 
 
c. It is also unclear whether the three components of catastrophizing (rumination, 
magnification, and helplessness) contribute equally to the prediction of dysfunction 
in fibromyalgia or whether certain components are more predictive than others. 
Information concerning the relative importance of the components of 
catastrophizing could help treatment providers to tailor interventions to facilitate 
positive outcomes. 
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3) Regarding Acceptance of pain: 
 
a. It has been established that the coping behavioural strategies are valuable in 
predicting important aspects of patient wellbeing and functioning. However, it is 
expected that acceptance of pain measures, accounted for even more variance in 
the outcomes scores. Therefore, acceptance will show a greater utility in 
comparison with the behavioural coping strategies. 
 
b. The findings will also permit us to observe differences between acceptance and 
behavioural strategies and to elucidate the targets of intervention in fibromyalgia 
patients.
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3.1 SEPARATA DEL ARTÍCULO 
 
Imagined exposure as treatment of catastrophizing in fibromyalgia: a pilot study.  
Rodero B, García J, Casanueva B, Sobradiel N. 
Publicado en: Actas Esp Psiquiatr. 2008 Jul-Aug;36(4):223-6.  
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tro de un tratamiento cognitivo-conductual (TCC) en el
dolor crónico.
Diseño. Diseño cuasi-experimental, de serie tempo-
ral, de un solo grupo. Con medida pretratamiento y pos-
tratamiento con y sin tratamiento.
Pacientes y método. Un grupo de pacientes (n=8)
(siete mujeres y un hombre) con fibromialgia diagnosti-
cados según los criterios del American College of Rheu-
matology (ACR). El TCC consistió en 11 sesiones de gru-
po y tuvo una duración de 15 semanas. Los pacientes
fueron valorados al inicio y al final del programa. Se es-
tudiaron las siguientes variables: la escala analógica vi-
sual (EAV), el nivel de catastrofismo y rumiación (PCS),
el Cuestionario de Impacto de Fibromialgia (FIQ) y la
sintomatología ansioso-depresiva (HADS). 
Resultados. Aunque se encontraron mejoras en to-
das las variables, no se evidenciaron diferencias estadís-
ticamente significativas en la EAV, el FIQ ni en la HADS.
Sí se evidenciaron diferencias estadísticamente significa-
tivas en el PCS (p<0,05) y en sus tres subescalas. Ade-
más el descenso en la puntuación de la rumiación con la
exposición en imaginación fue superior.
Conclusiones. El TCC es un tratamiento eficaz tanto
para el descenso del catastrofismo como de la rumiación.
La técnica de exposición en imaginación pudiera poten-
ciar en determinados casos esos resultados. Se necesitan
estudios con muestras más amplias para corroborar estos
resultados.
Palabras clave: 
Dolor. Catastrofismo. Rumiación. Tratamiento cognitivo-conductual.
INTRODUCTION
According to the current cognitive-behavioral models,
one of the most relevant mediating variables in chronic
pain (CP) is catastrophism (C)1. For most individuals, pain is
interpreted as unwanted and unpleasant, but not as catas-
trophic or terrible. On the contrary, for a minority of the
subjects, the experience of pain would have a catastrophic
interpretation and would lead to fear (of pain or of re-in-
Introduction. We want to assess the effectiveness of
a new approach (imagined exposure) for the Cognitive
Behavioural Treatment (CBT) in fibromyalgia.
Study design. Quasi-experimental design of a tem-
porary nature in a single group with pre and post and
with/without treatment.
Subjects and methods. Fibromyalgia patients, who met
the American College of Rheumatology’s criteria for FM. In
this study eight people took part, seven females and one
male, selected from fibromyalgia Cantabria Association. The
CBT consisted of 11 group sessions and lasted 15 weeks. All
patients were evaluated before and after the program. The
data were based on the following scales: visual-analog scale
(VAS) for pain intensity, the Fibromyalgia Impact Question-
naire (FIQ), the Pain Catastrophizing Scale (PCS) and the
Hospital Anxiety and Depression Scale (HADS). 
Results. Despite finding improvements in every var-
iable, no significant differences were found between pre
and postreatment in VAS, HADS and FIQ. However, after
treatment, significant differences were found in PCS (p<
0.05), and its three subscales. Moreover, rate decrease in
rumination was higher after imagined exposure.
Conclusion. These results suggest that CBT is effec-
tive either in catastrophizing decreasing or in rumination.
Imagined exposure may enhance the results in particular
cases. Further studies with larger samples are needed to
confirm these results.
Key words:
Pain. Catastrophizing. Rumination. Cognitive-behavioural therapy.
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Introducción. Se requiere determinar la eficacia de
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jury) and towards a vicious circle of fear-avoidance that
would limit activities and cause incapacity and pain. Catas-
trophism refers to a combination of negative thoughts and
expectations regarding pain1 that positively correlates with
greater intensity of the pain, emotional malaise, muscle and
joint weakness, incapacity, and worse results from the treat-
ment2. C is made up of three dimensions: magnification, 
rumination and helplessness3. Rumination refers to the fact
that the patient cannot get the idea out of his/her head,
cannot stop thinking about the pain; magnification, the
exaggeration of the threatening properties of the painful
stimulus and helplessness refers to the estimation that the
person has of not being able to do anything to influence
the pain. Of these three components, that which has the
most consistent relationship with pain intensity is rumina-
tion4. That is, the recurrent character of these thoughts plus
their negative aspect is that which is associated to greater
pain and worse functioning. 
The thought-stopping technique has long been used in
the treatment of emotional disorders in which there is ru-
minations, obsessions or worries (such as Post-traumatic
Stress Disorder, Obsessive-Compulsive Disorder or Genera-
lized Anxiety Disorder). Currently, it is known that even
though thought stopping can be effective in the short term,
this technique seems to have a negative long term impact
in this type of thinking, since these thoughts are accom-
panied by greater emotional malaise4-6. Another cognitive
technique proposed as treatment has been distraction. The
results obtained are similar to those of thought stopping so
that it is currently considered that this technique does not
provide much help for patients with chronic pain7. On the
contrary, one of the techniques that has been shown to be
most effective for the treatment of ruminations is imagined
exposure8. This consists in exposing the patient to the feared
stimuli in a hierarchical way to activate all the feared
areas (memory, emotion, cognition) without permitting avoid-
ance or escape (neutralization, suppression, distraction) 
until the anxiety level is reduced. The results support the ef-
fectiveness of this technique for a true suppression of the
undesired thought. Although it is considered that the rumi-
nations do not seem to be as intense in CP as in other emo-
tional disorders as, for example, generalized anxiety disor-
der8, this technique could be of great utility in patients with
excessive ruminations. Thus, the objective that we propose
in this pilot study is to check if the imagined exposure can
reduce rumination in patients with CP, specifically in fib-
romyalgia. In addition, it is hypothesized that when rumi-
nation is reduced, C and pain intensity is also decreased. 
METHOD
Design
Quasi-experimental design, temporal series, of a single
group, with pre- and post measurements, with and without
treatment.
Participants
The sample is made up of 8 adult persons, 7 women and
1 man who met the American College of Rheumatology cri-
teria for fibromyalgia. The patients participating in this pilot
study were obtained from the Cantabria Association of fi-
bromyalgia which is a reference site for the Regional Com-
munity of Cantabria (approximately 550,000 inhabitants).
Evaluation tests
Fibromyalgia was diagnosed with the clinical interview
according to the diagnostic criteria. The interview was con-
ducted by a Rheumatologist with wide clinical experience.
The tests used were:
— Visual analogue scale (VAS). On a 10 cm. long straight
line whose tips represent the limits of pain intensity
(none-unbearable). The patients estimated the pain
intensity experienced on the same day and in the last
week between 0-10.
— Fibromyalgia Impact Questionnaire (FIQ)9. This evalu-
ates the current condition of women with fibromyalgia
syndrome. The FIQ is a self-administered instrument
made up of 10 items that measure physical impair-
ment, work functioning, depression, anxiety, sleep,
pain, stiffness, fatigue and well-being. This instrument
has adequate reliability and validity, which justifies its
use in the clinical practice and in research.
— Hospital Anxiety and Depression (HADS)10. This is aimed
at evaluating anxiety and depression without confusing
the somatic symptoms characteristic of depression and
anxiety with the medical disease of the patient. This self-
administered questionnaire consists in 14 items, and is
made up of two subscales of 7 items, one aimed at eva-
luating depression and the other anxiety.
— Pain Catastrophizing Scale (PCS)3. It was used to me-
asure catastrophist thinking regarding the pain. It is a
scale made up of 13 items and three subscales: mag-
nification, rumination and helplessness. The score
used is a Likert scale from 0 to 4 points. This instru-
ment has been validated in Spanish by our team11.
Procedure
Evaluation
The evaluation measures were those of pre-treatment
and post-treatment, except for C that was also measured
two months prior to the intervention. All the scales are self-
administered by the patient.
Treatment
Different studies and meta-analyses have indicated the
great clinical utility and low cost of cognitive-behavioral
Imagined exposure as treatment of catastrophizing in fibromyalgia: a pilot studyB. Rodero, et al.
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treatments (CBT) for CP12. The manual proposed by Thorn13
was used for the treatment. This is a 10 session CBT to
which we added one "«extra» session. 
Session 1: the connection between stress and pain. Ses-
sion 2: identification of automated thoughts. Session 3:
evaluation of automated thoughts. Session 4: questioning
the automatic thoughts and constructing alternatives. Ses-
sion 5: nuclear beliefs. Session 6: nuclear beliefs on the
pain. Session 7: changing the coping. Session 8: coping with
ruminations-obsessions-worrying. Session 9: expressive writ-
ing. Session 10: assertive communication. Session 11: final
session.
The session added corresponds to number 8, after begin-
ning with the coping section. This is especially directed at
the subjects who show high rumination and consists in in-
structing the patients to write a story about the worse possi-
ble scenario imaginable for the future based on their great-
est fear, stressing those aspects that would generate the
greatest emotional malaise (How do you see yourself in this
situation? What do you think?, How do you feel?, etc.). The
story is recorded on a tape for subsequent presentation to
the patient. It is then recommended to them that they
should listen to this story between 30 and 60 minutes
(enough time for them to become habituated) until said
story no longer causes anxiety (in general between 10 and
15 sessions of exposure)13.
Statistics
Means and standard errors of mean, T test for compari-
son of two dependent samples and contrast for the signifi-
cance of the Pearson correlation between two quantitative
variables were obtained.
RESULTS
A total of 8 patients finally participated in the study, 2 of
whom were lost to follow-up. There were no statistically
significant differences of the two patients who dropped out
in relationship with the total of the participants in the
study regarding the demographic variables analyzed. All the
patients were women except for one. Mean age was 50.5
years. Almost all had a basic educational level-primary edu-
cation or similar (57 %). Only one patient had university
studies. A high proportion of the cases were married or liv-
ing with their mate and were housewives or early retired.
Manifestation time they had been suffering pain was a 
mean of 14.5 years. Table 1 summaries the results of the var-
iables studied, including the 2 subjects who did not partici-
pate in the Imagined exposure. The Last Observation Carried
Forward (LOCF) method was used. It should be stated that
although the pre and post-treatment score improves in all
the variables, significant differences were only found in PCS
catastrophism (p<0.05) and in its three subscales. The differ-
ence in the VAS intensity of pain (p=0.079) was not signi-
ficant, although it was close to significance level a=0.05. It
is relevant to mention that neither C nor any of its sub-
scales (especially rumination) correlated with pain intensity.
Another relevant piece of data is the stability of the C score
if there is no intervention. There are no significant differ-
ences between the pre-treatment measurement and that con-
ducted 2 months before subject selection (p=0.416). Finally,
in relationship to the two subjects who did not participate
in the imagined exposure, it can be stated that the direct
scores obtained in the rumination subscale for these (23%)
were different from the rest of the subjects if the Imagined
Exposure was performed and that they obtained a mean of
38% in the decrease of their scores. The mean difference in
the group without exposure was 1.5 (p=0.656). However, in
the group that did perform exposure, the mean difference
was 4 points although significant differences were not ob-
tained (p=0.120). This result may suggest that significance
would be found in this tendency with a larger sample.
DISCUSSION
This is the first study on the application of an imagined
exposure technique for chronic pain. We have studied if the
incorporation of this new component (imagined exposure)
into a treatment program that has already been shown to
be effective in successive occasions13 would improve the
therapeutic effect by reducing rumination or if a similar re-
sult would be produced. The most important limitation of
this research, that is justified as it is a pilot study, is its small
sample size. Our results are in line with previous studies that
demonstrate that catastrophizing correlates with reduc-
Imagined exposure as treatment of catastrophizing in fibromyalgia: a pilot studyB. Rodero, et al.
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Table 1 Summary of the treatment 
efficacy results
Grade of
Pretreat- Postreat- pretreatment-
ment ment postreatment
significance
PCS
Total 25.33±3.54 16±3.60 p=0.018
Magnification 5.12±1.46 3.16±0.87 p=0.050
Rumination 7.66±0.99 4.5±1.17 p=0.032
Helplessness 11.37±1.46 8.33±1.66 p=0.007
VAS 12.12±1.23 9.66±1.38 p=0.079
FIQ 50.12±5.09 40.16±5.09 p=0.116
HADS depression 8.5±1.45 6.83±1.24 p=0.119
HADS anxiety 9.12±1.21 9±2.06 p=0.702
PCS: Pain Catastrophizing Scale; VAS: Visual Analogue Scale of Pain;
FIQ: Fibromyalgia Impact Questionnaire; HADS: Hospital Anxiety and
Depression.
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tions in depressive symptoms and in pain behaviors as well
as with improvements in pain intensity14. One of the treat-
ments has been effective in reducing C of the CBT, with de-
creases of up to 40% in the PCS14. Although we have not
been able to demonstrate it in our study, rumination seems
to be the subscale of C that would best correlate with pain4.
To improve treatment of rumination, we used the imagined
exposure technique of irrational fears. Perhaps patients
diagnosed of fibromyalgia are not the best sample to use 
as a test of the imagined exposure. In generally these are
cases in whom most of the patients are elderly subjects
(50.5 years), in whom the years of evolution of their pain
has existed for many years (14.5 years) and who have high
psychiatric comorbidity.
The CBT is shown to be beneficial «per se» for the treat-
ment of rumination. In fact, two subjects who did not partic-
ipate in the specific exposure session (as they had a lower
cultural level and understanding difficulties) also decreased
their rumination, although 15% less than the subjects who
did participate in it. On the other hand, imagined exposure
showed the greatest success in a young woman with uni-
versity education and with high score in rumination (above
the 70 percentile). After the exposure, the patient reported
some less frequent, intense and long-lasting ruminations
that were also accompanied by an objective improvement 
in the VAS and in the FIQ. Thus, it does not seem to be advis-
able to propose imagined exposure to patients with lower
educational level or with poor cognitive level. On the other
hand, this technique could be very helpful, especially in
those patients with a high score in rumination (above the
70 percentile), with a middle-high education level and who
have a very intense irrational fear15. In any event, the exis-
tence of new studies that confirm these preliminary find-
ings and that approach another type of patients other 
than those with FM is necessary.
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La fibromialgia es una enfermedad cróni-
ca, de causa desconocida, que se carac-
teriza por la presencia de dolor musculo-
esquelético generalizado, asociado a una
serie de puntos dolorosos específicos que
permiten realizar el diagnóstico. Con fre-
cuencia se asocia a fatiga, alteraciones
del sueño y rigidez matutina1. Además de
por su elevada prevalencia, la fibromial-
gia se caracteriza por producir una im-
portante discapacidad y por la eficacia li-
mitada del tratamiento2.
La función del constructo «catastrofiza-
ción ante el dolor» (CAD) en la modula-
ción de las respuestas dolorosas ha reci-
bido una considerable atención en los
últimos años3. Se ha demostrado una re-
lación coherente entre la catastrofización
y las reacciones de malestar ante estímu-
los dolorosos3. Aunque los criterios defi-
nitorios de CAD no se han descrito explí-
citamente, existe un consenso general en
que incluye una orientación negativa y
exagerada hacia los estímulos dolorosos.
No está clara la etiología de la CAD. Se
ha demostrado que es crucial en su de-
sarrollo un modelo de apego inseguro4,
así como la sensibilidad ante la
ansiedad5. Algunas de las consecuencias
que se han asociado a la CAD son dolor
más intenso6, incremento de las conduc-
tas ante el dolor7, mayor consumo de
analgésicos8, disminución de las activida-
des diarias3, incapacidad laboral9, peor
pronóstico10 e ideación suicida11.
En pacientes con fibromialgia la CAD pa-
rece ser un factor de riesgo asociado tan-
to con la existencia de dolor generaliza-
do12 como con la disminución del umbral
del dolor13. Cuando se los compara con
personas que presentan enfermedades
que cursan con dolor crónico, como la
artritis reumatoide, los pacientes con fi-
bromialgia obtienen puntuaciones signifi-
cativamente más altas en la CAD. Otro
estudio14 indica que la CAD, indepen-
dientemente del grado de depresión, está
significativamente asociada con un in-
cremento de la actividad en las áreas ce-
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FUNDAMENTO Y OBJETIVO: La catastrofización ante el dolor se considera un factor pronóstico im-
portante en el dolor crónico en general y en la fibromialgia en particular. No hay versiones es-
pañolas validadas de ninguna de las escalas desarrolladas para medirla. El objetivo de este
estudio ha sido validar la versión española de la Pain Catastrophizing Scale (PCS), una de las
escalas más utilizadas para medir este constructo.
PACIENTES Y MÉTODO: Se ha realizado un estudio multicétrico, observacional y prospectivo en pa-
cientes con fibromialgia clínicamente estables e inestables. Se evaluaron la estructura facto-
rial, la validez convergente, la fiabilidad (consistencia interna y estabilidad temporal) y la sen-
sibilidad al cambio de la escala.
RESULTADOS: Se incluyó a 230 pacientes con fibromialgia de 12 centros de atención primaria de
Zaragoza. La escala presentó la misma estructura factorial de 3 factores descritos en el estudio
original (rumiación, magnificación y desesperanza), así como una adecuada consistencia inter-
na (alfa de Cronbach = 0,79), fiabilidad test-retest (coeficiente de correlación intraclase 
= 0,84) y sensibilidad al cambio (tamaño del efecto  2).
CONCLUSIONES: La versión española de la PCS muestra adecuadas propiedades psicométricas, si-
milares a las de la escala original, por lo que su uso estaría indicado en la práctica asistencial y
la investigación clínica en pacientes españoles con fibromialgia.
Palabras clave: Fibromialgia. Catastrofización. Dolor. Validación.
Validation of the Spanish version of the Pain Catastrophizing Scale in fibromyalgia
BACKGROUND AND OBJECTIVE: Pain catastrophization is considered an important risk factor for pain
in general and, specifically, for fibromyalgia. There are no validated Spanish versions of any of
the questionnaires developed to assess pain catastrophization. The aim of this study was to va-
lidate the Spanish version of the Pain Catastrophization Scale (PCS), one of the most used
questionnaires to assess pain catastrophization.
PATIENTS AND METHOD: A prospective, observational and multicentre study was carried out in clini-
cally stable and unstable patients with fibromyalgia. Factorial structure, convergent validity, re-
liability (internal consistency and test-retest) and sensitivity to change were assessed.
RESULTS: Two hundred and thirty patients from 12 primary care health centres were included.
The Spanish version of the PCS showed the same 3-factor structure (rumination, magnification
and helplessness) described in the original study. It also showed appropriate internal consis-
tency (Cronbach alpha = 0.79), test-retest reliability (intraclass correlation coefficient = 0.84)
and sensitivity to change (effect size  2).
CONCLUSIONS: The Spanish version of the PCS shows appropriate psychometric properties, simi-
lar to the English original scale. Therefore, PCS could be useful for clinical practice and rese-
arch in Spanish patients with fibromyalgia.
Key words: Fibromyalgia. Catastrophization. Pain. Validation.
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rebrales relacionadas con la anticipación
del dolor (córtex frontal medial, cerebe-
lo), con la atención al dolor (córtex cingu-
lado dorsal anterior, córtex prefrontal dor-
solateral), con aspectos emocionales del
dolor (cláustrum, íntimamente conectado
con la amígdala) y con el control motor.
Una de las escalas más utilizadas para
medir el constructo CAD es la Pain Catas-
trophizing Scale (PCS)9,11, un cuestionario
autoadministrado, cuya validez y fiabilidad
se han descrito previamente6. La PCS se
desarrolló mediante 4 estudios. En el pri-
mero se seleccionaron los ítems del cues-
tionario en una muestra de estudiantes de
psicología, mediante un análisis de com-
ponentes principales. En el segundo se
analizó la validez de constructo estudian-
do los grados de catastrofización medidos
por el cuestionario cuando el individuo in-
troduce un brazo en un recipiente con
agua congelada. También se realizó en es-
tudiantes de psicología. El tercero evaluó
la validez del cuestionario en una muestra
clínica: pacientes que iban a realizarse un
estudio electromiográfico. El cuarto y últi-
mo estudio analizó la relación entre CAD y
otros constructos como depresión, ansie-
dad o miedo al dolor, que también podrían
predecir la respuesta al dolor6. El cons-
tructo CAD, pese a su importancia, ape-
nas se ha estudiado en los pacientes con
fibromialgia15, uno de los trastornos de do-
lor crónico más frecuentes. Por otra parte,
la PCS no está validada en español.
El objetivo de este estudio ha sido, pues,
validar la versión española de la PCS, es
decir, examinar su estructura factorial,
validez convergente, fiabilidad (consis-
tencia interna y estabilidad temporal) y
sensibilidad al cambio de la escala en
pacientes con fibromialgia.
Pacientes y método
Diseño
Se ha realizado un estudio observacional, prospectivo
y multicéntrico, con un período de seguimiento de
una a 6 semanas, en pacientes de ambos sexos, 
de entre 18 y 65 años de edad, diagnosticados de fi-
bromialgia, que cumplían los criterios del Colegio
Americano de Reumatología16. Se seleccionaron de
forma consecutiva en 12 centros de atención prima-
ria de Zaragoza, durante el año 2006, entre los pa-
cientes que acudían a consulta y dieron su consenti-
miento para participar en el estudio.
En la visita inicial se clasificó a los pacientes en esta-
bles (los que no habían mostrado cambios clínicos
relevantes en los últimos 3 meses) e inestables (los
que sí habían presentado en dicho período). Se citó a
los pacientes estables para una visita de seguimiento
en el plazo de una semana a fin de evaluar la fiabili-
dad test-retest, mientras que a los pacientes inesta-
bles se les evaluó a las 6 semanas de la visita de in-
clusión, después de recibir el tratamiento adecuado,
con objeto de evaluar la sensibilidad al cambio de la
escala. La representación esquemática del estudio se
resume en la figura 1.
Este estudio forma parte de una amplia investigación
sobre las características psicológicas y la efectividad
del tratamiento psiquiátrico en pacientes con fibro-
mialgia17,18. El estudio fue aprobado por el Comité Éti-
co de Investigación Clínica de Aragón y sigue las nor-
mas éticas de la Declaración de Helsinki de 1975,
con la revisión de octubre de 2000. Todos los pa-
cientes firmaron un consentimiento informado antes
de su inclusión en el estudio.
Muestra
El tamaño muestral (n = 230) para realizar el análisis
factorial confirmatorio se calculó sobre la base de la ra-
zón recomendada19 de 10-15/1 entre el número de su-
jetos y el número de ítems del cuestionario (13 ítems).
Los tamaños muestrales mínimos para la realización de
los otros cálculos (validez, fiabilidad y sensibilidad al
cambio) eran muy inferiores a este número20.
Escala de evaluación objeto del estudio
La PCS es una escala autoadministrada de 13 ítems
y una de las más utilizadas para valorar el constructo
CAD. Comprende 3 dimensiones: a) rumiación; b)
magnificación, y c) desesperanza. Se obtuvo el per-
miso para traducir y validar la PCS de los autores ori-
ginales6. Dos nativos hispanohablantes, conocedores
de los objetivos de la PCS, tradujeron por primera vez
el cuestionario al español. Posteriormente, 2 nativos
angloparlantes, no familiarizados con el instrumento,
realizaron una retrotraducción del español al inglés.
Cualquier discrepancia entre las traducciones tanto
española como inglesa se resolvió por acuerdo. Un
tercer experto, nativo angloparlante, consideró equi-
valentes la versión original inglesa y la retrotraduc-
ción. La versión española final (recogida junto a la
original inglesa en el anexo I) se juzgó una traducción
adecuada de la original inglesa y fue aprobada por
los autores del cuestionario6. El intervalo teórico del
instrumento se sitúa entre 13 y 62, indicando las
puntuaciones bajas escasa catastrofización, y los va-
lores altos, elevada catastrofización.
Otros instrumentos de medida
Fibromyalgia Impact Questionnaire (FIQ). El FIQ, un
cuestionario autoadministrado de 10 ítems, mide el
estado de salud de los pacientes con fibromialgia21. El
primer ítem se centra en la capacidad de los pacien-
tes para realizar actividades físicas. En los 2 siguien-
tes, el paciente ha de indicar el número de días de la
semana anterior que se sintió bien y cuántos días de
trabajo había perdido. Los 7 restantes se refieren a la
capacidad de trabajar, al dolor, la fatiga, el cansancio
matutino, la rigidez, la ansiedad y depresión, todos
ellos medidos mediante escalas analógicas visuales.
En este estudio hemos utilizado la versión española
del FIQ, que ha sido traducida y validada22. El interva-
lo teórico del instrumento se sitúa entre 0 (mínimo im-
pacto de la enfermedad) y 100 (máximo impacto).
Hospital Anxiety and Depression Scale (HADS). La
HADS23 es una escala autoadministrada que mide la
ansiedad y depresión en pacientes con enfermeda-
des somáticas. Se compone de 14 ítems, que se va-
loran mediante una escala tipo Likert de 0 a 3 pun-
tos, y ha demostrado su idoneidad en la comunidad y
en entornos hospitalarios. Consta de 2 subescalas,
HADS-Dep y HADS-Ans, de 7 ítems cada una, que
valoran de forma independiente la depresión y la an-
siedad. El intervalo teórico de ambas subescalas es
de 0 (nula ansiedad o depresión) a 21 (máxima an-
siedad o depresión). La HADS está validada en po-
blación española24. Se eligió la HADS porque se con-
sidera uno de los mejores instrumentos para evaluar
la depresión y ansiedad en pacientes con enfermeda-
des médicas concomitantes como la fibromialgia24.
Fear Avoidance Belief Questionnaire (FABQ). El
FABQ es un instrumento de evaluación que mide los
pensamientos de evitación del miedo25. Se compone
de 16 ítems, que incluyen 2 subescalas: evitación del
miedo de los pensamientos sobre el trabajo (FAB-
Work) y evitación del miedo de los pensamientos so-
bre la actividad física (FAB-Phys). El paciente tiene
que puntuar cada aseveración de 0 (totalmente en
desacuerdo) a 6 (totalmente de acuerdo). El intervalo
de puntuaciones va de 0 a 96, reflejando los valores
altos un mayor grado de pensamientos de evitación
del miedo y los bajos, la ausencia de estas cognicio-
nes. El FABQ está traducido al español y validado26.
EuroQol-5D (EQ-5D). Es un instrumento estandarizado
que mide resultados de salud y es aplicable a una am-
plia gama de enfermedades y tratamientos. Proporcio-
na un perfil descriptivo y simple, así como un índice
único del estado de salud. El EQ-5D se concibió origi-
nalmente para complementar a otros instrumentos,
como el 36-ítem Short-Form Health Status Survey (SF-
36), el Nottingham Health Profile (NHP) u otros cues-
tionarios específicos de ciertas enfermedades, pero se
está empleando cada vez más de forma aislada. El
EQ-5D combina el sistema descriptivo del EuroQol y
una escala analógica visual (EuroQol VAS). La EuroQol
VAS mide el estado de salud autoevaluado en una es-
cala analógica visual de 0 (mínima calidad de vida) a
100 (máxima calidad)27. El EQ-5D abarca 5 dimensio-
nes de salud: movilidad, autocuidado, actividades ha-
bituales, dolor/incomodidad y ansiedad/depresión.
Cada dimensión se evalúa en 3 categorías (sin proble-
mas; problemas moderados; problemas extremos). La
evaluación consiste en medir cada uno de los 5 domi-
nios en una de los 3 categorías. En este estudio utili-
zamos la versión española validada del EQ-5D28.
Pain Visual Analogue Scale (PVAS). La PVAS se conci-
bió para ofrecer una valoración amplia y comprensible,
a la vez que subjetiva, de las dimensiones del dolor.
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Fiabilidad test-retest
(evaluada por el CCI, intervalo de 1 semana)
Validez convergente
(evaluada mediante el coeficiente de correlación
de Pearson)
Consistencia interna
(evaluada por el coeficiente alfa de Cronbach)
Validez de constructo
(evaluada mediante análisis factorial confirmatorio)
Sensibilidad al cambio
(evaluada mediante
el tamaño del efecto,
intervalo de 6 semanas)
 Pacientes estables
(n = 64)
Pacientes inestables
(n = 166)
Pacientes ambulatorios con diagnóstico de FM
(n = 230)
Fig. 1. Diagrama del estudio. CCI: coeficiente de correlación intraclase; FM: fibromialgia.
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Una escala visual analógica es una línea recta, ya sea
vertical u horizontal, cuya longitud representa el contí-
nuum de la experiencia dolorosa. Se compone de una
línea horizontal de 10 cm, con líneas perpendiculares
en los extremos, que representan los límites extremos
del constructo dolor que se está midiendo. Los puntos
de anclaje en cada extremo se caracterizan por una
expresión verbal breve del tipo «nada» o «sin dolor» en
un extremo, e «insoportable» en el otro. Los descripto-
res verbales se acompañan generalmente de un nú-
mero (p. ej., «nada» puede estar acompañado de 0 e
«insoportable», de 100). La validez y fiabilidad del
PVAS se han demostrado en estudios previos29.
Análisis estadístico
La validez de constructo de la PCS se evaluó median-
te un análisis factorial confirmatorio30. El modelo ini-
cial se basó en el modelo de 3 factores obtenidos de
análisis factoriales exploratorios previos6,15. Así, se su-
puso inicialmente que cada una de las 13 variables
analizadas estaba relacionada con uno y sólo uno de
los 3 factores descritos, incluyendo las 13 variables
en el factor en el que mostraban un mayor carga fac-
torial cuando se realizó un análisis factorial explorato-
rio con rotación varimax. Como estadígrafos de ajuste
se emplearon los habituales: a) 2/grados de libertad,
que se recomienda sea inferior a 3; b) índice de ajus-
te comparativo, que se recomienda que sea superior
a 0,90; y c) RMSEA (root-mean-square error of ap-
proximation) igual o inferior a 0,0830.
La consistencia interna se evaluó mediante el coefi-
ciente alfa de Cronbach, utilizando todos los valores
(pacientes estables e inestables) de la primera entre-
vista. Se considera adecuado, según criterios habi-
tualmente utilizados, cuando es superior a 0,720.
La fiabilidad test-retest se evaluó, sólo en el grupo de
pacientes estables, mediante el coeficiente de correla-
ción intraclase. La validez convergente de la PCS se
analizó mediante el coeficiente de correlación de
Pearson, tras confirmar gráficamente que su asocia-
ción era lineal con las medidas del estado de salud
según el paciente (evaluado con el FIQ), depresión y
ansiedad (medidas con la HADS), calidad de vida
(valorada con el EQ-5D), dolor (evaluado mediante la
PVAS) y pensamientos de evitación hacia el dolor
(medidos mediante el FABQ). Para evaluar la sensibi-
lidad al cambio se comparó, en el grupo de pacientes
inestables, la puntuación media de la primera y se-
gunda visitas. Para el tamaño del efecto del cambio
sintomático se calculó la diferencia de medias me-
diante la prueba de la t de Student para muestras
emparejadas, utilizando también la correlación entre
las puntuaciones de la primera y la segunda visitas.
Se considera pequeño un tamaño del efecto con va-
lores del tamaño del efecto de 0,2; moderado con va-
lores de 0,5, y grande con valores de 0,8 y
superiores20. Los valores se expresan como medias y
desviaciones estándar. Todos los tests se realizaron
con 2 colas. Una probabilidad de 0,05 se consideró
estadísticamente significativa. Todos los análisis esta-
dísticos se realizaron con el programa SPSS, versión
14 (SPSS Inc., Chicago, Illinois, EE.UU.), excepto el
análisis factorial confirmatorio, que se efectuó con el
programa LISREL, versión 8.30 (Scientific Software
International, Inc., Lincolnwood, Illinois, EE.UU.).
Resultados
Descripción de la muestra
De los 235 potenciales participantes, 3
(1,3%) declinaron participar y hubo que
eliminar a otros 2 (0,8%) porque rellena-
ron de forma incompleta los cuestiona-
rios. Así pues, la muestra final (tabla 1)
constó de 230 pacientes (64 estables y
166 inestables), con edades comprendi-
das entre 23 y 64 años, y edad media
(desviación estándar) de 47,3 (7,2) años.
Un total de 195 eran mujeres (84,7%) y
35 varones (15,2%), todos ellos descritos
a sí mismos como de etnia blanca euro-
pea. Habían presentado fibromialgia du-
rante 8,9 años de media (extremos: 1-22
años; mediana: 6 años) y 110 (47,8%)
recibían una pensión de invalidez.
Análisis factorial confirmatorio 
de la versión española de la escala
Se realizó un análisis factorial confirmato-
rio de la versión española de la PCS que
arrojó una solución factorial de 3 compo-
nentes con valores propios mayores de 1.
Las cargas factoriales de los diferentes
ítems, así como los estadígrafos de ajuste,
se muestran en la tabla 2. No se excluyó
ningún ítem del análisis debido a una co-
rrelación débil (r < 0,30) ítem-escala.
GARCÍA CAMPAYO J ET AL. VALIDACIÓN DE LA VERSIÓN ESPAÑOLA DE LA ESCALA DE LA CATASTROFIZACIÓN ANTE EL DOLOR 
(PAIN CATASTROPHIZING SCALE) EN LA FIBROMIALGIA
Med Clin (Barc). 2008;131(13):487-92 489
TABLA 2
Patrón matricial de la Pain Catastrophizing Scale (n = 230)
Componentes
Ítems
1 2 3
Correlación ítem-escala
Rumiación (variancia explicada: 39%)
8. Deseo desesperadamente que desaparezca el dolor 0,78 0,06 0,18 0,61
9. No puedo apartar el dolor de mi mente 0,82 0,03 0,10 0,68
10. No dejo de pensar en lo mucho que me duele 0,71 0,01 0,15 0,67
11. No dejo de pensar en lo mucho que deseo que desaparezca el dolor 0,74 0,02 0,01 0,70
Magnificación (variancia explicada: 11%)
6. Temo que el dolor empeore 0,18 0,88 0,09 0,45
7. No dejo de pensar en otras situaciones en las que experimento dolor 0,04 0,72 0,03 0,31
13. Me pregunto si me puede pasar algo grave 0,11 0,69 0,10 0,38
Desesperanza (variancia explicada: 10%)
1. Estoy preocupado todo el tiempo pensando en si el dolor desaparecerá 0,08 0,10 0,84 0,41
2. Siento que ya no puedo más 0,15 0,11 0,81 0,47
3. Es terrible y pienso que esto nunca va a mejorar 0,03 0,14 0,79 0,50
4. Es horrible y siento que esto es más fuerte que yo 0,28 0,02 0,81 0,57
5. Siento que no puedo soportarlo más 0,31 0,03 0,68 0,52
12. No hay nada que pueda hacer para aliviar la intensidad del dolor 0,24 0,21 0,76 0,49
Componentes: 1, rumiación; 2, magnificación; 3, desesperanza. Estadígrafos de ajuste: 2/grados de libertad = 3,0; RMSEA (root-mean-square error of approximation) = 0,08; índice de ajuste
comparativo = 0,91.
TABLA 1
Características sociodemográficas de la muestra
Variables Pacientes estables (n = 64) Pacientes inestables (n = 166)
Edad media (años)* 47,2 (7,0) 47,4 (7,3)
Sexo
Varones 11 (17,1%) 24 (14,4%)
Mujeres 53 (82,9%) 142 (85,6%)
Nivel de educación
Sin estudios 0 (0%) 1 (0,6%)
Estudios primarios 41 (64%) 95 (57,2%)
Estudios secundarios 20 (31,3%) 63 (37,9%)
Estudios universitarios 3 (4,7%) 7 (4,2%)
Situación laboral
Trabaja fuera de casa 12 (18,7%) 30 (18%)
Parado 3 (4,6%) 9 (5,4%)
Jubilado 0 (0%) 1 (0,6%)
Incapacidad laboral/invalidez permanente 32 (50%) 78 (46,9%)
Ama de casa 17 (26,5%) 48 (28,9%)
Diagnóstico DSM-IV
Trastorno depresivo mayor 15 (23,4%) 33 (19,8%)
Trastorno distímico 8 (12,5%) 15 (9%)
Trastorno adaptativo 4 (6,2%) 7 (4,2%)
Trastorno de ansiedad 7 (10,9%) 18 (10,8%)
Tiempo de evolución del trastorno
< 2 años 7 (10,9%) 18 (10,8%)
De 1 a < 5 años 26 (40,6%) 61 (36,7%)
> 5 años 31 (48,4%) 87 (52,4%)
DSM-IV: Manual Diagnóstico y Estadístico de los Trastornos Mentales, cuarta edición. 
*Media (desviación estándar).
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Análisis estadístico descriptivo
En la tabla 3 se presentan las medias,
desviaciones estándar, medianas y extre-
mos de la escala PCS y de las otras me-
didas utilizadas en el estudio. Los valores
de la PCS no se encontraban distribuidos
normalmente. Como puede verse, la
muestra comprende a pacientes con fi-
bromialgia que presentaban una relativa
discapacidad, elevados niveles de dolor,
evitación de éste y depresión, así como
una pobre calidad de vida y un grado re-
lativamente bajo de ansiedad.
Validez convergente
Medimos la relación entre la PCS y el
grado autopercibido de salud de los pa-
cientes con fibromialgia (medido con el
FIQ), depresión y ansiedad (valoradas
con la HADS), dolor (evaluado con la
PVAS), miedo al dolor (con el FABQ) y
calidad de vida (con el EQ-5D). Se espe-
raba que todas estas medidas se corre-
lacionaran con la CAD del paciente. Cal-
culamos los coeficientes de correlación
de Pearson, que se resumen en la tabla
4. La PCS global y sus subescalas se co-
rrelacionaron positivamente con todas
las demás medidas, excepto con la cali-
dad de vida, que, como era previsible,
se correlacionó de forma inversa. La
PCS muestra la máxima correlación con
el miedo al dolor (FABQ), seguido por el
estado de salud (FIQ), calidad de vida
(EQ-5D) y depresión (HADS-Dep), y las
correlaciones más débiles con la ansie-
dad (HADS-Ans) y el dolor (PVAS).
Consistencia interna
En la tabla 5 se muestra la consistencia
interna (coeficiente alfa de Cronbach,
con el intervalo de confianza del 95%)
de la PCS. Tanto para la PCS global
como para las 3 subescalas los valores
del alfa de Cronbach fueron mayores de
0,70.
Fiabilidad test-retest
La fiabilidad test-retest se evaluó, sólo en
los pacientes estables (n = 64), una se-
mana después de la evaluación basal (ta-
bla 5). Tanto el coeficiente de la PCS to-
tal como los de las 3 subescalas fueron
mayores de 0,70.
Sensibilidad al cambio
Se evaluó sólo en los pacientes inestables
(n = 166), al cabo de 6 semanas de la
evaluación basal, mediante el cálculo del
tamaño del efecto, a partir de las diferen-
cias de las medias y de los coeficientes
de correlación, entre ambas observacio-
nes (tabla 6). El cambio experimentado
en las puntuaciones de la PCS, evaluado
mediante el tamaño del efecto, fue im-
portante (d = 2,1-2,3) tanto para la PCS
total como para las 3 subescalas. Repre-
senta una mejora sobre la puntuación ini-
cial de más del 40% en todos los casos
(tabla 6).
Comprensión y factibilidad
El tiempo necesario para completar la
PCS fue de 10 min de mediana, con un
percentil 25 de 7 min y un percentil 75
de 13 min. Ningún paciente solicitó ayu-
da para la interpretación del cuestionario
y no hubo ningún ítem que dejara de
contestar un 5% o más de los pacientes.
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TABLA 3
Medias, desviación estándar, medianas e intervalos de la Pain Catastrophizing
Scale y de los otros cuestionarios utilizados en el estudio
Media DE Mediana Intervalo
PCS total 24,42 11,18 25,0 13-52
Rumiación 7,51 3,74 7,0 4-16
Magnificación 5,73 2,93 5,0 3-12
Desesperanza 11,64 5,97 12,0 6-24
FIQ 65,54 9,46 62 41-98
HADS-Dep 9,28 4,31 9 3-18
HADS-Ans 6,42 3,03 7 2-12
EQ-5D (escala analógica visual) 39,21 16,93 41 21-89
FABQ 72,21 11,32 73 10-95
PVAS 67,54 12,23 70 25-95
DE: desviación estándar; EQ-5D: EuroQol-5D; FABQ: Fear Avoidance Belief Questionnaire; FIQ: Fibromyalgia Impact Question-
naire; HADS: Hospital Anxiety and Depression Scale; PCS: Pain Catastrophizing Scale; PVAS: Pain Visual Analogue Scale.
TABLA 4
Correlación de la Pain Catastrophizing Scale con medidas del estado 
de salud, dolor, depresión, ansiedad y calidad de vida
FIQ PVAS HADS-Dep HADS-Ans FABQ EQ-5D
Subescalas
Rumiación 0,49a 0,35b 0,44a 0,27b 0,68a –0,43a
Magnificación 0,43a 0,33b 0,40a 0,26b 0,64a –0,40a
Desesperanza 0,44a 0,30b 0,41a 0,29b 0,66a –0,40a
PCS global 0,45a 0,32b 0,42a 0,28b 0,66a –0,41a
ap < 0,01. bp < 0,05.
EQ-5D: EuroQol-5D; FABQ: Fear Avoidance Belief Questionnaire; FIQ: Fibromyalgia Impact Questionnaire; HADS: Hospital An-
xiety and Depression Scale; HADS-Ans: subescala de ansiedad de la HADS; HADS-Dep: subescala de depresión de la HADS;
PVAS: Pain Visual Analogue Scale; PCS: Pain Catastrophizing Scale.
TABLA 5
Fiabilidad de la versión española de la Pain Catastrophizing Scale 
Propiedades
Subescalas
PCS total Rumiación Magnificación Desesperanza
Consistencia interna (n = 230)
Alfa de Cronbach 0,79 0,82 0,74 0,80
Fiabilidad test-retest (n = 64) 0,84 0,86 0,82 0,83
Puntuación media (DE) test 25,42 (12,12) 7,44 (4,03) 5,76 (2,84) 12,34 (6,85)
Puntuación media (DE) retest 24,93 (11,95) 7,52 (4,11) 5,49 (2,67) 11,93 (6,68)
CCI 0,94 0,93 0,93 0,95
CCI: coeficiente de correlación intraclase; DE: desviación estándar; PCS: Pain Catastrophizing Scale.
TABLA 6
Sensibilidad al cambio de la versión española de la Pain Catastrophizing 
Scale (n = 166)
Propiedades
Subescalas
PCS total Rumiación Magnificación Desesperanza
Puntuación basal media (DE) 25,42 (12,12) 7,44 (4,03) 5,76 (2,84) 12,34 (6,85)
Puntuación a las 6 semanas, 
media (DE) 13,12 (8,30) 3,86 (1,96) 2,82 (1,41) 6,24 (3,75)
Diferencia test-retest, media (DE) 12,30 (6,91)* 3,58 (2,15)* 2,82 (1,56)* 6,1(3,59)*
Correlación entre puntuaciones 
basales y a las 6 semanas 0,28 0,30 0,29 0,26
Tamaño del efecto (IC del 95%) 2,2 (1,7-2,7) 2,1 (1,6-2,6) 2,3 (1,7-2,8) 2,1 (1,7-2,7)
*p < 0,01.
DE: desviación estándar; IC: intervalo de confianza; PCS: Pain Catastrophizing Scale. 
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Discusión
Este estudio se realizó para valorar la uti-
lidad de la PCS en pacientes con fibro-
mialgia, un subtipo específico de pacien-
tes con dolor crónico. Se espera que la
PCS sea de gran valor para supervisar la
efectividad de los tratamientos en la fi-
bromialgia, sobre todo por la intensa rela-
ción de la CAD con medidas clave en es-
tos pacientes como son el dolor, el miedo
a éste, el estado general del paciente y la
depresión6,15. La importancia de este es-
tudio radica en que la PCS, uno de los
cuestionarios más utilizados en todo el
mundo para medir la CAD, se ha valida-
do al español y se ha utilizado en una en-
fermedad tan prevalente como la fibro-
mialgia. Nuestro estudio presenta como
limitación que no compara la PCS con
medidas objetivas de estrés, tales como
procedimientos médicos electrodiagnósti-
cos aversivos, la presión del esfigmoma-
nómetro o el frío. Sin embargo, estos mé-
todos se emplearon cuando se creó la
escala original6 y no suelen utilizarse en
las validaciones a otro idioma.
Los resultados del estudio confirman las
adecuadas propiedades psicométricas de
la versión española de la PCS en pacien-
tes con fibromialgia. Así, se mantiene la
estructura original de 3 factores descrita
por los autores6 y confirmada por Van
Damme et al15 en 3 muestras holandesas
de población sana, de dolor crónico y de
fibromialgia. La variancia explicada de
cada uno de los factores (rumiación:
39%; magnificación: 11%; desesperanza:
10%) es muy similar a la descrita por los
autores originales (un 41, un 10 y un 8%,
respectivamente)6. La reproducción de la
misma estructura es frecuente cuando se
compone de menos de 5 factores30. Los
valores de consistencia interna y de fiabi-
lidad test-retest son adecuados, superio-
res a 0,730. También la sensibilidad al
cambio es satisfactoria, con valores del
tamaño del efecto mayores de 2.
No se han realizado hasta la fecha estu-
dios sobre la correlación específica de
cada una de las 3 subescalas de la PCS
en la fibromialgia. En otras enfermedades
que cursan con dolor crónico, la subes-
cala de rumiación es la que en general se
correlaciona más estrechamente con la
intensidad del dolor y la discapacidad6,9.
El único estudio realizado en fibromialgia
con la PCS15 no analizó este punto, por lo
que no tenemos datos para poder com-
parar. Por otra parte, en el estudio origi-
nal de validación realizado en personas
sanas6, tanto la PCS global como la su-
bescala de rumiación se correlacionaron
mucho más intensamente con el dolor
que con la depresión. En nuestro estudio
en pacientes con fibromialgia, la subes-
cala de rumiación es la que mayor con-
sistencia interna y mayor correlación de
los ítems con la escala global presenta,
así como la de mayor variancia explicada.
Cuando analizamos las correlaciones de
la CAD con otras medidas, comprobamos
que hay una elevada correlación con la
evitación del dolor (medida mediante el
FABQ), dato esperable, ya que ambos
constructos son muy similares. Existen
correlaciones altas de la PCS con la dis-
capacidad (medida con el FIQ) y con la
calidad de vida (medida con el EQ-5D), lo
que indica que, sin haber solapamiento
de los constructos, la CAD muestra una
importante relación con ambas. También
existe una correlación relativamente ele-
vada con 2 variables clave en la fibromial-
gia: el dolor (medido con la PVAS) y la de-
presión (evaluado con la HADS). Sin
embargo, nuestros datos son diferentes
de los de los estudios realizados con la
PCS en otras enfermedades6,15, ya que en
nuestra muestra de fibromialgia la CAD se
correlaciona más estrechamente con la
depresión que con el dolor. Esto no es
sorprendente, ya que estudios previos
han demostrado la intensa correlación en-
tre la CAD y la depresión en estos pacien-
tes12,13. Por último, la correlación de la
PCS con la ansiedad es relativamente
baja, lo que indica el peso relativamen-
te escaso de esta variable en la CAD.
Pese a que la CAD se considera una de
las principales dianas terapéuticas en la
fibromialgia y otras enfermedades que
cursan con dolor crónico15, todavía no se
han llevado a cabo estudios sobre la efi-
cacia terapéutica de los tratamientos far-
macológicos o psicológicos sobre la CAD
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ANEXO 1
Escala de catastrofización ante el dolor
Nombre: ....................................................................................................................................................
Edad: .............................................. Sexo: .............................................. Fecha: ..................................
Todas las personas experimentamos situaciones de dolor en algún momento de nuestra vida. Tales
experiencias pueden incluir dolor de cabeza, dolor de muelas, dolor muscular o de articulaciones. Las
personas estamos a menudo expuestas a situaciones que pueden causar dolor como las enfermedades,
las heridas, los tratamientos dentales o las intervenciones quirúrgicas.
Estamos interesados en conocer el tipo de pensamientos y sentimientos que usted tiene cuando siente
dolor. A continuación se presenta una lista de 13 frases que describen diferentes pensamientos y
sentimientos que pueden estar asociados al dolor. Utilizando la siguiente escala, por favor, indique el grado
en que usted tiene esos pensamientos y sentimientos cuando siente dolor.
Everyone experiences painful situations at some point in their lives. Such experiences may include
headaches, tooth pain, joint or muscle pain. People are often exposed to situations that may cause pain
such as illness, injury, dental procedures or surgery.
We are interested in the types of thoughts and feelings that you have when you are in pain. Listed below are
13 statements describing different thoughts and feelings that may be associated with pain. Using the
following scale, please indicate the degree to which you have these thoughts and feelings when you are
experiencing pain.
0: Nada en absoluto 1: Un poco 2: Moderadamente 3: Mucho 4: Todo el tiempo
0: Not al all 1: To aslight degree 2: To a moderate degree 3: To a great degree 4: All the time
Cuando siento dolor… (When I’m in pain)
1. Estoy preocupado todo el tiempo pensando en si el dolor desaparecerá
(I worry all the time about whether the pain will end)
2. Siento que ya no puedo más
(I feel I can’t go on)
3. Es terrible y pienso que esto nunca va a mejorar
(It’s terrible and I think it’s never going to get any better)
4. Es horrible y siento que esto es más fuerte que yo
(It’s awful and I feel that it overwhelms me)
5. Siento que no puedo soportarlo más
(I feel I can’t stand it any more)
6. Temo que el dolor empeore
(I become afraid that the pain may get worse)
7. No dejo de pensar en otras situaciones en las que experimento dolor
(I think of other painful experiences)
8. Deseo desesperadamente que desaparezca el dolor
(I anxiously want the pain to go away)
9. No puedo apartar el dolor de mi mente
(I can’t seem to keep it out of my mind)
10. No dejo de pensar en lo mucho que me duele
(I keep thinking about how much it hurts)
11. No dejo de pensar en lo mucho que deseo que desaparezca el dolor
(I keep thinking about how badly I want the pain to stop)
12. No hay nada que pueda hacer para aliviar la intensidad del dolor
(There is nothing I can do to reduce the intensity of the pain)
13. Me pregunto si me puede pasar algo grave
(I wonder whether something serious may happen)
… Total
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en esta enfermedad. Esperamos que la
validación de este cuestionario facilite la
realización de dichos estudios en la po-
blación española afectada de fibromialgia.
En conclusión, este estudio confirma las
adecuadas características psicométricas
de la versión española de la PCS en pa-
cientes con fibromialgia. Además, indica
que en la fibromialgia la CAD se correlacio-
na más con la depresión que con el dolor,
a diferencia de otros estudios en población
sana y en enfermedades que cursan con
dolor crónico. Como es obvio, se requeri-
rían nuevos estudios específicamente dise-
ñados para confirmar este último punto.
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Abstract
Background: Fibromyalgia (FM) is a prevalent and disabling disorder characterised by widespread pain and other
symptoms such as insomnia, fatigue and depression. Catastrophisation is considered to be a key clinical symptom
in FM; however, few studies have investigated how contextual factors, such as catastrophisation, might contribute
to the duration of the pain. The present research examined the relationship among pain, catastrophic thinking and
FM impact, as a function of stage of chronicity.
Methods: In this cross-sectional study, the sample of 328 patients diagnosed with FM was divided into 3 groups
based on level of chronicity: Group A (6 months to 2 years, N = 46); Group B (2-4 years, N = 59); and Group C
(more than 4 years, N = 223). The three subscales of the Pain Catastrophising Scale (PCS), rumination,
magnification, and helplessness, were used as predictors of dysfunction. The Fibromyalgia Impact Questionnaire
and the McGill Pain Questionnaire were also administered. A hierarchical regression analysis was performed on the
entire sample and, subsequently, for each group to determine the effect of the continuous process variables
(castastrophising and pain) on the stages of chronicity.
Results: Total score and PCS subscales were strongly associated with pain and impact in all the stages of
chronicity in FM patients (r = 0.27-0.73, p < 0.05). For Group A, a regression analysis revealed that rumination
predicted FM impact beyond the variance accounted for by age and pain. Both magnification and helplessness
predicted impact in Group B, and helplessness was a significant predictor of impact in Group C.
Conclusion: These findings provide preliminary evidence that stage of chronicity is an important moderator of
psychological vulnerability for FM impact and should be taken into account by tailoring psychological
interventions.
Background
Fibromyalgia (FM) is defined by the American College
of Rheumatology (ACR) as chronic (>3 months), wide-
spread pain (axial plus upper and lower segment plus
left and right sided pain) and tenderness in at least 11
of 18 tender points [1]. Patients frequently describe sen-
sations of fatigue, sleep disturbances, morning stiffness,
symptoms associated with irritable bowel syndrome and
affective distress. The prognosis for symptomatic recov-
ery is generally poor, and the estimation for lifetime pre-
valence is approximately 2% in community samples
[2,3]. Most patients report a high degree of impairment
in their daily functioning. When compared to patients
with other chronic pain conditions, patients with FM
report higher levels of pain and functional disability and
judge their quality of life as poorer [4]. Moreover, they
make extensive use of health services, thus leading to
high costs for medical and societal care [5]. The syn-
drome’s pathology is not well understood, and to date,
no treatment has proven effective in fully alleviating its
symptoms. A number of meta-analyses and reviews have
been conducted on pharmacological [6,7] and non-phar-
macological [8-10] treatments available for FM.
Psychological treatments seem to have beneficial
short-term effects on the key symptoms of FM, but
these effects largely disappear over the long term. Most
studies to date have addressed the role of psychological
factors in the development of chronic pain following
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acute pain [11,12]. Several psychological constructs have
been associated with the prognosis of FM, such as fear-
avoidance [13], self-efficacy and personal control [14],
pain coping [15] and acceptance [16]. The construct
receiving the most attention currently appears to be cat-
astrophising [17]; this attention may be due to the con-
struct’s association with negative prognosis.
Catastrophising refers to a combination of negative
thoughts and expectations regarding pain, and research
shows that it is a critically important variable in under-
standing the experience of pain in rheumatologic disor-
ders and in other chronic pain conditions. Thus, this
thought process may be an important target for both
psychosocial and pharmacological treatment of pain
[18,19].
Indeed, it has been proposed that the development of
FM involves an interaction between the experience of
pain and catastrophising, but it is unclear when and
how this cognitive construct first becomes important
[20]. Consequently, there is a need to study the relation-
ship between catastrophising and dysfunction in relation
to the development of FM. One approach might be to
use cross-sectional comparisons where different stages
of chronicity provide a proxy for the development
process.
It is also unclear whether the three components of
catastrophising (rumination, magnification, and helpless-
ness) contribute equally to the prediction of dysfunction
in FM or whether certain components are more predic-
tive than others. Information concerning the relative
importance of the components of catastrophising could
help treatment providers to tailor interventions to facili-
tate positive outcomes.
The aim of the present research was to replicate and
extend the findings of Sullivan [21] with regard to FM.
To this end, the present study examined whether the
three components of catastrophising interacted with
chronicity (i.e., the length of time the individual had
been diagnosed with FM) in predicting the severity of
the FM impact (i.e., activity limitations due to pain).
Method
Design
This was a multi-centre, cross-sectional study.
Participants and setting
The study sample consisted of 328 patients from the Pain
Clinic, Santander (Spain) and 8 primary care centres in
Zaragoza (Spain) during the year 2009. To be included in
the study, patients were required to fulfil several inclu-
sion criteria: (1) be between 18 and 65 years old; (2) be
able to understand and read Spanish; (3) meet the ACR
criteria for primary FM [1]; and (4) have been diagnosed
by a Spanish National Health Service rheumatologist.
Exclusion criteria included the following: (1) diagnosis of
a severe Axis I psychiatric disorder (dementia, schizo-
phrenia, paranoid disorder, or abuse of alcohol and/or
drugs) or a severe Axis II disorder that, from the clini-
cian’s point of view, might prevent them from following
the study protocol; and (2) refusal to participate.
Measures
Demographic and Pain-Related Variables
Each participant was interviewed and asked to provide
information about a number of demographic and pain-
related variables, including age, work status, duration of
FM diagnosis, medications and other medical
treatments.
Catastrophising
The PCS is a 13-item scale designed to assess the cata-
strophising cognitions of individuals by asking them to
reflect on thoughts or feelings associated with past pain-
ful experiences [22]. It can be divided into three sub-
scales: rumination, magnification and helplessness. Each
item is scored from 0 (not at all) to 4 (always), and
scores range from 0 to 52. The PCS has good temporal
stability, internal consistency and validity. The Spanish
version of the PCS has been validated by the current
study’s authors and shows psychometric properties simi-
lar to those of the original questionnaire [23].
Pain Severity
The McGill Pain Questionnaire (MPQ) was used as a
measure of pain severity [24]. It consists primarily of
three types of descriptors, sensory words, affective
words and evaluative words, which are used by patients
to specify subjective pain experience. It also contains an
intensity scale and other items to determine the proper-
ties of pain experience. For the purposes of the present
study, the Pain Rating Index was used. The Pain Rating
Index has been recommended as a reliable and valid
measure of chronic pain experience. This instrument
has a translated and validated Spanish version [25].
Fibromyalgia Impact Questionnaire
The Fibromyalgia Impact Questionnaire (FIQ) is a 10-
item self-report questionnaire developed to measure the
health status of FM patients [26]. The first item focuses
on the patient’s ability to carry out muscular activities.
In the next two items, patients are asked to circle the
number of days in the past week they felt good and how
often they missed work. Finally, the last seven questions
(ability to work, pain, fatigue, morning tiredness, stiff-
ness, anxiety, depression) are measured using a visual
analogue scale. This instrument also has a translated
and validated Spanish version[27].
Procedure
The study questionnaires and protocol were approved by
the Ethical Committee of the regional health authority,
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and the patients signed consent forms attesting to their
willingness to participate. After consenting to the study,
recruited patients were given a battery of questionnaires
to complete. These questionnaires included a pain form
for demographic variables, the FIQ, the PCS and the
MPQ.
Patients were classified into 1 of 3 groups on the basis
of the chronicity of their FM disorder. Patients in
Group A had been diagnosed less than 2 years ago (N =
46), those in Group B had received the diagnosis
between 2 and 4 years ago (N = 59), and the members
of Group C had carried the diagnosis for more than 4
years (N = 223).
Statistical methods
Sample size
There are no previous studies assessing the distribution
of disease chronicity in patients with FM. The large
sample size was chosen to ensure a minimum of 45
patients in each group. Therefore, patients were
recruited from both a tertiary care setting (the Pain
Clinic, Santander; N = 175; 53.3%) and in primary care
centres in Zaragoza (N = 153; 46.7%).
Analysis strategy
In the descriptive analysis of the sample, means and
standard deviations were calculated for continuous vari-
ables (i.e., age and pain), and percentages were calcu-
lated for categorical variables (i.e., gender and treatment
setting). Analysis of variance (ANOVA) was used to
compare the three chronicity groups. Pearson correla-
tions were used to assess the relationship between pain
catastrophising (total score and subscales) and other
psychometric variables such as pain (measured with
MPQ) and impact of FM (measured with FIQ). A hier-
archical regression analysis was performed on the entire
sample to determine the effect of the continuous pro-
cess variables (castastrophising and pain) on FM impact.
All analyses were conducted with SPSS 15.
Results
No patients were rejected because of severe Axis I or
Axis II psychiatric disorder. Only two patients (0.006%)
refused to participate in the study. The study sample
consisted of 328 patients (93.9% women and 6.1% men),
aged 18-77 years (mean 49.5 years, SD: 10.6 years), and
all of them self-described as from the European ethnic
group. On average, the patients had been suffering from
FM for 11.3 years (range 6 months - 40 years), and
22.8% had been granted an invalidity pension.
First, the data were summarised and explored. The
mean scores on the measures were compared across the
stages of chronicity using Pearson Correlation Coeffi-
cients. Mean and standard deviations for demographic
and dependent variables are found in Table 1. Despite
variations across some measures, there were no signi-
ficant differences between groups for age, pain, the
catastrophising subscales or FM impact. Correlations
between the catastrophising subscales and pain and
FM impact are displayed for each chronicity group in
Table 2. In both cases, and in the three groups, catastro-
phising subscales were significantly correlated with pain
and the FM impact.
Following these analyses, the moderational effect of
the stage of chronicity was tested, as in the original
paper [21], using a hierarchical regression analysis. To
test whether stage of chronicity moderated the effect of
the catastrophising components (rumination, magnifica-
tion, and helplessness) on function, the interaction
between catastrophising and stage of chronicity was
added.
Firstly, the hierarchical regression analysis was per-
formed on the entire sample to test whether any of the
interactions between chronicity and the three catastro-
phising components was more predictive of FM impact
than the individual PCS subscales. Age was entered in
Step 1 of the analysis but did not contribute significant
variance. Pain severity was entered in Step 2 and con-
tributed 24% of variance to the prediction of FM impact,
r= 0.48, F = 95.9, p < 0.001. The PCS subscales were
entered in Step 3 of the analysis and contributed 8% to
the prediction of impact, r= 0.56, F = 48.0, p < 0.001.
The three interaction terms were entered in the final
step of the analysis, but they did not contribute any
additional variance to the prediction of FM impact.
Secondly, the nature of interactions was explored with
separate multiple regressions for each level of chronicity.
Pain intensity was used as a covariate in order to
address whether the catastrophising components con-
tributed to the variance in function beyond the variance
accounted for by pain. The results of regression analyses
predicting dysfunction in the three chronicity groups are
presented in Table 3. For Group A, pain was entered in
Table 1 Sample characteristics
Group A
(< 2 years)
Group B
(2-4 years)
Group C
(> 4 years)
Age 47.0 (9.8) 48.3 (11.0) 50.3 (10.5)
MPQ 38.8 (7.9) 40.2 (8.2) 40.9 (8.3)
FIQ 71.3 (16.4) 70.8 (16.5) 73.6 (16.1)
PCS subscales
Rumination 10.4 (4.2) 11.1 (4.1) 11.0 (4.0)
Magnification 6.7 (3.7) 6.6 (3.1) 6.6 (3.1)
Helplessness 13.8 (6.2) 15.4 (5.8) 15.5 (5.6)
PCS total 30.9 (14.3) 33.1 (11.9) 33.1 (11.6)
MPQ = McGill Pain Questionnaire.
FIQ = Fibromyalgia Impact Questionnaire.
PCS = Pain Catastrophising Scale. Values in parentheses are standard
deviations.
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Step 1 of the analysis and contributed to 30% of the var-
iance in ratings of impact, F = 17.91, p < 0.001. In Step
2 of the analysis, age was entered but did not contribute
significant variance. The three subscales of the PCS
were allowed to compete for entry in the next step of
the analysis, and only the rumination subscale met cri-
teria in the regression equation, F = 38.09, p < 0.001.
Rumination accounted for 36% of the variance in ratings
of FM impact beyond that accounted for by pain.
For Group B, pain was entered in Step 1 and
accounted for 25% of the variance in disability ratings, F
= 19.53, p < 0.001. When the three PCS scales were
allowed to compete in the next step of the analysis,
both magnification (F = 18.5, p < 0.001) and helpless-
ness (F = 18.5, p < 0.001) met criteria for entry in the
regression equation, and they accounted for roughly the
same percentage of the variance (17% and 16%, respec-
tively) in ratings of impact when controlling for pain.
For Group C, pain was also entered in Step 1 and
accounted for 21% of variance, F = 57.0, p < 0.001. The
helplessness subscale of the PCS was entered next
because it was the only one that met minimum criteria
for entry in the regression equation, F = 51.17, p <
0.001. It accounted for an additional 12% of the
variance.
Discussion
Most reviews of the current literature conclude that psy-
chological interventions in patients with FM are rela-
tively limited [8-10]. To improve treatment outcomes,
more evidence is needed from experimental and pro-
spective studies that examine the specific cognitive and
behavioural mechanisms responsible for the develop-
ment and maintenance of chronic pain and disability.
Such evidence would help treatment providers to
develop interventions tailored to a patient’s risk profile.
Although considerable research has been conducted to
elucidate the vulnerability factors associated with pain-
related disability, the role of vulnerability-relevant con-
textual factors has not been systematically investigated.
The purpose of the present study was to test the role
of FM impact in relation to a thinking process that
often accompanies, and appears to worsen, the experi-
ence of unremitting pain, namely, catastrophising, as a
function of stage of chronicity (i.e. number of years
since the FM diagnosis). From the current perspective,
the influence of catastrophising on FM impact was con-
sidered to be variable and dependent on the context
(i.e., duration of diagnosis) in which the catastrophising
thoughts occur.
Accordingly, the findings of the present study provide
preliminary evidence that the psychological correlates of
FM impact change over time. Specifically, regression
analyses revealed that stage of chronicity moderated the
relationship between the PCS subscales and FM impact.
In the group of patients who had been diagnosed with
FM for fewer than 2 years, rumination accounted for
significant unique variance in FM impact. Magnification
and helplessness predicted FM impact over and above
the variance accounted for pain severity for patients
who had been diagnosed for 2-4 years, and helplessness
was the strongest predictor of FM impact in the group
of patients diagnosed for more than 4 years.
Additionally, results are concordant with what was
expected. Patients who have suffered from FM for less
than 2 years are characterised by exaggerated threat
appraisals (rumination), which may contribute to the
Table 2 Correlations between PCS subscales and pain
and impact
Group Rumination Magnification Helplessness Total PCS
MPQ (pain)
A (< 2 years) 0.43** 0.44** 0.53** 0.50**
B (2-4 years) 0.27* 0.40** 0.47** 0.42**
C (> 4 years) 0.32** 0.23** 0.36** 0.34**
FIQ (impact)
A (< 2 years) 0.76** 0.63** 0.68** 0.73**
B (2-4 years) 0.48** 0.59** 0.58** 0.60**
C (> 4 years) 0.46** 0.38** 0.50** 0.50**
Group A (n = 46), Group B (n = 59), Group C (n = 223). MPQ = McGill Pain
Questionnaire; FIQ = Fibromyalgia Impact Questionnaire; PCS = Pain
Catastrophising Scale. * p < 0.05, ** p < 0.01.
Table 3 Prediction of FM impact for each stage of
chronicity
Predicting FM impact in Group A
Variables Beta RÂ² Pearson r
Step1 Pain 0.55** 0.30 0.55**
Step2 Pain 0.32** 0.66 0.81**
Rumination 0.61**
Predicting FM impact in Group B
Variables Beta RÂ² Pearson r
Step1 Pain 0.50** 0.25** 0.50**
Step2 Pain 0.28* 0.42** 0.64**
Magnification 0.45**
Step2 Pain 0.30* 0.41** 0.64**
Helplessness 0.44**
Predicting FM impact in Group C
Variables Beta RÂ² Pearson r
Step1 Pain 0.46** 0.21** 0.46**
Step2 Pain 0.30** 0.33** 0.58**
Helplessness 0.39**
The impact was measured with the Fibromyalgia Impact Questionnaire,
catastrophising with the Pain Catastrophising Scale and pain with the McGill
Pain Questionnaire. * p < 0.05, ** p < 0.01.
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development of an overly cautious or fearful approach
to physical activity. In patients who have suffered from
FM for more than 4 years, helplessness appraisals may
accentuate the impact on function These results are also
in line with those of previous studies on chronic pain,
in which rumination was the best predictor of severity
of disability in patients who had been experiencing pain
for approximately 3 years [28], and helplessness was the
best predictor of severity in patients who had been
experiencing pain for approximately 9 years [29].
The present findings suggest that interventions that
consider stage of chronicity as a moderator of vulner-
ability for impact may yield more positive outcomes
than standardised approaches to the management of
FM. Cognitive therapies should be more focused on spe-
cific assessments (threat or helplessness) depending on
the context to optimise treatment outcomes These find-
ings also suggest that there is an additional facet to con-
sider with regard to the relationship between
catastrophising and FM impact, one that derives from a
contextual view of how thoughts will variably influence
behaviour dependent upon history, situation and, of
course, stage of chronicity.
Finally, it is notable that catastrophising was a stron-
ger predictor of FM impact than pain itself for the three
different stages of chronicity and that catastrophising
remained constant over time, despite the fact that FM
impact increased. These findings suggest that not only is
the type of intervention important but also the timing of
treatment. The findings accentuate the significance of
early detection and treatment of patients who are at risk
of developing FM and related problems [30]. Intervening
early in the course of a pain condition may help prevent
maladaptive patterns of pain coping and illness beha-
viours that are resistant to treatment, and it may have
the potential to reduce or prevent the negative impacts
of FM that, in turn, will reduce societal and medical
costs. It follows that early intervention is far more likely
to be effective than interventions administered in the
later stages of the condition. Psychological treatments
that are initiated shortly after a patient has been diag-
nosed with FM can help prevent long-term dysfunction
and chronicity.
As Sullivan has pointed out [21], the results of our
study are limited mainly because our correlational meth-
ods cannot unambiguously determine whether catastro-
phising leads to higher levels of FM impact or vice
versa. Given the consistent relationship between cata-
strophising and FM impact, however, it is clear that
there are important contextual processes at work.
Experimental, longitudinal, or clinical methods are
needed to illuminate these processes. A second limita-
tion of this study lies in the accuracy of the chronicity
classifications. One of the main difficulties that FM
patients face is failure to receive the FM diagnosis until
well after the onset of the disease. It is estimated that
there is a 3 year delay in the diagnosis of FM in Spain
[31]. Therefore, it is possible that some of the subjects
in this research who were classified as being in one of
the earlier stages of chronicity had actually been suffer-
ing from pain for some time previously. A final limita-
tion concerns the recruiting methods; because half of
the subjects were recruited from a specialised clinic, the
sample as a whole may not be representative of all
patients with FM.
Conclusion
The findings of this study highlight the important con-
tribution of contextual factors in prolonging the pain
condition, and as such, they have clinical implications
for the assessment of FM. The study of contextual
determinants of psychological vulnerability will play a
role in the development of tailored interventions. Recent
developments of Contextual Therapies aimed at pain
acceptance have shown that such therapies are relevant
in the treatment of chronic pain [32,33]. Based on these
preliminary but promising findings, we conclude that if
patients with FM were to be subdivided consistent with
their distinctive contextual cognitive and behavioural
patterns, and if interventions were subsequently modi-
fied to match these specific risk profiles, the efficacy of
psychological treatment programs could be substantially
advanced.
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assessment of acceptance in fibromyalgia
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Abstract
Background: The aim of this study was to validate a Spanish version of the Chronic Pain Acceptance Questionnaire 
(CPAQ). Pain acceptance is the process of giving up the struggle with pain and learning to live a worthwhile life despite 
it. The Chronic Pain Acceptance Questionnaire (CPAQ) is the questionnaire most often used to measure pain 
acceptance in chronic pain populations.
Methods: A total of 205 Spanish patients diagnosed with fibromyalgia syndrome who attended our pain clinic were 
asked to complete a battery of psychometric instruments: the Pain Visual Analogue Scale (PVAS) for pain intensity, the 
Hospital Anxiety and Depression Scale (HADS), the Medical Outcome Study Short Form 36 (SF-36), the Pain 
Catastrophising Scale (PCS) and the Fibromyalgia Impact Questionnaire (FIQ).
Results: Analysis of results showed that the Spanish CPAQ had good test-retest reliability (intraclass correlation 
coefficient 0.83) and internal consistency reliability (Cronbach's α: 0.83). The Spanish CPAQ score significantly correlated 
with pain intensity, anxiety, depression, pain catastrophising, health status and physical and psychosocial disability. The 
Scree plot and a Principal Components Factor analysis confirmed the same two-factor construct as the original English 
CPAQ.
Conclusion: The Spanish CPAQ is a reliable clinical assessment tool with valid construct validity for the acceptance 
measurement among a sample of Spanish fibromyalgia patients. This study will make it easier to assess pain 
acceptance in Spanish populations with fibromyalgia.
Background
Fibromyalgia is a chronic musculoskeletal pain disorder
of unknown aetiology, characterised by widespread pain
and muscle tenderness and often accompanied by fatigue,
sleep disturbance and depressed mood [1,2]. The progno-
sis for symptomatic recovery is generally poor, and the
estimation for lifetime prevalence is approximately 2% in
community samples [3]. The syndrome's pathology is not
well understood and, to date, no treatment has proven
effective in fully alleviating its symptoms.
In the last decade, "acceptance" has emerged as a valu-
able construct for contextual or third wave psychothera-
pies. Although sometimes misinterpreted as surrender
[4], the real concept is far from this idea. Acceptance of
chronic pain involves the individual reducing unsuccess-
ful attempts to avoid or control pain and focusing instead
on participation in valued activities and the pursuit of
personally relevant goals [5].
Hayes described, for the first time, a general measure of
acceptance and experiential avoidance, the Acceptance
and Action Questionnaire [6,7]. The CPAQ was devel-
oped by Geiser [8] as an adaptation of this assessment for
patients with chronic pain. Subsequent analyses carried
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Page 2 of 10out by McCracken [5,9,10] critically evaluated the con-
tent and factor structure, improving the questionnaire.
Factor analysis of the main tool for measuring accep-
tance, the Chronic Pain Acceptance Questionnaire
(CPAQ), initially reveals 34 items and four components,
which are as follows: activity engagement; pain willing-
ness; thought control and chronicity. Based on evaluation
of the psychometric properties of these four subscales,
however, McCracken et al. [5] reduced the CPAQ to only
20 items and two subscales (activity engagement and pain
willingness). A recent confirmatory factor analysis has
provided further support for these 20 items and two-fac-
tor construct of the CPAQ [11].
The Activity Engagement subscale consists of eleven
items and gauges the extent to which a person follows
their activities in a normal way regardless of their experi-
ence of pain. The Pain Willingness subscale has nine
items and measures how much a patient believes that
avoiding or controlling pain are strategies that work for
him. A total score is reached by combining both sub-
scales. Previous research studies [5,9,12,13] show that
acceptance of pain and willingness to act in its presence
are associated with reports of lower pain intensity, less
pain-related anxiety and avoidance, less depression, less
physical and psychosocial disability, more daily uptime
and better work status. Contrary to what is expected,
pain acceptance does not correlate with pain intensity.
The reason for this lack of correlation is that acceptance
can be considered as similar to a personality trait, with a
normal distribution in the population, and is independent
from pain level. Finally, acceptance of pain predicts better
adjustment on measures of patient functioning than per-
ceived pain intensity does, which continues to be true
even when pain intensity is factored out (see [14,15] for
review papers on this subject).
These results imply the potential of an improved out-
come for acceptance-based clinical methods for chronic
pain management. The CPAQ has already been validated
in German [16] and Chinese [17]; however, currently, a
measure of acceptance of pain is not available in Spanish.
Therefore, we translated the revised version of the CPAQ
into Spanish and tested its reliability and validity in Span-
ish patients suffering from fibromyalgia.
Materials and methods
Participants
Sample size was calculated according to the recom-
mended 10:1 ratio of the number of subjects to the num-
ber of test items [18]. The final study sample consisted of
205 patients attending the Pain Clinic (Santander, Spain)
and Fibromyalgia Unit (Hospital Miguel Servet, Zara-
goza) during the year 2009. To be included in the study,
patients had to fulfil the American College of Rheumatol-
ogy (ACR) criteria for primary fibromyalgia1, which was
diagnosed by a Spanish National Health Service rheuma-
tologist. The only exclusion criterion was a medical or
psychiatric disorder that impeded the patient's ability to
correctly answer the questionnaire. The study question-
naires and protocol were approved by the Ethical Com-
mittee of the regional health authority, and patients
signed a consent form attesting to their willingness to
participate in the study.
After consenting to the study, recruited patients were
given a battery of questionnaires for completion. All
patients completed these instruments on the day of the
visit. These included a pain form for demographic and
pain-related variables, including the translated Spanish
version of the CPAQ to be validated, a Pain Visual Ana-
logue Scale (PVAS) for pain intensity, and the validated
Spanish versions of the Hospital Anxiety and Depression
Scale (HADS), the Short Form 36 (SF 36), the Pain Catas-
trophising Score (PCS) and the Fibromyalgia Impact
Questionnaire (FIQ).
Translation of the CPAQ
Two researchers, who were aware of the objectives of the
CPAQ, did the first translation into Spanish. Each
researcher translated the questionnaire separately. Subse-
quently, two native English teachers who had no knowl-
edge regarding the instrument carried out back-
translations. Finally the two English versions were judged
equivalent by a third native English teacher, [5]. Any dif-
ferences between the translators were resolved by mutual
agreement. Both translators and authors were present at
the agreement. The authors read and write technical Eng-
lish and know the psychological construct to be assessed
with the questionnaire well. We have followed the usual
guidelines for cross-cultural adaptations [19]. The origi-
nal authors accepted the questionnaire to be translated.
They were sent the final version of the paper, and they
agree with the results.
Measurement tools
1 Pain Visual Analogue Scale (PVAS)
The PVAS consists of a 10 cm long straight line whose
tips represent the limits of pain intensity (none to
unbearable). The patients estimated the pain intensity
experienced on the same day between 0 and 10.
Chronic Pain Acceptance Questionnaire (CPAQ)
The Chronic Pain Acceptance Questionnaire (CPAQ) is a
20-item inventory designed to measure acceptance of
pain. (see additional file 1: Spanish version of CPAQ) [5].
There are two principle factors measured by this ques-
tionnaire: activities engagement and pain willingness. All
items are rated on a 0 (never true) to 6 (always true) scale.
Nine items measuring pain willingness were reverse-
keyed. Following the scoring procedure of McCracken et
al. [5], a single total score was calculated based on the
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suring activities engagement. The maximum possible
total score is 120, with a higher score indicating better
acceptance. Complete information about the scoring cal-
culation is given in the additional file 1: Spanish version
of CPAQ.
Hospital Anxiety and Depression Score (HADS)
The HADS [20] is a self-report scale designed to screen
for the presence of depression and anxiety disorders in
medically ill patients. It is appropriate for use in both
community and hospital settings and contains 14 items
rated on 4-point Likert-type scale. Two subscales
assessed depression and anxiety independently (HADS-
Dep and HADS-Anx, respectively). It has been validated
in a Spanish sample [21]. This is one of the most used
questionnaires for the assessment of depression and anxi-
ety in medical patients. We have used the cut-off point
recommended in the validated Spanish version of the
HADS [21], which is the same recommended by the orig-
inal authors [20]: scoring 8+ on both the anxiety and
depression scales. A cut off of 8 or more in HADS means
suspected depression or anxiety.
Medical Outcome Study Short Form 36 (SF-36)
The Medical Outcome Study Short Form 36 (SF-36) is a
36-item instrument designed to measure general health
status and health-related quality of life [22]. One item
assesses perceived change in health status, while 35 items
examine eight generic domains in both physical and men-
tal health. The 8 domains include Physical Function (PF),
Physical Role (RP), Bodily Pain (BP), General Health
(GH), Vitality (VT), Social Function (SF), Emotional Role
(RE) and Mental Health (MH). Scores on each subscale
range from 0 to 100, with higher scores indicating better
health status. The Spanish version of SF-36 has been
shown to be reliable with good construct validity [23].
Pain Catastrophising Scale (PCS)
The PCS is a 13-item scale designed to assess the catas-
trophising cognitions of individuals by asking them to
reflect on thoughts or feelings associated with present
painful experiences [24]. The PCS can be subdivided into
three subscales: rumination, magnification and helpless-
ness. Each item is scored from 0 (not at all) to 4 (always),
and scores range from 0 to 52. It has good temporal sta-
bility, internal consistency and validity. The Spanish ver-
sion of the PCS has been validated by our team showing
similar results to the original questionnaire [25]. Only the
total score of the PCS was used in this investigation.
Fibromyalgia Impact Questionnaire (FIQ)
The Fibromyalgia Impact Questionnaire (FIQ) is a 10-
item self-report questionnaire developed to measure the
health status of fibromyalgia patients [26]. The first item
focuses on the patient's ability to carry out muscular
activities. In the next two items, patients are asked to cir-
cle the number of days in the past week they felt good and
how often they missed work. Finally, the last seven ques-
tions (ability to work, pain, fatigue, morning tiredness,
stiffness, anxiety and depression) are measured with the
visual analogue scale. This instrument has a translated
and validated Spanish version [27].
Validation process
Patients diagnosed with fibromyalgia, fulfilling the crite-
ria previously described, who attended our clinics during
the year 2009 were invited to participate until the
expected sample was completed. In a subsample of 64
patients, test-retest reliability for a 2-week interval was
calculated. Face validity was assessed asking patients
from the Spanish Association of Fibromyalgia whether
they thought that the test could adequately measure their
pain acceptance. Construct validity was determined by
correlating the Spanish CPAQ scores to validated Spanish
versions of various psychometric instruments and com-
paring the results with those obtained from the original
English version. As the FIQ, HADS and PCS reflect
health status, mood changes and emotional distress (cata-
strophising) in fibromyalgia patients, we anticipated that
higher CPAQ scores would be associated with lower FIQ,
HADS and PCS scores. For patients' general health well-
being, including physical, emotional and social functions,
the SF-36 is able to measure these domains under eight
different subscales. We predicted that acceptance, as
measured by the CPAQ, should positively correlate to SF-
36 subscales. Exploratory factor analysis was carried out
as part of the validity test.
Statistics
Demographic data was analysed using the descriptive sta-
tistics of mean, standard deviation (SD) and range. Age
and duration of pain were used as continuous variables.
The remaining variables were used as dichotomous ones.
The dichotomised categories and their prevalence for
each variable are as follows: gender was dichotomised
into male and female; marital status was grouped into
married and single/separated/widowed; work status was
divided into employed and unemployed and educational
level was dichotomised into elementary/primary and sec-
ondary/tertiary. The CPAQ correlations were established
with female, married, employed and secondary educa-
tional level.
The association between the Spanish CPAQ and demo-
graphic characteristics were evaluated using Pearson cor-
relations. Cronbach's α coefficient was used to examine
the internal consistency (ideally, α should range between
0.7-0.9) of the questionnaire. Test-retest reliability was
assessed using analysis of variance intraclass correlation
coefficients (ICC) [28]. ICC will range between 0 and 1,
with values approaching 1 representing good reliability.
Pearson correlations were also used to assess the relation-
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ables, such as pain intensity, anxiety, depression, pain
catastrophising, health status and social functioning, as
measured by various Spanish versions of the instruments.
Finally, principle components analysis with varimax rota-
tion was used to analyse the factorial structure of the
Spanish version of CPAQ. All the variables studied
showed a normal distribution. All statistical analyses
were conducted using the Statistical Package for Social
Science version 15.0 (SPSS 15.0) for Windows.
Results
None of the participants were ruled out because of the
exclusion criteria. The study sample consisted of 205
patients (90.7% women and 9.3% men) between the ages
of 26 and 77 years (mean 50.0 years, SD: 9.7 years). Each
of the subjects described themselves as being of European
ethnic origin. On average, the patients had suffered from
fibromyalgia for 12.1 years (range 1-55 years), and 25.2%
had been granted a disability pension. Two-thirds (65.7%)
of patients were unemployed, whereas 34.3% of patients
were employed full- or part-time. The majority of the
participants were married (73.6%), while the rest were
single/separated/widowed (26.4%) individuals. Finally,
most participants had an elementary-primary education
(59%), while 41% had received a secondary-tertiary edu-
cation.
The mean CPAQ total score was 40.9 (SD 18.5, range 5-
102). This amounted to a mean item rating of 2.0, which
most closely corresponds with the lower range of the 0-6
scale and the rating category "Seldom true" for the aver-
age acceptance item. The mean for the subscales of activ-
ity engagement and pain willingness were 23.0 (SD 14.2,
range 0-59) and 18.1 (SD 9.7, range 0-53), respectively.
The scores for other instruments are summarised in
Table 1.
There was no significant association between CPAQ
total score and most demographic characteristics, includ-
ing age, sex, marital status, duration of pain or education
level. However, work status (r = 0.140, P = 0.056) was
almost correlated to CPAQ, suggesting that there might
be an association (Table 2).
For assessing face validity a sample of patients (N =
200) randomly recruited from the Spanish Association of
Fibromyalgia were asked whether they thought that the
test could adequately measure their pain acceptance. A
total of 93.5% (187 out of 200) of them agreed.
The overall ICC value was 0.83 with individual values
(Table 3) ranging from 0.32 (item 20) to 0.88 (item 2).
Regarding the two subscales of the CPAQ, test-retest reli-
ability values are as follows: Activity engagement (ICC:
0.85; 95% CI: 0.81-0.89) and Pain willingness (ICC: 0.82;
95%CI: 0.79-0.86). Cronbach's α for the CPAQ was 0.83.
The item-total correlations for most items were moderate
(mean 0.406, SD 0.213). Communalities ranged from
0.169 (item 7) to 0.633 (item 1). The Scree Plot (Figure 1)
indicated that a two-factor solution was optimal. Both
Table 1: Mean and SD of Scores of the Spanish Versions of 
Various Instruments (N = 205)
Instruments Mean SD
CPAQ (0-120) 40.9 18.5
Activity 
engagement 
subscale (0-66)
23.0 14.2
Pain willingness 
subscale (0-54)
18.1 9.7
PVAS (0-10) 7.9 1.5
HADS-anx (0-21) 12.2 4.3
HADS-dep (0-21) 11.2 4.7
PCS-total (0-52) 32.4 12.8
FIQ (0-100) 72.0 16.4
SF36-PF (0-100) 34.1 21.4
SF36-RP (0-100) 7.4 21.4
SF36-BP (0-100) 19.2 16.2
SF36-GH (0-100) 24.8 14.3
SF36-VT (0-100) 15.6 15.1
SF36-SF (0-100) 35.2 24.2
SF36-RE (0-100) 24.0 38.9
SF36-MH (0-100) 38.3 20.2
Table 2: Associations between the Spanish version of the CPAQ and demographic parameters.
Demographic parameters Association Significance
Age 0.025 P = 0.736
Sex 0.103 P = 0.160
Marital Status 0.186 P = 0.321
Education level 0.162 P = 0.422
Duration of pain -0.042 P = 0.591
Work status 0.140 P = 0.056
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ponents analysis with Varimax Rotation revealed a satis-
factory percentage of Total Variance explained by the two
factors 27.4% and 13.4%, respectively (Table 4), as well as
a corresponding Component Matrix (Table 5). These val-
ues are consistent with the original model of McCracken
et al. [5] and subsequent studies [11,17], providing fur-
ther support for the two-factor CPAQ.
The Pearson correlation was used to assess the relation-
ship between CPAQ and other psychometric instru-
ments, and the results are summarised in Table 6. The
CPAQ total score and the subscale for activity engage-
ment were significantly correlated with all of the other
psychometric instruments, including the VAS, HADS,
PCS, FIQ and SF36. Whereas the subscale for pain will-
ingness was only significantly correlated to certain scales.
Discussion
The psychometric properties of the Spanish version of
the CPAQ among patients with fibromyalgia patients are
adequate. The Scree plot indicated a two-factor construct
of the translated questionnaire similar to its original Eng-
lish version. Both factors had eigenvalues greater than
one. Principal Components with Varimax Rotation
revealed a satisfactory percentage of Total Variance
explained (40.7%) by the two factors. Looking at the
Component Matrix of the two-factor construct, individ-
ual items could be allocated to the same subscales as they
were in the English version of the CPAQ. Therefore, con-
struct validity of the translated CPAQ can be supported.
We have selected a two-factor solution, although it was
not the only possible solution. More than two factors had
eigenvalues above 1, and the Scree plot was not absolutely
clear in supporting this decision. We have selected this
solution because it seems the more coherent from a clini-
cal point of view. This is the same factor structure
obtained by both the original authors [5] and the German
and Cantonese validations previously carried out [16,17].
This has been defended by many other studies on pain
acceptance [29-33]. We are currently carrying out a con-
firmatory factor analysis in a different population of
patients with fibromyalgia, and preliminary results also
seem to support this two-factor solution.
Figure 1 Scree Plot indicates an optimal two-factor solution for the Spanish version of CPAQ.
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retest reliability (overall ICC 0.83 with 95% CI 0.79-0.86)
and internal consistency reliability (Cronbach's α 0.83).
Items n° 13 and 20 showed lower test-retest reliability
than the other items (ICC < 0.5). In the original
McCraken study, these data are not available [5], and in
the Chinese validation study [17], ICC values are higher
than 0.5 (item 13: 0.55 and item 20: 0.76). Both items
belong to the subscale "Acceptance of pain". We are not
sure why the test-retest reliability was low, but we suggest
that cultural factors may play a role. Many Spanish pain
patients have a quite passive viewpoint of pain and con-
sider pain difficult to control by will power alone.
As tends to happen in fibromyalgia surveys, the SF-36
scores were below average. In this case, the average total
score for CPAQ in this fibromyalgia group (mean 40.9
with SD of 18.5) was lower than other samples, where
usually the mean is around 50 [12,13,16,17]. Statistical
analysis showed that greater acceptance of pain and activ-
ity participation were associated with lower reported
pain intensity, less anxiety, depression and emotional dis-
tress, as well as worse general health status and health-
related quality of life (measured with the SF-36). These
findings were in concordance with reports from previous
studies [5,12,13]. It is also remarkable that the FIQ, a
questionnaire specifically designed for fibromyalgia
patients to measure health status, showed the highest
correlation with the CPAQ, indicating how important
acceptance is in predicting the impact of fibromyalgia. As
far as we know, there are no acceptance studies among
fibromyalgia patients using these scales, thus, it was not
possible to compare our results.
Regarding demographic data, the variable duration of
pain has received special attention, as it may indicate that
acceptance of chronic pain is in some way a product of
experience or something acquired over time. In fact, one
recent work showed a positive correlation between the
CPAQ and duration of pain [17]. However, in our
research, as in the majority of studies, no correlation with
duration of pain was found, suggesting that the length of
time a person has suffered from pain may not account for
whether a person is accepting of pain or not. Further
studies may be required to clarify the factors contributing
to such discrepancies.
Table 3: Item Means and SD, Intraclass Correlations (ICC) with 95% Confidence Interval (CI), Item-total correlations, 
Cronbach's α if item deleted for Spanish version of CPAQ (N = 205)
Item no. Mean SD ICC
(95% CI)
Item-total 
correlation
Cronbach's α if 
item deleted
1 2.4 1.9 0.83 (0.73-0.90) 0.592 0.81
2 2.1 1.7 0.88 (0.80-0.92) 0.583 0.81
3 1.7 1.8 0.72 (0.55-0.83) 0.480 0.82
4 1.9 1.8 0.56 (0.27-0.73) 0.367 0.82
5 1.9 1.9 0.54 (0.25-0.72) 0.415 0.82
6 2.1 1.8 0.82 (0.72-0.89) 0.566 0.81
7 2.5 2.0 0.61 (0.36-0.76) 0.164 0.83
8 2.2 1.8 0.75 (0.60-0.85) 0.488 0.81
9 1.7 1.7 0.85 (0.76-0.91) 0.554 0.81
10 2.1 1.9 0.64 (0.41-0.78) 0.495 0.81
11 2.5 2.1 0.81 (0.69-0.88) 0.241 0.83
12 2.4 1.9 0.65 (0.42-0.79) 0.395 0.82
13 2.1 2.0 0.47 (0.12-0.67) 0.197 0.83
14 2.1 1.9 0.52 (0.22-0.71) 0.312 0.82
15 1.9 1.8 0.80 (0.67-0.88) 0.531 0.81
16 2.3 2.0 0.65 (0.42-0.78) 0.126 0.83
17 1.7 1.8 0.60 (0.34-0.75) 0.401 0.82
18 1.6 1.9 0.59 (0.32-0.75) 0.378 0.82
19 2.0 1.9 0.69 (0.49-0.81) 0.509 0.81
20 1.3 1.7 0.32 (0.12-0.59) 0.339 0.82
Overall ICC was 0.83 (95% confidence interval: 0.79-0.86)
Cronbach's α of the total score was 0.83
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supported the content validity of the Spanish version of
the CPAQ. In the future, the Spanish CPAQ could help to
illustrate treatment mechanisms. To reach this goal, the
next step would be to assess the responsiveness of the
CPAQ to intervention. Further research with longitudinal
designs and multivariate models would be required to
investigate treatment mechanisms.
As McCracken has already pointed out [5], the results
of our study are limited because correlation methods can-
not unambiguously determine whether acceptance leads
to decreased levels of disability and distress or vice versa.
Given the consistent relationship between acceptance
and these measures, however, we would suggest that
there are important behavioural processes at work.
Experimental, longitudinal or clinical methods are
needed to illuminate these processes. Finally, another
possible limitation could be that the sample was recruited
from a specialised clinic and, thus, may not be represen-
tative of all patients with fibromyalgia. This could be the
reason for the lower CPAQ scores in this sample.
These findings hold potentially significant implications
for the treatment of patients with fibromyalgia and
chronic pain at a time in psychology when the usefulness
of traditional, control-based approaches is under ques-
tion. The increasingly popular Contextual Therapies
approach proposes that attempting to control negatively
valenced internal events, such as pain sensations and neg-
ative emotional reactions, is problematic. For example,
from the Acceptance and Commitment Therapy (ACT)
perspective, attempts to control aversive experiences are,
in the best case, an unproductive endeavour that can hin-
der the pursuit of valued experiences or, in the worst case,
an additional source of distress [34]. Experimental data
suggest that some common control-based strategies to
manage acute pain may be detrimental to functioning
and adaptation [35,36]. Existing psychological treatments
for chronic pain, such as ACT [37] or specific contextual
therapy for chronic pain [38], aim to increase pain
patients' pain acceptance on multiple levels.
Finally, in order to prevent misunderstandings, it
should be noted that acceptance of chronic pain is but
Table 4: Forced two-factor solution by Principal Items Loading and Varimax Rotation for the Spanish version of the CPAQ 
(N = 205).
Initial Eigenvalues Extraction Sums of Squared 
Loadings
Rotation Sums of Squared Loadings
Component Total % of
Variance
Cumulative
%
Total % of
Variance
Cumulative
%
Total % of
Variance
Cumulative
%
1 5.480 27.400 27.400 5.480 27.400 27.400 5.284 26.421 26.421
2 2.675 13.377 40.778 2.675 13.377 40.778 2.871 14.356 40.778
3 1.441 7.205 47.983
4 1.086 5.429 53.412
5 1.026 5.131 58.543
6 .965 4.827 63.370
7 .834 4.170 67.540
8 .802 4.010 71.550
9 .716 3.581 75.131
10 .638 3.191 78.322
11 .619 3.096 81.418
12 .580 2.898 84.317
13 .547 2.735 87.051
14 .509 2.547 89.598
15 .478 2.392 91.990
16 .417 2.084 94.075
17 .362 1.809 95.884
18 .307 1.533 97.416
19 .265 1.324 9.740
20 .252 1.260 100.000
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Table 5: Two-factor solution: Factor Loadings by Principal Components Analysis on Items of the Spanish version of the 
CPAQ (N = 205).
Factor Loadings Communalities
Summary Item Content 1 2
Q1 = I am getting on with the business of 
living no matter what my level of pain is
.796 .006 .633
Q2 = My life is going well, even though I 
have chronic pain
.747 .076 .564
Q6 = Although things have changed, I am 
living a normal life despite my chronic 
pain
.739 .057 .549
Q8 = There are many activities I do when I 
feel pain
.706 -.022 .499
Q9 = I lead a full life even though I have 
chronic pain
.702 .125 .508
Q19 = It's a relief to realise that I don't 
have to change my pain to get on with my 
life
.686 .043 .473
Q15 = When my pain increases, I can still 
take care of my responsibilities
.674 .101 .464
Q3 = It's OK to experience pain 636 .088 .412
Q10 = Controlling pain is less important 
than other goals in my life
.619 .108 .394
Q12 = Despite the pain, I am now sticking 
to a certain course in my life
.593 -.061 .355
Q5 = It's not necessary for me to control 
my pain in order to handle my life well
.560 .042 .316
Q20 = I have to struggle to do things 
when I have pain
.095 .664 .450
Q18 = My worries and fears about what 
pain will do to me are true
.140 .662 .458
Q14 = Before I can make any serious 
plans, I have to get some control over my 
pain
.062 .620 .388
Q13 = Keeping my pain level under 
control takes first priority whenever I'm 
doing something
-.041 .549 .303
Q11 = My thoughts and feelings about 
pain must change before I can take 
important steps in my life
.011 .533 .284
Q16 = I will have better control over my 
life if I can control my negative thoughts 
about pain
-.150 .528 .302
Q17 = I avoid putting myself in situations 
where my pain might increase
.269 .528 .351
Q4 = I would gladly sacrifice important 
things in my life to control this pain better
.218 .483 .281
Q7 = I need to concentrate on getting rid 
of my pain
-.032 .410 .169
(Items sorted according to loadings by factor and size for easier comprehension.)
The bold numbers (items) belong to the respective factor.
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Page 9 of 10one part of a contextual model of chronic pain and its
treatment. Other relevant processes include, among oth-
ers, present-focused awareness, values-based guidance of
actions and cognitive defusion. It will be interesting to
continue to explore the influence of these processes on
patient functioning.
In conclusion, the study confirms the adequate psycho-
metric properties of the Spanish version of the CPAQ in
fibromyalgia patients. Although acceptance is considered
to be one of the key processes of recovery in pain syn-
dromes, there have been hardly any studies in our coun-
try to enhance our knowledge of this concept. This study
will make it easier to assess acceptance in Spanish popu-
lations.
Additional material
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
BR, JGC, BC and ASS conceived the study design. BC performed the clinical
diagnosis of fibromyalgia. YLdH and BR collected the data. BR and JVL con-
ducted the statistical analysis, and all authors interpreted the results, drafted
the manuscript and read and approved the final manuscript.
Acknowledgements
The authors would like to thank Dr Lance M. McCracken for his advice and 
granting us permission to translate the Chronic Pain Acceptance Question-
naire. This research study has been possible thanks to the grant "Análisis de la 
correlación y la validez predictiva de los constructos psicológicos relacionados 
con el dolor en pacientes con fibromialgia" (PI09/90301) from Instituto de 
Salud Carlos III, Madrid, Spain.
Author Details
1Department of Psychology, Centro Rodero, Clínica de Neurociencias, 
Santander, Spain, 2Department of Psychiatry, Miguel Servet University Hospital, 
Instituto Aragonés de Ciencias de la Salud, Spain, 3Rheumatology Clinic, 
Santander, Spain, 4Department of Psychology, University of Zaragoza, Instituto 
Aragonés de Ciencias de la Salud, Spain, 5Research and Development Unit - 
Parque Sanitario Sant Joan de Déu & Fundación Sant Joan de Déu, Sant Boi de 
Llobregat, Barcelona, Spain, REDIAPP "Red de Investigación en Actividades 
Preventivas y Promoción de la Salud" (Research Network on Preventative 
Activities and Health Promotion) (RD06/0018/0017 and 6Instituto Aragonés de 
Ciencias de la Salud, Zaragoza, Spain
References
1. Wolfe F, Smythe HA, Yunus MB, Bennet RM, Bombardier C, Goldenberg DL, 
Tugwell P, Campbell SM: The American College of Rheumatology. 
Criteria for the classification of fibromyalgia. Report of the Multicenter 
Criteria Committee.  Arthritis Rheum 1990, 33:160-172.
2. Hudson JI, Pope HG Jr: The relationship between fibromyalgia and 
major depressive disorder.  Rheum Dis Clin North Am 1996, 22:285-303.
3. Wolfe F, Anderson J, Harkness D, Bennet RM, Caro XJ, Goldenberg DL, 
Russell IJ, Yunus MB: Health status and disease severity in fibromyalgia: 
results of a six-center longitudinal study.  Arthritis Rheum 1997, 
40:1571-1579.
4. LaChapelle D, Lavoie BA, Boudreau BA: The meaning and process of pain 
acceptance. Perceptions of women living with arthritis and 
fibromyalgia.  Pain Res Manage 2008, 3:201-210.
5. McCracken LM, Vowles KE, Eccleston C: Acceptance of chronic pain: 
Component analysis and a revised assessment method.  Pain 2004, 
107:159-166.
6. Hayes SC: A contextual approach to therapeutic change. Psychotherapists in 
Clinical Practice: Cognitive and Behavioural Perspectives Edited by: Jacobsen 
N. New York: Guildford Press; 1987:327-387. 
Additional file 1 Spanish version of the CPAQ.
Received: 28 September 2009 Accepted: 12 April 2010 
Published: 12 April 2010
This article is available from: http://www.hqlo.com/content/8/1/37© 2010 Rodero et l; licensee BioMed Central Ltd. is an Open Access articl  distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Health nd Quality of Li e Outcomes 2010, 8:37
Table 6: Correlation between Spanish version of CPAQ scores (total and subscales) and other Spanish instruments.
Instruments Correlation (T) Correlation (AE) Correlation (PW)
VAS -0.446 ** -0.427 ** -0.306 **
HADS-anx -0.447 ** -0.456 ** -0.210 **
HADS-dep -0.503 ** -0.605 ** -0.093
PCS-total -0.461 ** -0.388 ** -0.344 **
FIQ -0.603 ** -0.649 ** -0.231**
SF36-PF 0.397 ** 0.415 ** 0.169*
SF36-RP 0.248 ** 0.298 ** 0.056
SF36-BP 0.394 ** 0.495 ** 0.068
SF36-GH 0.438 ** 0.410 ** 0.239**
SF36-VT 0.395 ** 0.381 ** 0.197**
SF36-SF 0.450 ** 0.526 ** 0.101
SF36-RE 0.388 ** 0.386 ** 0.187**
SF36-MH 0.390 ** 0.415 ** 0.098
* Significant: P < 0.05
** Significant: P < 0.01
T = Total score of Spanish version of CPAQ
AE = Activity Engagement subscale of Spanish version of CPAQ
PW = Pain Willingness subscale of Spanish version of CPAQ
Rodero et al. Health and Quality of Life Outcomes 2010, 8:37
http://www.hqlo.com/content/8/1/37
Page 10 of 107. Hayes SC, Strosahl K, Wilson KG: Acceptance and Commitment Therapy: An 
experiential approach to behavior change New York: Guilford; 1999. 
8. Geiser DS: A comparison of acceptance-focused and control-focused 
psychological treatments in a chronic pain treatment centre University of 
Nevada-Reno; Unpublished doctoral dissertation; 1992. 
9. McCracken LM: Learning to live with the pain: acceptance of pain 
predicts adjustment in persons with chronic pain.  Pain 1998, 74:21-27.
10. McCracken LM: Behavioural constituents of chronic pain acceptance: 
results from factor analysis of the Chronic Pain Acceptance 
Questionnaire.  J Back Musculoskeletal Rehabil 1999, 13:93-100.
11. Vowles KE, McCracken LM, McLeod C, Eccleston C: The Chronic Pain 
Acceptance Questionnaire: Confirmatory factor analysis and 
identification of patient subgroups.  Pain 2008, 140:284-291.
12. Vowles KE, McCracken LM, Eccleston C: Processes of change in treatment 
for chronic pain: The contributions of pain, acceptance and 
catastrophising.  Eur J Pain 2007, 11:779-787.
13. Vowles KE, McCracken LM, Eccleston C: Patient functioning and 
catastrophising in chronic pain: the mediating effects of acceptance.  
Health Psychol 2008, 27:136-143.
14. García Campayo J, Rodero B: Cognitive and affective aspects of pain.  
Reumatol Clin 2009. doi:10.1016/j.reuma.2009.03.001
15. McCracken LM, Vowles KE: Acceptance of chronic pain.  Curr Pain 
Headache Rep 2006, 10:90-94.
16. Nilges P, Köster B, Schmidt CO: Pain acceptance - concept and validation 
of a German version of the chronic pain acceptance questionnaire.  
Schmerz 2007, 21:57-67.
17. Ning MC, Ming TW, Mae JY, Ping CP: Validation of the Chronic Pain 
Acceptance Questionnaire (CPAQ) in Cantonese-Speaking Chinese 
Patients.  J Pain 2008, 9:823-832.
18. Kline RB: Principles and practices of structural equation modelling.  In 
Methodology in the social sciences Edited by: Kenny DA. New York: The 
Guildford Press; 1998. 
19. Guillemin F, Bombardier C, Beaton D: Cross-cultural adaptation of 
health-related quality of life measures: literature review and proposed 
guidelines.  J Clin Epidemiol 1993, 46:1417-32.
20. Zigmond AS, Snaith RP: The hospital anxiety and depression scale.  Acta 
Psychiatr Scand 1983, 67:361-370.
21. Tejero A, Guimerá EM, Farré JM, Peri JM: Clinical use of HADS in 
psychiatric samples: a sensitivity, reliability and validity study (in 
Spanish).  Rev Dep Psiquiatr Fac Med Barc 1986, 13:233-238.
22. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, 
Westlake L: Validating the SF-36 health survey questionnaire: new 
outcome measure for primary care.  BMJ 1992, 305:160-4.
23. Alonso J, Prieto L, Antó JM: The Spanish version of the SF-36 Health 
Survey (the SF-36 health questionnaire): an instrument for measuring 
clinical results.  Med Clin 1995, 104:771-776.
24. Sullivan MJL, Bisop SC, Pivik J: The pain catastrophizing scale: 
development and validation.  Psychol Assess 1995, 7:524-532.
25. García Campayo J, Rodero B, Alda M, Sobradiel N, Montero J, Moreno S: 
Validation of the Spanish version of the Pain Catastrophizing Scale in 
fibromyalgia.  Med Clín 2008, 131:487-492.
26. Burckhardt CS, Clark SR, Bennet RM: The Fibromyalgia Impact 
Questionnaire: development and validation.  J Rheumatol 1991, 
18:728-733.
27. Rivera J, Gonzalez T: The Fibromyalgia Impact Questionnaire: a 
validated Spanish version to assess the health status in women with 
fibromyalgia.  Clin Exp Rheumatol 2004, 22:554-560.
28. Bedard M, Martin NK, Krueger P, Brazil K: Assessing reproducibility of 
data obtained with instruments based on continuous measurements.  
Experimental Aging Research 2000, 26:353-365.
29. Carr JL, Moffett JA, Sharp DM, Haines DR: Is the Pain Stages of Change 
Questionnaire (PSOCQ) a useful tool for predicting participation in a 
self-management programme? Further evidence of validity, on a 
sample of UK pain clinic patients.  BMC Musculoskelet Disord 2006, 7:101.
30. Mason VL, Mathias B, Skevington SM: Accepting low back pain: is it 
related to a good quality of life?  Clin J Pain 2008, 24:22-29.
31. McCracken LM, Eccleston C: Coping or acceptance: what to do about 
chronic pain?  Pain 2003, 105:197-204.
32. McCracken LM, Eccleston C: A comparison of the relative utility of 
coping and acceptance-based measures in a sample of chronic pain 
sufferers.  Eur J Pain 2006, 10:23-29.
33. McCracken LM, Yang SY: The role of values in a contextual cognitive-
behavioural approach to chronic pain.  Pain 2006, 123:137-145.
34. Hayes SC, Bissett RT, Korn Z, Zettle RD, Rosenfarb IS, Cooper LD, Grundt 
AM: The impact of acceptance versus control rationales on pain 
tolerance.  Psychol Rec 1999, 49:33-47.
35. Cioffi D, Holloway J: Delayed costs of suppressed pain.  J Pers Soc Psychol 
1993, 64:274-282.
36. McCracken LM, Vowles KE, Gauntlett-Gilbert J: A prospective 
investigation of acceptance and control-oriented coping with chronic 
pain.  J Behav Med 2007, 20:339-349.
37. Dahl J, Wilson KG, Luciano C, Hayes SC: Acceptance and commitment 
therapy for chronic pain Reno, NV: Context Press; 2005. 
38. McCracken LM: Contextual cognitive-behavioural therapy for chronic pain 
Seattle, WA: IASP Press; 2005. 
doi: 10.1186/1477-7525-8-37
Cite this article as: Rodero et al., Validation of the Spanish version of the 
Chronic Pain Acceptance Questionnaire (CPAQ) for the assessment of accep-
tance in fibromyalgia Health and Quality of Life Outcomes 2010, 8:37
Publications 
 
“AFFECTIVE AND COGNITIVE ASPECTS IN FIBROMYALGIA: THE ROLES  OF CATASTROPHIZING AND ACCEPTANCE” 84 
 
 
 
3.5 SEPARATA DEL ARTÍCULO 
 
Relationship between behavioural coping strategies and acceptance in patients with 
fibromyalgia syndrome: elucidating targets of interventions.  
 
Rodero B, Casanueva B, Luciano JV, Gili M, Serrano-Blanco A, García-Campayo J.  
 
Publicado en: BMC Musculoskelet Disord. 2011 Jun 29;12:143. 
Publications 
 
“AFFECTIVE AND COGNITIVE ASPECTS IN FIBROMYALGIA: THE ROLES  OF CATASTROPHIZING AND ACCEPTANCE” 85 
 
 
RESEARCH ARTICLE Open Access
Relationship between behavioural coping
strategies and acceptance in patients with
fibromyalgia syndrome: Elucidating targets of
interventions
Baltasar Rodero1, Benigno Casanueva2, Juan V Luciano3,6*, Margalida Gili4,6*, Antoni Serrano-Blanco3,6* and
Javier García-Campayo5,6*
Abstract
Background: Previous research has found that acceptance of pain is more successful than cognitive coping
variables for predicting adjustment to pain. This research has a limitation because measures of cognitive coping
rely on observations and reports of thoughts or attempts to change thoughts rather than on overt behaviours. The
purpose of the present study, therefore, is to compare the influence of acceptance measures and the influence of
different behavioural coping strategies on the adjustment to chronic pain.
Methods: A sample of 167 individuals diagnosed with fibromyalgia syndrome completed the Chronic Pain Coping
Inventory (CPCI) and the Chronic Pain Acceptance Questionnaire (CPAQ).
Results: Correlational analyses indicated that the acceptance variables were more related to distress and
functioning than were behavioural coping variables. The average magnitudes of the coefficients for activity
engagement and pain willingness (both subscales of pain acceptance) across the measures of distress and
functioning were r = 0.42 and 0.25, respectively, meanwhile the average magnitude of the correlation between
coping and functioning was r = 0.17. Regression analyses examined the independent, relative contributions of
coping and acceptance to adjustment indicators and demonstrated that acceptance accounted for more variance
than did coping variables. The variance contributed by acceptance scores ranged from 4.0 to 40%. The variance
contributed by the coping variables ranged from 0 to 9%.
Conclusions: This study extends the findings of previous work in enhancing the adoption of acceptance-based
interventions for maintaining accurate functioning in fibromyalgia patients.
Background
Fibromyalgia (FM) syndrome is a chronic rheumatologic
disorder of unknown aetiology that affects between 2
and 4% of the general population [1]. Some environ-
mental familial factors, such as learned strategies for
coping with problems in life, have been pointed to as
intrinsic parts of the pathogenesis of fibromyalgia [2].
The traditional approach to treatment typically focuses
on symptom reduction through medical management or
self-management approaches, often within the context
of multidisciplinary pain management programs [3].
Behavioural and cognitive-behavioural treatments,
which are included in these programs, are based on the
idea that modifying an individual’s responses to his or
her condition will reduce disability and suffering from
chronic pain. Researchers had paid attention to the fact
that although chronic pain could lead to dysfunction
among some individuals, others seem to adjust relatively
well to the ongoing experience of pain; additionally,
these researchers tried to identify the factors that
* Correspondence: jvluciano@sjd-ssm.com; mgili@uib.es; aserrano@sjd-ssm.
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promote adaptive functioning in the face of pain. Along
these lines, a great deal of research has examined the
range and efficacy of patients’ “coping” strategies [4]. It
has been assumed that an individual’s choice of coping
strategies will determine his or her adjustment to
chronic pain, and research has focused largely on identi-
fying healthy strategies. Unfortunately, research using
coping strategies has more readily identified detrimen-
tal–rather than specific and adaptive–coping responses.
For example, coping responses such as guarding or rest-
ing have often shown a strong positive association with
disability and distress [5,6].
Therefore, researchers and clinicians have begun to
embrace emerging psychological theories that discuss
acceptance in relation to the effects of aversive thoughts,
moods, or sensations. Acceptance-based interventions
attempt to teach clients to feel emotion and bodily sen-
sations more fully and without avoidance and to notice
the presence of thoughts without following, resisting,
believing, or disbelieving them [7]. However, it is under-
stood that experiential avoidance is a process in which
an individual attempts to change the form or frequency
of a private event that he or she is unwilling to experi-
ence. Although experiential avoidance might be effective
in the short term, in the long term, it seriously limits
quality of life. Most of the actions of patients with
chronic pain are aimed at avoiding painful sensations
and emotions as well as thoughts or memories asso-
ciated with pain, but paradoxically, as has been widely
documented [8,9], avoidance behaviour leads to
disability.
A great deal of research supports the role of pain
acceptance in the daily functioning of people with
chronic pain. In clinical samples, the acceptance of pain
is associated with less pain, distress and disability
[10-12] and with greater psychological wellbeing [13]. In
treatment outcome studies, acceptance-based methods
are associated with improved emotional, psychosocial
and physical functioning and with reduced healthcare
use [14-17].
The traditional medical approach uses strategies (e.g.,
encouraging wellness-focused strategies and discouraging
illness-focused strategies) [18] to alleviate or avoid symp-
toms. In contrast, acceptance-based interventions, rather
than attempt to eliminate unwanted experiences, help
the individual to identify valued directions, start to act in
those directions and, thus, to follow a meaningful life.
For this purpose, patients are taught how to make willing
contact with and tolerate the experience of pain or other
distressing events that might appear, without attempts to
control them [19]. Coping with pain is directly trying to
change pain, and what the person feels and thinks about
pain. Acceptance of pain is directing efforts towards
functioning and living; acceptance is “coping” with life.
McCracken and Eccleston [20,21] each found that
acceptance of pain accounted for much more variance
in measures of patient functioning–including disability,
work status, depression and pain-related anxiety–than
did a measure of cognitive strategies. Both studies used
the Coping Strategies Questionnaire (CSQ) [22]; how-
ever, the CSQ has been observed to be more heavily
weighted towards the measurement of cognitive rather
than behavioural coping strategies, and this represents a
limitation [23]. Cognitive coping instruments depend on
patient memory to gauge accurately what the patient
usually does to cope. It is possible that patients may
place more weight on their most recent coping efforts
when rating their “usual” coping responses. Memory is
also mood-dependent, and because pain can influence
mood, it can likewise affect memory [24]. To deal with
these concerns, the utilisation of measures of beha-
vioural coping efforts that are readily observable, such
as rest, medication or exercise, is highly recommended.
The primary aim of this study was to replicate and
extend the findings of previous studies using the
Chronic Pain Coping Inventory (CPCI) [18], which is an
inventory that is focused on behavioural strategies. In
addition to having been validated in a sample of Spanish
patients with fibromyalgia [25], this questionnaire has
explained unique and significant variance in measures of
adjustment when compared to the CSQ [6,26]. It was
expected that the acceptance-based measures would
continue to show greater utility in comparison with the
behavioural coping strategies in predicting important
aspects of patient distress and functioning. Furthermore,
the CPCI will allow us to observe differences between
acceptance and behavioural strategies and to elucidate
the targets of intervention in pain management.
Methods
Settings and Participants
The study sample consisted of 167 patients who were
recruited from the 41 primary healthcare centres in the
city of Zaragoza, Spain, during the year 2010.
To be included in the study, patients were required to
fulfil several inclusion criteria: (1) be between 18 and 67
years old; (2) be able to understand and read Spanish;
(3) meet the American College of Rheumatology criteria
for primary FM [1]; and (4) have been diagnosed by a
Spanish National Health Service rheumatologist. Exclu-
sion criteria included the following: (1) diagnosis with a
severe Axis I psychiatric disorder (dementia, schizophre-
nia, paranoid disorder, or abuse of alcohol and/or drugs)
or a severe Axis II disorder (personality disorder) that,
from the clinician’s point of view, might prevent them
from following the study protocol; and (2) refusal to
participate. The study questionnaires and protocol were
approved by the Ethical Committee of the regional
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health authority, and the patients signed a consent form
attesting to their willingness to participate.
Measures
Demographic and Pain-Related Variables
Each participant was interviewed and provided informa-
tion about a number of demographic and pain-related
variables including age, work status, time diagnosed
with FM, medications and other medical treatments.
Visual Analogue Scale (VAS)
The Visual Analogue Scale (VAS) consists of a 10 cm
long straight line whose extremities represent the limits
of pain intensity (from none to unbearable). Patients
estimated the pain intensity experienced between 0 and
10 at the time that they were interviewed.
Physical symptoms
The number of comorbid physical symptoms was
obtained from a standardised symptom checklist [27].
This self-report checklist instructs participants to indi-
cate whether they experienced each of the 75 symptoms
for at least 3 months over the past year. A score was
obtained by totalling the affirmative responses to all 75
symptoms. Sample symptoms include dry eyes, short-
ness of breath, dizziness, irregular heartbeat, tingling in
the extremities, urinary urgency, and coughing spells.
Chronic pain acceptance questionnaire (CPAQ)
The Chronic Pain Acceptance Questionnaire (CPAQ) is
a 20-item inventory designed to measure the acceptance
of pain [12]. There are two principal factors measured
by this questionnaire: activities engagement and pain
willingness. All items are rated on a 0 (never true) to 6
(always true) scale. Nine items measuring pain willing-
ness were reverse-keyed. Following the scoring proce-
dure, a single total score was calculated based on the
nine reverse-keyed items and the other eleven items
measuring activities engagement. The maximum possi-
ble total score is 120, with a higher score indicating bet-
ter acceptance. The Spanish version of the CPAQ
showed sound psychometric properties (a = 0.79-0.86)
and good test-retest reliability (intraclass correlation
coefficient 0.83) [28].
The Chronic Pain Coping Inventory - 42 (CPCI-42)
The Chronic Pain Coping Inventory (CPCI) [18] was
originally a 65-item self-report questionnaire; based on
recent analyses, it has been shortened to 42 items [29].
It asks patients to rate the frequency of use of beha-
vioural and cognitive strategies over the previous week.
It has the same CPCI-65 strategies, which are grouped
into the following eight subscales: Guarding, Resting,
Asking for Assistance, Relaxation, Task Persistence,
Exercise/Stretch, Seeking Social Support and Coping
Self-Statements. This instrument was translated and
validated into Spanish by our team. Reliability coeffi-
cients were adequate based on the current data (a =
0.65-0.82) and test-retest reliability (intraclass correla-
tion coefficient 0.76) [25].
Hospital Anxiety and Depression Score (HADS)
The HADS [30] is a self-report scale designed to screen
for the presence of depression and anxiety disorders in
medically ill patients. It is appropriate for use in both
community and hospital settings and contains 14 items
rated on 4-point Likert-type scales. Two subscales assess
depression and anxiety independently. The HADS has
been validated in a Spanish sample [31] and has demon-
strated good reliability and validity. The test-retest relia-
bility presented correlation coefficients above 0.85, and
the internal consistency showed satisfactory coefficients
a = 0.86 (anxiety) and a = 0.86 (depression).
Medical Outcome Study Short Form 36 (SF-36)
The Medical Outcome Study Short Form 36 (SF-36) is a
36-item instrument designed to measure general health
status and health-related quality of life [32]. One item
assesses perceived change in health status, while 35
items examine eight generic domains in both physical
and mental health. The eight domains include Physical
Function, Physical Role, Bodily Pain, General Health,
Vitality, Social Function, Emotional Role and Mental
Health. Scores in each subscale range from 0 to 100
with higher scores indicating better health status. The
Spanish version of SF-36 has been shown to be reliable
with good construct validity (a = 0.78-0.96) [33].
Fibromyalgia Impact Questionnaire (FIQ)
The Fibromyalgia Impact Questionnaire (FIQ) is a 10-
item self-report questionnaire developed to measure the
health status of fibromyalgia patients [34]. The first item
focuses on the patient’s ability to perform functional
activities. In the next two items, patients are asked to
circle the number of days in the past week that they felt
good and the number of days that they missed work.
Finally, the last seven questions (ability to work, pain,
fatigue, morning tiredness, stiffness, anxiety, and depres-
sion) are measured with the visual analogue scale. This
instrument has a translated and validated Spanish ver-
sion [35] that showed good psychometric properties (a
= 0.82-0.86) and good test-retest reliability (intraclass
correlation coefficient 0.74) [28].
Statistical methods
Sample size
The sample size was calculated based on the population
that suffers from FM in the region of Aragon, which
according to previous studies [1] can be estimated in
36,000 patients out of a total of 1,200,000 inhabitants
that live in Aragon. With a confidence level of 95% and
an estimated error of 5% based on previous studies
[20,21], a sample of 167 patients was necessary for an
adequate power calculation [36]. EPIDAT 3.1 was used
to calculate the sample size.
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Analysis strategy
Prior to analyses, a factor analysis was performed to
determine if there was any overlapping between scales.
Results suggested excluding four SF-36 subscales: first,
the Physical Role and Bodily Pain subscales and, second,
the Emotional Role and Mental Health subscales because
of their overlap with the FIQ and HADS scales, respec-
tively. Next, to compare and contrast our results, we fol-
lowed the same steps as McCracken and Eccleston’s
previous papers [20,21]. First, a correlation analysis with
the Bonferroni correction (a= 0.05/n) was used to assess
the relationship among acceptance subscales, coping
scores, and measures of pain and functioning [37]. Addi-
tionally, Cohen’s criteria [38] were taken into account to
evaluate the substantive significance of correlations (large
correlations are those > 0.50, medium correlations are
from 0.30 to 0.49, and small correlations are from 0.10 to
0.29). Then, two sets of hierarchical regression analyses
were performed to investigate combined and unique rela-
tions of acceptance and coping scores with measures of
functioning. The criterion variables included pain, num-
ber of symptoms, FM impact, general health, vitality,
anxiety, depression and physical and social functioning.
In the first set of analyses, the eight coping variables were
tested as predictors for entry at the predictive model, and
then the two acceptance scores were tested for entry (p
<0.05 to enter, p > 0.10 to remove). In the second set of
analyses, the order of entry was reversed; first, the accep-
tance scores were tested for entry, and then the coping
scores were tested. Together, this regression method is
designed to show which variable set accounts for the lar-
gest increment of unique variance in the measures of
pain and functioning. Condition indices were inspected
to flag excessive collinearity in the data (a condition
index over 30 suggests serious collinearity problems). All
statistical analyses were performed using the SPSS 15 sta-
tistical package.
Results
Characteristics of the participants
The study sample consisted of 167 patients (90.4%
women and 9.6% men), aged 19 - 67 years (50.6 years,
SD = 9.9 years); all of them were self-described as from
the Caucasian ethnic group. On average, the patients
had been suffering from fibromyalgia for 12.3 years
(range 1 - 40 years), and 19.7% had been granted an
invalidity pension.
Correlational analyses between study measures
Results from correlational analyses of acceptance sub-
scales, coping scores, and measures of pain and func-
tioning are shown in Table 1.
Both acceptance scores were correlated with task per-
sistence but negatively correlated with guarding, resting
and asking for assistance. Furthermore, pain willingness
was negatively correlated with relaxation and seeking
social support.
The acceptance subscales were significantly correlated
with almost all nine of the measures of pain and func-
tioning in the expected direction. The average magni-
tudes of the coefficients for activity engagement and
pain willingness across the measures of distress and
functioning were r = 0.42 and 0.25, respectively.
Forty-three out of 71 of the correlations between the
coping scores and measure of pain and functioning were
significant, at p < 0.05. The average magnitude of the
significant correlation was r = 0.17. Guarding, resting
and asking for assistance were reliably associated with
poorer functioning in nine out of nine measures includ-
ing greater pain, number of symptoms, anxiety and
depression. Seeking social support was also related to
greater problems with functioning, reaching significance
in four out of nine measures. In only 10 out of 71
instances did coping scores corre-late with measures of
distress and functioning in a way that suggested a posi-
tive relationship. Task persistence was associated with
better functioning in eight out of nine measures. Coping
self-statements were associated with two out of nine
measures. Contrary to our expectations, exercise/stretch
did not show any correlation with the diverse variables,
and relaxation was associated with a greater number of
symptoms and worse physical functioning.
After the Bonferroni correction for multiple tests,
fifty-one correlations still remained significant. Forty-six
of these correlations fulfil the most stringent criteria
used (p= 0.00069; 0.05/72). Within this criterion, it is
noteworthy that there were sixteen out of 19 possible
correlations between the acceptance scores and measure
of pain and functioning, which demonstrate the impor-
tance of the acceptance measures. Only four correlations
met with the second corrected p-value (p= 0.0028; 0.05/
18), and, finally, only one correlation complied with the
less stringent criteria (p= 0.003125; 0.05/16).
Hierarchical regression analyses
Table 2 shows the results of the first set of regression
analyses. Resting and task persistence showed significant
contributions to six of the nine regression equations.
Guarding made significant contributions to four of the
nine regression equations, coping self-statements and
relaxation contributed to two, and exercise and seeking
social support contributed to one. In general, resting
predicted greater pain, fibromyalgia impact, anxiety, and
depression and predicted worse vitality and social func-
tioning. Guarding predicted a greater impact on general
function and worse general health and physical and
social functioning. Relaxation predicted a greater num-
ber of symptoms and worse general health. However,
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coping self-statements predicted better general health
and less depression. Exercise contributed to better gen-
eral health, and seeking social support contributed to
better social functioning. Furthermore, it is worth noting
that task persistence made significant contributions to
six of the nine regression equations, and its predictions
were associated with better wellbeing, including less
pain, impact, anxiety, and depression, and better physi-
cal and social functioning. Asking for assistance was the
unique subscale that did not make any contribution.
Both acceptance scores were selected together in four
out of nine equations; otherwise, activity engagement
was selected as a predictor of the number of symptoms,
impact, vitality, social functioning and depression, but
pain willingness alone did not predict any variable. The
sums of variance increments attributed to all selected
coping variables ranged from 7.4 to 37%. The variance
increments for the acceptance scores ranged from 3.2 to
12%. Across the seven equations, the average variance
contributed by coping and acceptance were 20 and 8%,
respectively.
Table 3 includes the results of the second set of
regressions in which the acceptance scores were entered
prior to the coping scores. Both acceptance scores were
selected together as predictors in six out of nine
equations. Activity engagement was selected alone as a
predictor of a number of symptoms, including social
functioning and depression. In each case, acceptance
predicted better functioning. Resting and guarding were
selected as significant predictors in three out of nine
equations with both predicting poorer functioning. It is
remarkable that there was not any significant coping
predictor for anxiety. The variance contributed by
acceptance scores ranged from 4.0 to 40%. The variance
contributed by the coping variables ranged from 0 to
9%. Across the nine equations, the average variance con-
tributed by acceptance was 22%, while the average var-
iance contributed by coping was 4.7%.
Discussion
The purpose of this study was to compare the accep-
tance of chronic pain with behavioural coping in pre-
dicting adjustment to chronic pain and, in the process,
to replicate and extend McCracken and Eccleston’s ear-
lier papers [20,21]. The results of the present work can
be summarised as follows: a greater acceptance of
chronic pain was associated with less pain, symptoms,
fibromyalgia impact, anxiety, and depression as well as
with better general health, vitality and physical and
social functioning. Regarding behavioural coping
Table 1 Correlations of Acceptance scales and Coping strategies with Pain, Number of symptoms, Fibromyalgia impact,
General health, Anxiety and Depression (N = 167)
Activity
engagement
Pain
willingness
Pain
(VAS)
Number of
symptoms
Physical
functioning
General
health
Vitality Social
functioning
Fibromyalgia
Impact
Anxiety Depression
Acceptance-
measures
Activity
engagement
-0.42**c -0.20** 0.44**c 0.41**c 0.33**c 0.50**c -0.62**c -0.42**c -0.53**c
Pain
willingness
0.28**c -0.32**c -0.14 0.34**c 0.35**c 0.28**c 0.17* -0.32**c -0.31**c -0.27**c
Coping
strategies
Guarding -0.42**c -0.29**c 0.28**c 0.16* -0.46**c -0.30**c -0.34**c -0.35**c 0.49**c 0.25**b 0.28**c
Resting -0.45**c -0.37**c 0.34** 0.22** -0.29**c -0.28**c -0.39**c -0.39**c 0.54**c 0.35**c 0.41**c
Asking for
assistance
-0.35**c -0.19* 0.23**a 0.15* -0.33**c -0.24**b -0.33**c -0.18* 0.42**c 0.17* 0.22**
Relaxation -0.06 -0.25**b 0.01 0.30**c -0.18* -0.14 -0.07 -0.14 0.10 0.05 -0.02
Task
persistence
0.49**c 0.17* -0.34**c -0.10 0.35**c 0.24**b 0.21** 0.30**c -0.37**c -0.30**c -0.37**c
Exercise/
Stretch
0.08 -0.11 -0.01 0.11 -0.00 0.06 0.04 0.00 0.05 0.00 -0.07
Seeking
social
support
-0.14 -0.21** 0.17* 0.09 -0.20** -0.07 -0.10 0.01 0.20** 0.21** 0.02
Coping self-
statements
0.10 -0.08 -0.10 0.08 -0.02 0.21** 0.06 0.08 -0.06 -0.11 -0.24**
Note: Pain was assessed with a 100 mm visual analogue scale, Number of symptoms with standardised symptom checklist, General functioning with some of the SF-36
subscales, the Fibromyalgia impact with the FIQ, and Anxiety and Depression with the HADS.
*p < 0.01; **p < 0.05; Bonferroni-corrected p values; a = 0.003125 (0.05/16); b = 0.0028 (0.05/18); c = 0.00069 (0.05/72).
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strategies, guarding and resting were consistently asso-
ciated with a greater fibromyalgia impact and, individu-
ally, with less healthy functioning. Regression analyses
revealed that in the first and more conservative model,
acceptance added to the variance explained, indepen-
dently of coping, all of the outcomes, with variance
increments averaging 8% (compared to 20% for coping).
When the model was reversed, many of the coping
effects diminished, and acceptance continued to inde-
pendently predict outcome on all adjustment measures
with variance increments averaging 22% (compared to
4.7% for coping).
Although this study confirmed that acceptance of pain
can still account for more variance than various mea-
sures of behavioural coping, in a range of important
measures of distress and patient functioning, the results
of this study were slightly different from those of other
studies [20,21]. There are two possible reasons for these
differences. First, previous studies used cognitive coping
questionnaires, and it may be possible that behavioural
coping predicts both distress and functioning better.
Another possible reason is that fibromyalgia is a chronic
disorder characterised by a large number of symptoms.
Previous work has pointed out the possibility of fibro-
myalgia patients showing fewer acceptance scores than
other pain conditions [28], so this would also explain
the lack of a greater difference between measures.
Indeed, the acceptance mean scores for other pain con-
ditions were 47.8, 49.0 and 50.4 [15,17,39], which are
substantially different from our fibromyalgia sample,
where the mean score was 40.3.
Previous research has shown on more than one occa-
sion that CPCI has three well-defined groups [18,29]:
the illness-focused group (guarding, resting and asking
for assistance), the wellness-focused group (task persis-
tence, relaxation, exercise/stretching and coping self-
statements), and a neutral group (seeking social sup-
port). Most of our results are concordant with previous
studies, but there are also some incoherent results.
Relaxation was associated with a greater number of
symptoms and worse general health; the exercise/stretch
strategy only contributed to explaining one positive vari-
able; and the coping self-statements only contributed to
explaining two. Unfortunately, these results are usual
when presumably adaptive strategies are sought, and a
series of studies has shown they are only weakly or
Table 2 Hierarchical regression analyses examining
prediction of Pain, Number of symptoms, General
functioning, Fibromyalgia impact, Anxiety and
Depression after controlling for Coping strategies
Predictor b (final) ΔR2 p < R2
Pain
1. Task persistence -0.15 0.11 0.001
Resting 0.09 0.051 0.01 0.16
2. Activity engagement -0.22 0.050 0.01
Pain willingness -0.19 0.030 0.01 0.24
Number of symptoms
1. Relaxation 0.26 0.074 0.001 0.07
2. Activity engagement -0.17 0.032 0.01 0.10
Impact
1. Resting 0.25 0.28 0.001
Guarding 0.17 0.058 0.001
Task persistence -0.01 0.028 0.01 0.37
2. Activity engagement -0.42 0.11 0.001 0.49
Physical functioning
1. Guarding -0.24 0.18 0.001
Task persistence 0.13 0.064 0.01 0.24
2. Activity engagement 0.26 0.066 0.001
Pain willingness 0.16 0.024 0.05 0.33
General health
1. Guarding -0.18 0.083 0.001
Coping self-statements 0.29 0.089 0.001
Relaxation -0.18 0.033 0.05
Exercise/Stretch 0.13 0.025 0.05 0.23
2. Pain willingness 0.23 0.067 0.001
Activity engagement 0.20 0.032 0.05 0.33
Vitality
1. Resting -0.30 0.16 0.001 0.16
2. Activity engagement 0.22 0.043 0.001 0.20
Social functioning
1. Resting -0.17 0.13 0.001
Task persistence 0.05 0.041 0.01
Guarding -0.14 0.021 0.05
Seeking social support 0.16 0.028 0.05 0.22
2. Activity engagement 0.35 0.084 0.001 0.30
Anxiety
1. Resting 0.13 0.11 0.001
Task persistence -0.08 0.032 0.05 0.15
2. Pain willingness -0.21 0.056 0.01
Activity engagement -0.22 0.031 0.05 0.23
Depression
1. Resting 0.22 0.15 0.001
Task persistence -0.08 0.070 0.001
Coping self-statements -0.18 0.041 0.01 0.26
2. Activity engagement -0.35 0.080 0.001 0.34
Note: Pain was assessed with a 100 mm visual analogue scale, Number of
symptoms with standardised symptom checklist, General functioning with
some of the SF-36 subscales, the Fibromyalgia impact with the FIQ, and
Anxiety and Depression with the HADS.
In these analyses, the eight Coping scale scores were tested for entry (p < .05)
and removal (p > 0.10) on initial steps based on statistical criteria. After
Coping scores meeting criteria were selected, the Acceptance scores were
similarly tested for entry.
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inconsistently related to functioning [40-42]. Further-
more, as in previous studies regarding coping strategies
[25,29], our results show types of patient behaviour that
lead to more suffering and poor functioning and not the
types of patient behaviour that lead to less suffering and
better functioning. For example, strategies such as
guarding or resting seem to be reliable in predicting
poor wellbeing. However, there is one behavioural cop-
ing subscale that predicted good functioning consis-
tently–task persistence–and this is also in agreement
with previous studies [18,29].
From a traditional medical approach, it is assumed
that good strategies need to be identified and targeted
in order to improve outcome treatment. Although well
intended, such approach shows that it is difficult to con-
clude which type of strategies are adaptive without tak-
ing into account the context. It might be appropriate to
interpret the strategy in light of the intention, avoidance
or non-avoidance. Strategies aimed at reducing symp-
toms (e.g., relaxation) or fibromyalgia impact (e.g., as
resting or guarding) as well as at avoiding unwanted pri-
vate thoughts, feelings and sensations are generally asso-
ciated with a poorer general functioning. Conversely,
strategies that are focused on proceeding despite symp-
toms–tolerance for symptoms–paradoxically are asso-
ciated with less symptoms, less fibromyalgia impact, less
distress, and better general functioning. Therefore, it
seems that in chronic conditions, where the psychologi-
cal area is of great importance, the acceptance-based
approach is highly recommendable.
The results obtained here are limited mainly due to
the cross-sectional design of the study: correlation
methods cannot unambiguously infer a causal relation-
ship. Additional research should compare acceptance
scores and coping methods in an experimental pain
situation [43]. Second, the list of coping questionnaires
validated in Spanish is limited. The domain of coping
was sampled with the contents of only one inventory,
the CPCI. Other inventories exist that conceptualise
pain coping strategies in different ways with potentially
different results. Furthermore, to obtain a more repre-
sentative sample, specifically of the male gender, it
would be desirable for subsequent studies to use larger
samples. Finally, another possible limitation could be
that the sample in this study was a non-treatment-
seeking population whose pain duration was longstand-
ing. It is therefore possible that this sample of
fibromyalgia patients may have responded differently
from others.
Conclusions
The main conclusion of the present study is that the
coping-behaviours strategies often targeted within treat-
ments have not been shown to be related to outcomes
as predicted. Additionally, acceptance measures may
offer more utility in guiding treatment. It seems wise,
therefore, for targets of intervention to focus not only
on what the clients must accomplish but also on how
Table 3 Hierarchical regression analyses examining
prediction of Pain, Number of symptoms, General
functioning, Fibromyalgia impact, Anxiety and
Depression after controlling for Acceptance of pain
Predictor b (final) ΔR2 p < R2
Pain
1. Activity engagement -0.25 0.17 0.001
Pain willingness -0.22 0.041 0.01 0.21
2. Task persistence -0.17 0.022 0.05 0.23
Number of symptoms
1. Activity engagement -0.17 0.040 0.01 0.04
2. Relaxation 0.26 0.067 0.01 0.10
Impact
1. Activity engagement -0.42 0.38 0.001
Pain willingness -0.06 0.024 0.05
2. Resting 0.23 0.071 0.001 0.40
Guarding 0.17 0.021 0.05 0.49
Physical Functioning
1. Activity engagement 0.33 0.22 0.001
Pain willingness 0.16 0.038 0.01 0.26
2. Guarding -0.25 0.054 0.01 0.31
General health
1. Activity engagement 0.23 0.17 0.001
Pain willingness 0.26 0.060 0.01 0.24
2. Coping self-statements 0.25 0.043 0.01
Guarding -0.17 0.024 0.05 0.30
Vitality
1. Activity engagement 0.20 0.13 0.001
Pain willingness 0.11 0.031 0.05 0.16
2. Resting -0.27 0.057 0.01 0.21
Social functioning
1. Activity engagement 0.41 0.24 0.001 0.24
2. Resting -0.19 0.030 0.05 0.27
Anxiety
1. Activity engagement -0.31 0.15 0.001
Pain willingness -0.25 0.057 0.01 0.21
Depression
1. Activity engagement -0.38 0.26 0.001 0.26
2. Resting 0.23 0.035 0.01
Coping self-statements -0.19 0.038 0.01 0.33
Note: Pain was assessed with a 100 mm visual analogue scale, Number of
symptoms with a standardised symptom checklist, General functioning with
some of the SF-36 subscales, the Fibromyalgia impact with the FIQ, and
Anxiety and Depression with the HADS.
In these analyses, the two Acceptance of pain scores were tested for entry (p <
.05) and removal (p > 0.10) criteria. The eight Coping scale scores were tested
for entry or removal on subsequent steps based on the same statistical criteria.
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one can encourage them to accomplish the necessary
tasks. Acceptance-based interventions seem to promote
a motivational context that makes it easier for the client
to move forward. There are ongoing studies in this area
trying to re-appraise some of the coping responses
defined as adaptive within current psychological frame-
works [44-46]. Additional research is needed to clarify
the processes underlying the acceptance-based strategies.
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Currently, it is widely acknowledged that fibromyalgia is a complex condition involving 
pathophysiological, psychological, emotional and environmental factors. Concerning the 
psychological area, a much scientific literature is focused on optimizing psychological interventions. 
One suggested way to improve the treatment efficacy is to better match treatments to patient’s 
characteristics. Matching research requires careful examination of patient characteristics, treatment 
components, and patient-treatment interactions. Baron and Kenny (1986) clearly distinguish 
between moderators and mediators when studying associations between two variables. Briefly, 
moderators provide the answer to the question "In what circumstances does a treatment effect 
appear?" whereas mediators are concerned with the question "How does treatment work?" 
Moderators are looked for when the association is unexpectedly absent or weak. Mediators are 
examined when the researcher wants to examine the intermediate variables by which the 
association can be explained. Thus, it is proposed to classify dimensions of the treatment process 
as mediator or moderator variables (Vlaeyen & Morley, 2004). In therapy research, moderator 
variables partition the independent variable into subsets, of which some strengthen the 
effectiveness of the treatment while others do not. In fact, moderators may be common to several 
treatments. Potential moderators are dose of treatment, therapist’s skilfulness and competence, and 
patient expectancies about the treatment. Mediators are intervening variables that produce the 
relationship between the treatment and the outcome, and which are unique to the treatment 
associated with a specific match. Characteristic of mediator variables is that they account for 
greater variation in the dependent variable than the independent variable does. Crucial for the 
identification of mediators is an advanced insight into the mechanisms of change of the treatment 
studied. 
The mediators role has been the centre of this thesis. Some of the contemporary mediators 
that have been pointed out by researchers as core targets of intervention in the field of pain include 
catastrophizing, acceptance, mental defeat, injustice, mindfulness or psychological flexibility. 
Specifically, this thesis will evaluate the role of two specific mediators - catastrophizing and 
acceptance, which seem essential in the field of chronic pain - in association with multiple 
outcomes. But at the time of starting this thesis, none of them had its own Spanish adaptation, nor 
was there any paper in existence relating to them in our country, clearly a lack in development. For 
this reason, the thesis was also carried out to provide and promote psychological research on 
chronic pain (Fibromyalgia) in Spain  
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4.1 Validations of the Spanish versions of the PCS and CPAQ in fibromyalgia 
A large body of research has recently been devoted to the development of psychological 
constructs questionnaires in the field of pain. Such questionnaires are increasingly used in clinical 
trials (Alda et al., 2011; Dahl, Wilson & Nilsson, 2004) to determine the impact of psychological 
interventions on quality of life in chronic pain patients. Without exception, all the measures so far 
developed are in the English language and are intended for use in English-speaking countries. 
There is nonetheless a need for measures specifically designed to be used in non English-speaking 
countries and also among immigrant populations, since cultural groups vary in disease expression 
and in their use of various health care systems. This need has become more acute with the growing 
number of large multicentre multicountry trials.  
In order to meet that need, two options are available: (1) to develop a new measure, and (2) 
to use a measure previously developed in another language. The first option, the generation of a 
new questionnaire is a time consuming process in which the bulk of the effort is devoted to the 
conceptualization of the measure and the selection and reduction of its items. In the second option, 
if the transposition of a measure from its original cultural context is done by simple translation it is 
unlikely to be successful because of language and cultural differences (Berkanovic, 1980). 
Furthermore, the perception and the ways in which health problems are expressed vary from culture 
to culture (Kleinman, Eisenberg & Good, 1978). To be successful this option requires a systematic 
approach to the translation and to the cross-cultural adaptation process of the questionnaires.  
We proceeded to validate and adapt the Pain Catastrophizing Scale (Sullivan, Bishop & 
Pivik, 1995; PCS) and the Chronic Pain Acceptance Questionnaire (McCracken, Vowles & 
Eccleston, 2004; CPAQ). Once we obtained permission from the original authors, we followed the 
usual guidelines for cross-cultural adaptations (Translation, Back-translation, Committee review, 
Pre-testing) (Guillermin, Bombardier & Beaton, 1993). In summary, the psychometric properties of 
the Spanish validated version of the PCS as well as the CPAQ, were adequate. The Scree plot 
indicated the same number of factors as the original English versions. Principal Components with 
Varimax Rotation revealed a satisfactory percentage of Total Variance explained by the two 
psychological constructs. Looking at the Component Matrix, individual items could be allocated to 
the same subscales as in the English version. In addition, face validity, internal consistency and 
test-retest reliability, fulfilled criteria established. Therefore, construct validity of the translated 
versions can be supported. 
Catastrophizing and acceptance have proven to be key targets of treatment in chronic pain 
approaches and results regarding both of them are consistent with previous findings. Specifically, 
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we have found that catastrophizing is positively related to the reported severity of pain, anxiety, 
depression, disability and worse general functioning and health status. Contrarily, greater 
acceptance of chronic pain was associated with less severity of pain, number of symptoms, anxiety, 
depression, disability and better general health, vitality and physical and social functioning.  
In conclusion, these studies will make it possible to assess catastrophizing and acceptance 
in Spanish populations. Furthermore, the validation of these two questionnaires widely used 
throughout the world, will be invaluable for monitoring the effectiveness of treatments. Finally, these 
results add support to the importance of both as treatment mediators. It seems that neither of these 
constructs appears to dominate over the other, both contribute. However, it is expected that one of 
them will be the stronger predictor depending on the treatment model utilized. It might be 
catastrophizing using a CBT approach but acceptance under an ACT intervention. 
4.2 Catastrophizing 
Patients who fail to significantly improve with treatment often share common personality 
characteristics, including neuroticism, anxiety, external locus of control, negative affectivity, and a 
cognitive set referred to as catastrophizing (Affleck, Tennen, Urrows, & Higgins, 1992; Asghari & 
Nicholas, 1999; Gatchel & Weisberg, 2000). Catastrophizing refers to an exaggerated negative 
mental set brought to bear during the experience of pain (Sullivan et al., 2001). Individuals who 
catastrophize expect the worst from their pain problem, ruminate about pain sensations, and feel 
helpless about controlling their pain. It is not surprising that these individuals have a poor 
adjustment to pain as compared to patients who are not burdened by such maladaptive cognitions. 
CBT is one of the most prevalent treatments for patients with fibromyalgia. Multimethod 
CBT typically consists of a combination of various therapeutic elements, such as cognitive 
restructuring, pain-coping skills, problem-solving techniques, goal setting, increasing activity levels, 
activity pacing, stress management and adjustment of pain-related medication, and frequently also 
comprises educational and relaxation components. 
It is apparent that CBT intervention has a limited effect on the outcome measures, namely, 
pain, disability and mood. Only a few studies have shown improvement after CBT methods and 
techniques, and even then the positive effects frequently disappeared in the long run. But, the 
outcomes might be improved if more targeted psychological interventions are used. So we planned 
two studies focused on targeting aspects related to catastrophzing. The first, aims at one specific 
cognitive variable (rumination). The second, goes for the possible role of the contextual factors 
(stages of chronicity). 
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4.2.1 Imagined Exposure as treatment of catastrophzing in fibromyalgia: a pilot study    
Catastrophizing is a relevant mediator of CBT treatment and it is characterized by 
rumination, magnification and helplessness. Of these three components, the one which has the 
most consistent relationship with pain intensity is rumination. That is, the recurrent character of 
these thoughts plus their negative aspect is that which is associated with greater pain and worse 
functioning. Indeed, chronic pain generates a wide range of fears, not just those relating to pain, 
injury, and disability but also ones relating to future possible health status. When we worry, we 
engage in ruminative self-talk (private or public) that is typically about threat to self in the future. 
Worry is thought to be functional because it maintains a vigilance for a real or perceived threat to 
self in the future (“I have to keep in mind”) and promotes problem-solving to remove the threat or 
avoid its consequences (“I must do something about that”). Chronic pain patients, however, report 
unsurprisingly that they worry more about pain and their health than any other topic, and that they 
experience these worries as highly intrusive, unpleasant, and difficult to diminish (Eccleston, 
Crombez & Aldrich, 2001). Despite the aversive experience of worry, they find it difficult to stop. 
Patients report worrying about who they will be in the future and their ability to change the 
seemingly inevitable consequences of chronic pain. It seems that what may characterize chronic 
pain patients is the extent to which they persevere in unsuccessful attempts to solve insoluble 
problems (van den Hout et al. 2003).  
The main approach developed to treat ruminations from the CBT perspective is Thought 
Stopping. This technique is a form of aversion training that is based on the assumption that the 
introduction of an aversive stimulus will produce a response that is different from the undesirable, 
habitual emotional response (e.g. anxiety) (Wolpe, 1973). In the thought stopping procedure, the 
therapist yells “stop!” or delivers a painful shock when the individual signals that an unwanted 
thought has appeared. However, major criticism of thought stopping has been raised based in later 
research. Research has consistently found an ironic effect, such that suppression is associated with 
more frequent thought occurrences and more distress over thoughts (Ehlers & Clark 2000). 
Rumination has been related to greater negative affect and depressive symptoms, negatively 
biased thinking, poor problem-solving, impaired motivational and inhibition of instrumental behavior 
and impaired concentration and cognition.  
Therefore, we proposed a different technique for rumination treatment known as Imaginal 
Exposure, and it is based on the same principles as in vivo exposure. In vivo exposure involves 
graduated exposure to the upsetting stimulus itself. The goal is to repeatedly activate all the fear 
structures (e.g. memories, emotion, cognition) without allowing avoidance or escape behaviors until 
the anxiety decreases on its own. Salkovskis and Westbrook (1989) developed an exposure 
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procedure for obsessions-ruminations that are accompanied by a covert (i.e., mental), rather than 
overt compulsive act in which the rumination is repeated on audiotape. The tape is fixed in a loop 
so that repeats itself. In this manner the individual is exposed to the rumination without having the 
opportunity of using mental ritual. The crucial aspect of the exposure in treatment of ruminations is 
that the individual be fully aware of all details of the scene and, the exposure session not be 
terminated until there has been a significant reduction in anxiety. Treatment outcome studies 
suggest that imaginal exposure treatment is effective for ruminations relative to other psychological 
techniques, with high end state functioning observed in 40-60% of individuals (Craske, 2000). 
The manual specifically designed to reduce catastrophizing and proposed by Thorn was 
used for the treatment (Thorn, 2004). This is a 10 session CBT to which we added one additional 
session. Session 1: the connection between stress and pain. Session 2: identification of automated 
thoughts. Session 3: evaluation of automated thoughts. Session 4: questioning the automatic 
thoughts and constructing alternatives. Session 5: nuclear beliefs. Session 6: nuclear beliefs on the 
pain. Session 7: changing the coping. Session 8: coping with ruminations-obsessions-worrying. 
Session 9: expressive writing. Session 10: assertive communication. Session 11: final session. 
 
The session added corresponds to number 8, after beginning with the coping section. This 
is especially directed at subjects who show high rumination and consisted in instructing the patients 
to write a story about the worse possible scenario imaginable for the future based on their greatest 
fear, stressing those aspects that would generate the greatest emotional malaise (How do you see 
yourself in this situation? What do you think?, How do you feel?, etc.). The story is recorded on a 
tape for subsequent presentation to the patient. It is then recommended to them that they should 
listen to this story between 30 and 60 minutes (enough time for them to become accustomed) until 
said story no longer causes anxiety (in general between 10 and 15 sessions of exposure). 
 
Results from our study cannot be conclusive as it was conceived as a pilot study. 
Nevertheless it allows us to extract some ideas. Firstly, CBT seems to be an adequate approach to 
reduce catastrophizing. Results indicated that participants not only improved in catastrophizing but 
also reported reductions in pain intensity, anxiety, depression and disability. Secondly, this study 
would support the fact that despite some literature available defending catastrophizing as a 
personality trait, and therefore stable, catastrophizing might be susceptible to being altered by CBT. 
Thirdly, although rumination could potentially be a crucial subscale, it is not always the most intense 
so it would not be recommendable to incorporate imagined exposure for every case. Finally, 
patients usually report their ruminations as less frequent, intense, or distressing after the imaginal 
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exposure, consequently this technique might be highly recommended in those cases where 
rumination clearly predominates.  
4.2.2 Stages of chronicity in fibromyalgia and catastrophizing: a cross-sectional study 
Regarding the contextual factor, we can see that in recent years, considerable research has 
addressed the role of psychological factors in the development of disability (Boersma& Linton, 
2006; Denison, Asenlof & Lindberg, 2004; McCracken & Gutierrez, 2011; Tang et al., 2010; 
Vlaeyen & Linton, 2012; Vowles, McCracken & O´Brien 2011). This literature has revealed that a 
variety of cognitive and affective variables play a significant role in determining the severity of pain-
related disability. However, there has been little attention given to how contextual factors associated 
with persistent pain might interact with vulnerability factors in contributing to pain-related disability.  
The study of contextual determinants of psychological vulnerability in persistent pain disorders 
holds promise in contributing to the refinement of theoretical models on the relationship between 
psychology and pain and may also contribute to the development of interventions that can be 
tailored to meet specific patient needs (Sullivan, Sullivan & Adams, 2002).  
The objective of this research was to examine whether duration of chronicity interacted with 
psychological vulnerability factors in determining the severity of pain-related disability (i.e. activity 
limitations due to pain measured by the Fibromyalgia Impact Questionnaire). For the purposes of 
this research, duration of chronicity was defined as the length of time the individual had been 
diagnosed with fibromyalgia. “Catastrophizing” was chosen as the psychological vulnerability factor 
for study. 
When a fibromyalgia patient principally attends the state health centre things usually occur very 
differently from that expected. The patient comes to the pain unit because pain and tiredness have 
stopped him from working or functioning generally. Most of the patients do not get better following 
the usual treatment and their pain and disability do not improve. Apart from ineffective treatments, 
their prognosis will depend on the practitioner (pro- or anti-fibromyalgia) who attends (Muller & 
Stratz, 2004; Gralow, 2004). Often these individuals undergo several diagnostic procedures, are 
referred to different specialists and later are treated with suspicion, questioning the authenticity of 
the disability due to the fact that they are not improving as expected.  
Under these circumstances, the potential importance of duration of chronicity as a contextual 
determinant of pain-related disability can be very different. In the early stages, there may be 
considerable uncertainty about the underlying basis of pain symptoms and the medical 
prognosis and the patient is probably going to be worried about the potential loss of function, 
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independence and financial security. However, in a later stage, it is likely that after repeated 
failures in diagnostic procedures and treatment interventions, the fibromyalgia patient is prone 
to expect less in the resolving of their symptoms, treatment outcome and, in many cases, the 
early worries about possible losses will have changed into reactions about actual losses.  
The findings in our study provide preliminary evidence that the psychological correlates of pain-
related disability change over time in fibromyalgia. Specifically, regression analyses revealed that 
stage of chronicity moderated the relationship between the PCS subscales and disability. In the 
group of patients who had been diagnosed with fibromyalgia for less than 2 years, rumination 
accounted for significant unique variance in disability. Magnification and helplessness predicted 
disability over and above the variance accounted for pain severity for patients who had been 
diagnosed for 2-4 years, and helplessness was the strongest predictor of disability in the group of 
patients diagnosed for more than 4 years. 
These findings are consistent with a pattern of results that has emerged in previous research in 
different pathologies. For example, Sullivan et al. (1998) reported that the rumination subscale of 
the PCS was the best predictor of severity of disability in patients who had been experiencing 
chronic pain for approximately 3 years. Vienneau, Clark, Lynch & Sullivan (1999) reported that the 
helplessness subscale of the PCS was the best predictor of severity of disability in patients who had 
been experiencing for approximately 9 years. Although differences in sample composition limit the 
conclusions that can be drawn from these studies, the pattern of results is nevertheless consistent 
with the present findings and supports the view that chronicity may be an important moderator of 
psychological vulnerability for pain-related disability. In summary, the results suggest that 
interventions that consider stage of chronicity as a moderator of vulnerability for pain-related 
disability may yield more positive outcomes than standardized approaches to the management of 
fibromyalgia.  
There is increasing research indicating that patients with fibromyalgia cannot be considered a 
homogeneous group (Turk, 2005; Turk, Okifuji, Sinclair & Starz, 1998; Turk & Rudy, 1988). 
Fibromyalgia patients differ with respect to the etiology and course of their pain symptoms and, 
more importantly, they differ with respect to the areas of psychological and social functioning that 
are likely to be affected by their pain condition. The time may be approaching when assessment 
protocols can be developed to yield profiles of psychological vulnerability and dysfunction in 
fibromyalgia patients that will permit the administration of individually tailored intervention programs. 
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4.3 Relationship between behavior coping strategies and acceptance in patients with 
fibromyalgia syndrome: Elucidating targets of interventions. 
Although chronic pain can lead to dysfunction among some individuals, others appear to 
adjust relatively well to the ongoing experience of pain. For example, even though the prevalence of 
depression is substantially higher in chronic pain patients than in groups of individuals without pain, 
the majority of chronic pain patients are not clinically depressed (Love, 1987). Even in the most 
dysfunctional group of chronic pain patients, those referred to pain clinics, studies have found that 
only about one-third meet standard diagnostic criteria for major depression (Turner & Romano, 
1984). Similarly, while inactivity and disability are commonly seen in chronic pain patients, many 
individuals can learn to function fairly normally despite the presence of chronic pain (Doleys, 
Crocker & Patton, 1982; Fordyce, 1976). Finally, many individuals in the general population 
experience pain frequently, yet continue to work productively and rarely seek medical assistance 
(Taylor & Curran, 1985). Because chronic pain is not synonymous with disability and depression, it 
is important to identify the factors which promote adaptive functioning in the face of pain. 
Models of stress and coping may be useful in explaining adjustment differences among 
chronic pain populations (Turner, 1991). Using such models as a conceptual base, a number of 
researchers have developed several self-report measures of cognitive or behavioral coping 
strategies. The pain coping measure most widely used in studies of adults with non-specific chronic 
pain syndromes (e.g. chronic musculoskeletal pain) is the Coping Strategies Questionnaire (CSQ; 
Rosenstiel & Keefe, 1983), which has been found to be associated consistently with adjustment to 
chronic pain (Lester, Lefebvre & Keefe, 1996). 
The CSQ as well as most studies regarding coping with chronic pain are focused on 
teaching individuals strategies to control or eliminate pain in a broad range of forms, including 
thought suppression, imaginative distraction, sensory attention, emotional or mood manipulations, 
and stress inoculation. Unfortunately, it has been difficult to reliably identify specific, adaptive, 
coping responses. For example, whilst methods such as increasing activities, engaging in exercise, 
using distraction, or practicing relaxation are presumed to be adaptive, a series of studies has 
shown they are only weakly or inconsistently related to functioning (Jensen, Turner & Romano, 
2007). These findings illustrate a significant issue - in essence, if the processes assumed to 
determine the effectiveness of the treatment have not held up under empirical scrutiny, alternative 
processes must be considered.  
On the other hand, there are a small number of empirical studies that have demonstrated a 
positive association between acceptance and successful adaptation to chronic pain. Jacob et al. 
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(1993) reported that people who accommodate to pain, defined as the ability to live a satisfying life 
despite chronic pain, demonstrated less depression and less overt pain behavior. Schmitz et al. 
(1996) have shown that pain patients who modify unachievable goals or substitute more achievable 
ones (accommodation) report less pain-related suffering. McCracken (1998) found that patients with 
more accepting responses to chronic pain showed better adjustment as measured by the self-report 
of depression, anxiety, and disability. In a similar and more recent study McCracken et al. (1999) 
found that accepting pain was the most powerful predictor of whether patients are classified as 
dysfunctional or adaptive copers, independent of pain intensity or depression. 
Therefore, we proposed a study to replicate and extend the findings of earlier comparisons 
of coping and acceptance approaches to chronic pain using a different coping questionnaire this 
time. Previous studies used coping questionnaires based on cognitive strategies (CSQ) but there is 
a limitation because these measures rely on the observation and report of thoughts or attempts to 
change thoughts (McCracken & Eccleston, 2003; 2006). This time, coping strategies derived from 
behavioral strategies would be applied. The Chronic Pain Coping Inventory (CPCI; Jensen et al., 
1995) was developed to assess behavioral and cognitive pain coping strategies such as exercise, 
guarding, resting and coping self-statements that are targeted as part of many multidisciplinary pain 
management programs. The purpose of this study was to compare acceptance and behavioral 
coping in predicting adjustment to chronic pain as measured by anxiety, depression, pain, number 
of symptoms, disability, physical functioning, general health, vitality and social functioning. 
As we predicted, results confirmed that acceptance of pain can still account for more 
variance than various measures of behavioral coping, in a range of important measures of distress 
and patient functioning. This study also demonstrated that coping behaviors strategies have not 
been shown to be related to outcomes in the way we assumed they would. For example, relaxation 
was associated with a greater number of symptoms and worse general health. Finally, this study 
also helps us to clarify misconceptions about acceptance as an act of resignation or surrender. As 
we can see from the results, acceptance has nothing in common with strategies such us guarding, 
resting or relaxation and means much more. Those patients who accept chronic pain are not 
passive, they engage in daily activities, feel efficacious, and are motivated to complete their 
activities. In conclusion, acceptance measures may offer more utility in guiding treatment. Item 
content directly fits a positive and activity orientated treatment approach of exposure and behavioral 
activation and seems to promote a motivational context which makes it easier for the patient to go 
ahead. 
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4.4 Limitations 
The results obtained here are limited mainly due to the cross-sectional design of the study: 
correlation methods cannot unambiguously infer causal relationship. However, given the consistent 
relationship between psychological constructs (catastrophizing and acceptance) and pain outcomes, 
it is clear that there are important processes at work. Experimental, longitudinal, or clinical methods 
are needed to illuminate these processes. Secondly, in order to obtain a more representative 
sample, specifically of the male gender, it would be desirable if subsequent studies used larger 
samples. Another possible limitation could be the recruiting methods. Sometimes half of the 
subjects were recruited from a specialised clinic and for the others the study was based on a non 
treatment-seeking population whose pain duration was longstanding. It is therefore possible that 
these samples of fibromyalgia patients may have responded differently.  
Finally, depending on the study, there are specific limitations concerning each one. For example, 
in the study regarding the stages of chronicity, one of the main difficulties that fibromyalgia patients 
face is failure to receive the diagnosis until well after the onset of the disease. It is estimated that 
there is a 3 year delay in Spain. Therefore, it is possible that some of the subjects in this research 
who were classified as being in one of the earlier stages of chronicity had actually been suffering 
from pain for some time previously; regarding the study about acceptance and coping, the list of 
coping questionnaires validated in Spanish is limited. We sampled the domain of coping with the 
contents of just one inventory, the CPCI. Other inventories exist that conceptualize pain coping 
strategies in different ways with potentially different results.  
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1. Validation process: 
 
Both psychometric properties of the Spanish validated versions of the Pain Catastrophzing 
Scales and the Chronic Pain Acceptance Questionnaire are adequate. The Scree plot 
indicated the same number of factors as the original English versions. Principal 
Components with Varimax Rotation revealed a satisfactory percentage of Total Variance 
explained by the two psychological constructs. Looking at the Component Matrix, individual 
items could be allocated to the same subscales as they were in the English version. 
Therefore, construct validity of the translated versions can be supported. 
 
2. Regarding Catastrophizing 
 
2.1 Cognitive-behavioral treatment targeting reduction of catastrophizing for fibromyalgia 
reduced negative cognitive and affective variables. Furthermore, Imagined Exposure 
technique might contribute to enhance the improvement in those cases where the 
ruminations scores are emphasized. 
 
2.2 The influence of catastrophizing on global functioning in fibromyalgia patients is 
variable and dependent on the context (i.e., duration of diagnosis) in which the 
catastrophizing thoughts occur. Therefore, this issue should be taken into account by 
tailoring psychological interventions. 
 
2.3  Specifically, regression analyses revealed that rumination accounted for significant 
unique variance in FM impact in the group of patients who had been diagnosed with 
FMS for less than 2 years; Magnification and helplessness predicted FM impact over 
and above the variance accounted for pain severity for patients who had been 
diagnosed for 2-4 years, and helplessness was the strongest predictor of FM impact in 
the group of patients diagnosed for more than 4 years. 
 
2.4  Catastrophizing was a stronger predictor of global functioning than pain itself for the 
three different stages of chronicity and the catastrophizing remained constant over time, 
despite the fact that fibromyalgia impact increased. 
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2.5 These findings suggest that not only is the type of intervention important but also the 
timing of the treatment. The results accentuate the significance of early detection and 
treatment of patients who are at risk of developing fibromyalgia and related problems. 
Intervening early in the course of a pain condition may help prevent maladaptive 
patterns of pain coping and illness behaviours that are resistant to treatment, and it 
may have the potential to reduce or prevent the negative impacts of fibromyalgia that, 
in turn, will reduce societal and medical costs.  
 
2.6 If patients with fibromyalgia were to be subdivided consistent with their distinctive 
contextual cognitive and behavioural patterns, and if interventions were subsequently 
modified to match these specific risk profiles, the efficacy of psychological treatment 
programs could be substantially advanced. 
 
 
3. Regarding Acceptance: 
 
3.1 Acceptance of chronic pain predicted adjustment to chronic pain better than    
behavioural coping strategies in fibromyalgia patients. 
 
3.2 A greater acceptance of chronic pain in fibromyalgia patients was associated with less 
pain, symptoms, fibromyalgia impact, anxiety, and depression as well as with better 
general health, vitality and physical and social functioning. 
 
3.3 Our results found that most of the behavioural coping strategies showed types of 
patient behaviour that lead to more suffering and poor functioning. In turn, acceptance 
of pain components, showed the types of patient behaviour that lead to less suffering 
and better functioning. 
 
3.4 The coping behaviours strategies often targeted within psychological treatments have 
not been shown to be related to outcomes as predicted. Additionally, acceptance 
measures may offer more utility in guiding treatment. 
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1. Proceso de validación: 
 
Las propiedades psicométricas de los dos cuestionarios validados, la escala de 
catastrofización ante el dolor (Pain Catastrophzing Scales; PCS) y el cuestionario de 
aceptación del dolor crónico (Chronic Pain Acceptance Questionnaire; CPAQ) resultaron 
adecuadas.  
 
2. Catastrofismo: 
 
2.1 El Tratamiento Cognitivo-Conductual parece adecuado para reducir la frecuencia de 
los pensamientos catastrofistas y la mejora en la calidad de vida de los pacientes. 
Además, la técnica de exposición en imaginación podría ser recomendable para 
aquellos pacientes caracterizados por una notable rumiación. 
 
2.2 La influencia del catastrofismo en el funcionamiento general de los pacientes con 
fibromialgia es variable y depende del contexto en el que se dan los pensamientos 
catastrofistas (ej. tiempo desde el diagnóstico). Por tanto, esta cuestión debería ser 
tenida en cuenta para dirigir adecuadamente las intervenciones psicológicas  
 
2.3 En concreto, el análisis de regresión mostró que era la subescala de rumiación la que 
mejor explicaba la discapacidad de los pacientes que habían sido diagnosticados de 
fibromialgia en un periodo menor a 2 años. En el grupo de pacientes que habían sido 
diagnosticados de fibromialgia en un periodo de entre 2 y 4 años, fueron las 
subescalas de magnificación e indefensión. Por último, la escala de indefensión fue el 
predictor más robusto en el grupo de pacientes que habían sido diagnosticados en un 
periodo mayor a 4 años. 
 
2.4 En los tres estadios, el catastrofismo predijo mejor el funcionamiento global del 
paciente que la intensidad de dolor. Además,  a pesar de que la discapacidad de los 
sujetos tendía a incrementarse con el tiempo, el indicador del catastrofismo se 
mantenía constante. 
 
Conclusiones 
 
“AFFECTIVE AND COGNITIVE ASPECTS IN FIBROMYALGIA: THE ROLES  OF CATASTROPHIZING AND ACCEPTANCE” 118 
 
2.5 Estos resultados resaltan la importancia de una intervención temprana en pacientes 
con fibromialgia que pudiera prevenir patrones de afrontamiento desadaptados. Esto 
se traducirían una reducción de costes futuros tanto médicos como sociales.  
 
2.6 La eficacia de los programas de tratamiento psicológico podrían mejorar 
sustancialmente si clasificáramos a los pacientes de fibromialgia según sus 
características conductuales y cognitivas y las intervenciones se dirigiesen 
específicamente a esas variables de riesgo. 
 
 
3. Aceptación: 
 
3.1 La aceptación del dolor crónico predijo mejor que las estrategias de afrontamiento 
conductuales la adaptación al dolor crónico. 
 
3.2 Una mayor aceptación del dolor crónico en los pacientes con fibromialgia estuvo 
asociada con menor dolor, número de síntomas, ansiedad, depresión, discapacidad y 
mejor estado de salud general, vitalidad y funcionamiento tanto físico como social.  
 
3.3 Nuestros resultados mostraron que la gran mayoría de estrategias de afrontamiento 
conductuales (ej; relajación, descanso, pedir ayuda) parecen conducir a mayor 
sufrimiento y un pobre funcionamiento. En cambio, los dos componentes de la 
aceptación mostraron tipos de de conducta que conducen a un menor sufrimiento y un 
mejor funcionamiento. 
 
3.4 Las estrategias de afrontamiento conductuales que a menudo son objetivos de 
tratamientos psicológicos parecen no relacionarse con los resultados de la manera que 
se esperaban. Los componentes de aceptación parecen ofrecer mayor utilidad para 
guiar el tratamiento.  
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 Escala de Catastrofización ante el dolor. Spanish version of The Pain 
Catastrophizing Scale (PCS) 
 
 
ESCALA DE CATASTROFIZACION (PCS) 
 
Nombre:…………………………………………………………………………………   
Edad:…………… Género: …….……….   Fecha: …………………………………….. 
 
Todas las personas experimentamos situaciones de dolor en algún momento de nuestra vida. Tales experiencias 
pueden incluir dolor de cabeza, dolor de muelas, dolor muscular o de articulaciones. Las personas estamos a menudo 
expuestas a situaciones que pueden causar dolor como las enfermedades, las heridas, los tratamientos dentales o las 
intervenciones quirúrgicas. 
Estamos interesados en conocer el tipo de pensamientos y sentimientos que usted tiene cuando siente dolor. A 
continuación se presenta una lista de trece frases que describen diferentes pensamientos y sentimientos que pueden 
estar asociados al dolor. Utilizando la siguiente escala, por favor indique el grado en que usted tiene esos 
pensamientos y sentimientos cuando siente dolor. 
 
0  Nada en absoluto   1  Un poco    2  Moderadamente    3  Mucho    4 Todo el tiempo 
 
 
Cuando siento dolor... 
 
1.- Estoy preocupado todo el tiempo pensando en si el dolor desaparecerá. 
 
2.-  Siento que ya no puedo más. 
 
3.- Es terrible y pienso que esto nunca va a mejorar. 
 
4.- Es horrible y siento que esto es más fuerte que yo. 
 
5.- Siento que no puedo soportarlo más. 
 
6.- Temo que el dolor empeore. 
 
7.- No dejo de pensar en otras situaciones en las que experimento dolor. 
 
8.- Deseo desesperadamente que desaparezca el dolor. 
 
9.- No puedo apartar el dolor de mi mente. 
 
10.- No dejo de pensar en lo mucho que me duele. 
 
11.- No dejo de pensar en lo mucho que deseo que desaparezca el dolor. 
 
12.- No hay nada que pueda hacer para aliviar la intensidad del dolor. 
 
13.- Me pregunto si me puede pasar algo grave. 
 
…Total 
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 Cuestionario de Aceptación ante el dolor crónico. Spanish version of The 
Chronic Pain Acceptance Questionnaire (CPAQ) 
  
Instrucciones: A continuación, encontrará una lista de afirmaciones. Puntúe cada una de ellas haciendo un círculo en 
el número que mejor defina la frecuencia con la que dicha información es cierta para usted. Utilice la siguiente escala 
de puntuación para hacer su elección. Por ejemplo, si cree que una afirmación es “siempre cierta” para usted, deberá 
seleccionar un 6 en el espacio para su respuesta. 
 
0 1 2 3 4 5 6 
Nunca cierta 
Muy 
raramente 
cierta 
Raramente 
cierta 
A veces 
cierta 
A menudo 
cierta 
Casi siempre 
cierta 
Siempre 
cierta 
 
1. Continúo haciendo las cosas de la vida diaria sea cual sea mi nivel de dolor ……. 
2. Mi vida va bien, aunque tenga dolor crónico …… 
3. No importa sentir dolor …… 
4. Si tuviera que sacrificar cosas importantes de mi vida para controlar mejor este dolor, lo haría con 
mucho gusto …… 
5. No necesito controlar el dolor para poder llevar bien mi vida …… 
6. Aunque las cosas han cambiado, llevo una vida normal pese a mi dolor crónico … 
7. Tengo que concentrarme para poder librarme del dolor …… 
8. Hay muchas actividades que hago cuando tengo dolor …… 
9. Llevo una vida plena aunque tenga dolor crónico …… 
10. Controlar el dolor es un objetivo menos importante que otros objetivos de mi vida  
11. Antes de poder tomar decisiones importantes en mi vida, mis ideas y sentimientos hacia el dolor deben 
cambiar …… 
12. A pesar del dolor, ahora me ciño a una dirección concreta en mi vida …… 
13. Tener controlado el nivel de dolor es la primera prioridad cuando hago algo …… 
14. Antes de poder hacer planes en serio, tengo que tener algo de control sobre el dolor …… 
15. Cuando aumenta el dolor, puedo seguir ocupándome de mis responsabilidades … 
16. Podría controlar mejor mi vida si pudiera controlar mis pensamientos negativos sobre el dolor …… 
17. Evito enfrentarme a situaciones en las que el dolor pudiera aumentar …… 
18. Mis preocupaciones y miedos sobre lo que el dolor puede hacerme son auténticos  
19. Es un alivio darse cuenta de que no tengo por qué cambiar el dolor para seguir con mi vida …… 
20. Cuando tengo dolores, me cuesta mucho hacer cosas …… 
 
Puntuación: 
Disposición para las actividades = Sume los ítems 1, 2, 3, 5, 6, 8, 9, 10, 12, 15, 19. 
Aceptación del dolor = Invierta las puntuaciones de los ítems 4, 7, 11, 13, 14, 16, 17, 18, 20 y súmelas. 
Total = Disposición para las actividades + Aceptación del dolor.  
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